
<html lang="en"     class="pb-page"  data-request-id="c20d5702-59bc-4b45-bc33-f729c27029cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-9;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01581;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Fragment-to-Lead Medicinal Chemistry Publications in 2018" /></meta><meta name="dc.Creator" content="Daniel A.  Erlanson" /></meta><meta name="dc.Creator" content="Iwan J. P.  de Esch" /></meta><meta name="dc.Creator" content="Wolfgang  Jahnke" /></meta><meta name="dc.Creator" content="Christopher N.  Johnson" /></meta><meta name="dc.Creator" content="Paul N.  Mortenson" /></meta><meta name="dc.Description" content="This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties..." /></meta><meta name="Description" content="This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 8, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01581" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01581" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01581" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01581" /></link>
        
    
    

<title>Fragment-to-Lead Medicinal Chemistry Publications in 2018 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01581" /></meta><meta property="og:title" content="Fragment-to-Lead Medicinal Chemistry Publications in 2018" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0012.jpeg" /></meta><meta property="og:description" content="This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties, and ligand efficiency are discussed for the 2018 examples as well as for the combined 111 F2L examples covering 2015–2018. While the overall properties of fragments and leads have remained constant, a number of new trends are noted, for example, broadening of target class coverage and application of FBDD to covalent inhibitors. Moreover, several studies make use of fragment hits that were previously described in the literature, illustrating that fragments are versatile starting points that can be optimized to structurally diverse leads. By focusing on success stories, the hope is that this Perspective will identify and inform best practices in fragment-based drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01581"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01581">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01581&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01581&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01581&amp;href=/doi/10.1021/acs.jmedchem.9b01581" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4430-4444</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01476" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01622" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Fragment-to-Lead Medicinal Chemistry Publications in 2018</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Daniel A. Erlanson</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel A. Erlanson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +001 415 407 8080. E-mail: <a href="/cdn-cgi/l/email-protection#80e4e1eee9e5ecaee5f2ece1eef3efeec0e6f2efeef4e9e5f2ede5e4f3aee3efed"><span class="__cf_email__" data-cfemail="97f3f6f9fef2fbb9f2e5fbf6f9e4f8f9d7f1e5f8f9e3fef2e5faf2f3e4b9f4f8fa">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+A.++Erlanson">Daniel A. Erlanson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8807-4159" title="Orcid link">http://orcid.org/0000-0001-8807-4159</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Iwan J. P. de Esch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iwan J. P. de Esch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iwan+J.+P.++de+Esch">Iwan J. P. de Esch</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wolfgang Jahnke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wolfgang Jahnke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for Biomedical Research, Chemical Biology and Therapeutics, 4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Jahnke">Wolfgang Jahnke</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7003-3305" title="Orcid link">http://orcid.org/0000-0002-7003-3305</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher N. Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher N. Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+N.++Johnson">Christopher N. Johnson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8618-9729" title="Orcid link">http://orcid.org/0000-0001-8618-9729</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Paul N. Mortenson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul N. Mortenson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+N.++Mortenson">Paul N. Mortenson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3583-3163" title="Orcid link">http://orcid.org/0000-0002-3583-3163</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01581&amp;href=/doi/10.1021%2Facs.jmedchem.9b01581" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4430–4444</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 September 2019</li><li><span class="item_label"><b>Published</b> online</span>8 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01581" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01581</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4430%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniel%2BA.%2BErlanson%252C%2BIwan%2BJ.%2BP.%2Bde%2BEsch%252C%2BWolfgang%2BJahnke%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D9%26contentID%3Dacs.jmedchem.9b01581%26title%3DFragment-to-Lead%2BMedicinal%2BChemistry%2BPublications%2Bin%2B2018%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4444%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01581"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5115</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01581" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Fragment-to-Lead Medicinal Chemistry Publications in 2018&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;A. Erlanson&quot;},{&quot;first_name&quot;:&quot;Iwan&quot;,&quot;last_name&quot;:&quot;J. P. de Esch&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Jahnke&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;N. Johnson&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;N. Mortenson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;4430-4444&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01581&quot;},&quot;abstract&quot;:&quot;This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties, and ligand efficiency are discussed for the 2018 examples as well as for the combined 111 F2L examples covering 2015–2018. While the overall properties of fragments and leads have remained constant, a number of new trends are noted, for example, broadening of target class coverage and application of FBDD to covalent inhibitors. Moreover, several studies make use of fragment hits that were previously described in the literature, illustrating that fragments are versatile starting points that can be optimized to structurally diverse leads. By focusing on success stories, the hope is that this Perspective will identify and inform best practices in fragment-based drug discovery.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01581&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01581" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01581&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01581" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01581&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01581" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01581&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01581&amp;href=/doi/10.1021/acs.jmedchem.9b01581" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01581" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01581" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01581%26sid%3Dliteratum%253Aachs%26pmid%3D31913033%26genre%3Darticle%26aulast%3DErlanson%26date%3D2020%26atitle%3DFragment-to-Lead%2BMedicinal%2BChemistry%2BPublications%2Bin%2B2018%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D9%26spage%3D4430%26epage%3D4444%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/jmcmar.2020.63.issue-9/20200514/jmcmar.2020.63.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">This Perspective, the fourth in an annual series, summarizes fragment-to-lead (F2L) success stories published during 2018. Topics such as target class, screening methods, physicochemical properties, and ligand efficiency are discussed for the 2018 examples as well as for the combined 111 F2L examples covering 2015–2018. While the overall properties of fragments and leads have remained constant, a number of new trends are noted, for example, broadening of target class coverage and application of FBDD to covalent inhibitors. Moreover, several studies make use of fragment hits that were previously described in the literature, illustrating that fragments are versatile starting points that can be optimized to structurally diverse leads. By focusing on success stories, the hope is that this Perspective will identify and inform best practices in fragment-based drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><p class="first">Fragment-based drug discovery (FBDD) has become a mainstream method for discovering new biologically active compounds, with dozens of compounds in the clinic and dozens of new publications each year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The number, diversity, and distribution of these papers make it difficult to keep abreast of recent trends, so for the past 3 years we have compiled fragment-to-lead (F2L) success stories from each year into a series of Perspectives.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> This fourth installment focuses on papers published in 2018 and includes a broader discussion of general trends.</p><p>Each qualifying F2L example is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. As with previous years, each selection must meet the following criteria:<ul class="NLM_list-list_type-bullet"><li><p class="inline">Fragment hit has a molecular weight (MW) < 300.</p></li><li><p class="inline">Fragment hit originates from screening (e.g., bioassay, biophysical method, X-ray, virtual screen, or any combination thereof) or by deconstruction of a known ligand.</p></li><li><p class="inline">Potency/affinity of the lead is equal to or better than 2 μM.</p></li><li><p class="inline">The improvement in potency/affinity from fragment to lead is at least 100-fold.</p></li><li><p class="inline">The publication date (as defined by the primary citation) for the article falls within the calendar year 2018.</p></li></ul></p><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Fragment to Lead Publications from 2018<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">()</a>–<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">()</a><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">()</a><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">()</a><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">()</a><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">()</a><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">()</a><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">()</a><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">()</a><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">()</a><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">()</a><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">()</a><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">()</a><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">()</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">()</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">()</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">()</a><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">()</a><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">()</a><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">()</a><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">()</a><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">()</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">()</a><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">()</a><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">()</a><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">()</a><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">()</a><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0006.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0007.gif" alt="" id="GRAPHIC-d7e288-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0008.gif" alt="" id="GRAPHIC-d7e289-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0009.gif" alt="" id="GRAPHIC-d7e290-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0010.gif" alt="" id="GRAPHIC-d7e291-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0011.gif" alt="" id="GRAPHIC-d7e292-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">ClogP values were determined using Daylight version 4.9.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Ligand efficiency<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (LE) is expressed in units of kcal·mol<sup>–1</sup> per non-hydrogen atom and is calculated with <i>R</i> = 0.001 987 kcal·mol<sup>–1</sup>·K<sup>–1</sup> and <i>T</i> = 298 K. Standard state is assumed to be 1 M. Ligand-lipophilicity efficiency<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (LLE, also called LipE<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a>) is dimensionless, and Astex ligand-lipophilicity efficiency<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (LLE<sub>AT</sub>) has the same units as LE.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">N/A: not applicable; X-ray structure not reported or used.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">X-ray structure of a closely related compound.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">NA: LE, LLE, and LLE<sub>AT</sub> not applicable for irreversible inhibitors.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Fold change in potency is assumed to be >100 as the fragment is likely to be less potent than 200 nM based on 96% inhibition at 10 μM.</p></div></div><div></div></div><p>Inevitably, these strict criteria exclude some good FBDD stories, e.g., protein–protein interaction targets such as KRAS-PDEδ and BCL6,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> epigenetic readers such as the YEATS domain of eleven-nineteen-leukemia protein (ENL),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and kinases including PI3Kδ and Aurora A.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Some other “near-misses” that illustrate emerging concepts or trends are discussed in more detail below.</p><p>As in the three previous Perspectives, only the first instance of a fragment-to-lead program that meets the criteria is included in the summary table. So, for example, a paper discussing the further optimization of a compound that had first crossed the fragment to lead threshold prior to 2018 would not make the cut. Several of these examples will however be discussed below in the text.</p><p>Potential articles for inclusion were identified as described in detail in the last Perspective.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Briefly, SciFinder<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> was searched with a variety of terms. Articles that cited a key 2009 review were also examined.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><i>Journal of Medicinal Chemistry</i>, <i>ACS Medicinal Chemistry Letters</i>, <i>Bioorganic & Medicinal Chemistry Letters</i>, and <i>Bioorganic & Medicinal Chemistry</i> were examined in more detail as collectively they provided more than three-quarters of the entries from previous years.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Finally, 2018 articles mentioned on the Practical Fragments blog<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> were examined.</p><p>This process resulted in a manageable number of publications, each of which was carefully evaluated. Ultimately, a total of 25 papers were selected for inclusion. As was the case for both 2016 and 2017, one paper contained two F2L examples that meet the criteria (table entries 1 and 2).</p><p>The distribution of targets for 2015–2018 is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Perhaps the most striking feature is the four nontraditional FBDD targets published in 2018. Last year we noted that no ion channels and only one GPCR had been included as targets in the past 3 years. The 2018 examples encompass another GPCR (entry 23), an ion channel (entry 24), and a nuclear hormone receptor (entry 25). Fragment-based phenotypic screens also seem to be on the rise. In addition to entry 26, a phenotypic screen for <i>Leishmaniasis</i> inhibitors identified low micromolar hits, but no chemistry optimization was described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Also, a chapter in the book <i>Phenotypic Screening</i> provides a detailed description of a fragment-based phenotypic screen to find adipocyte modulators;<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> this is a follow-up to a 2017 paper.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></p><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Distribution of target class for the F2L examples from each year reviewed (27 in 2015, 28 in 2016, 30 in 2017, and 26 in 2018), as well as the total for all 111 examples from 2015 to 2018.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>One trend we noted for 2017 was a number of papers describing “warheads” that can covalently react with a target.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Boronic acids are known to form covalent bonds with serine and threonine residues in proteins,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and as the compound identified through phenotypic screening (entry 26) contains a boronic acid ester, it seems likely that this molecule may be acting covalently on one or more targets, though this modality remains to be confirmed. In addition, the 2018 set provided the first covalent lead example that unambiguously meets all the F2L criteria for inclusion (entry 4). Further optimization of this covalent BTK inhibitor is described in two additional papers.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> Other articles describing covalent screening in 2018 that did not meet the F2L criteria include a series of ketone-based inhibitors of enteroviral 3C protease<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and a rapid assay to discover irreversible CDK2 inhibitors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> These examples indicate that applying fragment-based approaches to covalent binders is an area of intensive development.</p><p>Over the past 4 years more than a quarter of F2L examples target kinases, consistent with their high representation among FBDD-derived clinical compounds.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Even so, 2018 was notable, with kinases representing 34% of the entries. The one protease in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, USP7 (entry 10), was also represented in 2017 (entry 9).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Interestingly though, the two F2L programs identified very different molecules that bind in separate allosteric sites. Fragment-derived inhibitors against a related protease, USP2a, were also described in 2018,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> though they did not meet the criteria for table inclusion.</p><p>Screening methods are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>; it is beyond the scope of this review to describe the methods in detail, but all of them are covered in a recent book.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> As in 2017, biochemical assays dominate, used in half of examples. As with last year, many of these were applied to enzymes, though three 2018 bromodomain F2L programs stemmed from biochemical assays. The past 2 years show an uptick of biochemical screens compared to 2015 and 2016, when fewer than 40% of initial hits came from such assays.</p><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Distribution of screening methods for the F2L examples from each year reviewed as well as the total for all 111 examples. Where multiple screening techniques were used in an example, each individual screen has been counted separately, so the sum of all methods is greater than 100%: Tm, thermal shift; SPR, surface plasmon resonance; DSLS, differential static light scattering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Thermal shift assays were used in just two examples in 2018 and not at all in 2017, significantly lower than observed in 2015 and 2016. Perhaps researchers are moving away from high-throughput but less easily interpretable assays.</p><p>Collectively, ligand-observed NMR and protein-observed NMR were used in just 12% of the 2018 F2L campaigns, compared to the 33% average seen for 2015–2017. However, ligand-based NMR methods still account for the second largest fraction over 2015–2018. One use of protein-observed NMR that did not meet the criteria for inclusion in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> involved magic angle spinning of the 42 kDa neonatal Fc receptor (FcRn).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Whether use of this technique is a one-off or part of a larger trend remains to be seen.</p><p>Virtual screening was used in just a few of the 2018 examples but is the fourth most prevalent technique for the full 2015–2018 data set. Two nontabulated examples made heavy use of virtual screening, particularly for optimization. The first example uses diversity-oriented target focused screening, or DOTS,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> a platform that combines virtual screening with automated synthesis. In one example, the procedure resulted in a 60-fold improvement, leading to a submicromolar inhibitor for the first bromodomain of BRD4. This is similar to the AutoCouple approach for computational fragment growing, which led to nanomolar inhibitors of the bromodomain CBP (cyclic-AMP response element binding protein, entry 19 in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Both of these approaches were able to make use of crystallographic data to support modeling efforts. In the third example, Chevillard et al. employed a “growing via merging” approach to obtain 40-fold improved submicromolar binders of the β2-adrenergic receptor (β2AR) starting from previously reported fragments for which the binding mode was predicted using molecular docking studies.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></p><p>Literature mining, or starting with a known hit, contributed to 4 of the 26 examples in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. One of the advantages of FBDD is that, because fragments are so simple, creative medicinal chemists can rapidly make changes to identify unprecedented chemotypes. Fast-follower approaches and knowledge-based design have been mainstays of drug discovery long before Sir James Black’s famous dictum that “the most fruitful basis for the discovery of a new drug is to start with an old drug.”<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> As fragment-based methods become increasingly established, literature-mining is likely to continue to grow. Three of the 2018 cases involved kinases (entries 5, 7, and 8), where hinge-binding moieties make for ideal fragments in terms of ligand efficiency and affinity. The fourth involved the sole example of an ion channel (entry 24), which was aided considerably by crystallography. As structural biology continues to make advances against membrane-bound targets, we should expect more such cases.</p><p>For 2018, crystallography itself was a primary fragment-finding method in just two examples, though this was an increase over 2017. That is not to say crystallography was unimportant: more than three-quarters of the examples reported a crystal structure for the fragment, lead, or both. Crystallography is the most effective method for studying binding interactions in detail, and Drwal et al. analyzed the structures of more than 1000 protein-bound fragments and more than 1800 larger molecules.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> They found that fragments generally maintain their binding mode during optimization, though with enough exceptions that researchers need to be wary.</p><p>Six examples were not enabled by crystallography, up from just 3 each for 2016 and 2017 and 4 for 2015. Predictably, these include the GPCR (entry 23) and phenotypic screen (entry 26), where structural information is difficult or impossible to obtain. The other cases all involved enzymes, where modeling could be used productively. Indeed, 10 of the 26 examples did not report using a crystal structure for the fragment, and in most of these cases computational approaches were sufficient for lead optimization. As modeling becomes ever more powerful and more structures become available, this trend seems likely to continue. A review dedicated to the optimization of fragments in the absence of crystallographic information was recently published.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> All that said, structural information remains essential for successful advancement of many targets.</p><p>Different screening methods vary in strengths and weaknesses,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and these can become apparent when looking at the cumulative data. In <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, screening methods are grouped by the affinity of the fragments. Not surprisingly, biochemical assays predominate for more potent fragments (IC<sub>50</sub> or <i>K</i><sub>i</sub> < 100 μM). Fragments derived from the literature are also prominent among the most potent fragments (IC<sub>50</sub> or <i>K</i><sub>i</sub> < 10 μM), which is not surprising given that a potent fragment is more likely to attract interest. In contrast, biophysical methods such as ligand- and protein-observed NMR and X-ray crystallography become more prevalent for weaker fragments, where biochemical screens may prove challenging. Awareness of the affinity limits for different techniques is important not just in fragment screening but also in validation and optimization. For example, weak fragments that show no activity in a biochemical assay can still be good starting points and should not be discarded for lack of confirmation. In such cases optimization may well be dependent on biophysical assays.</p><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of screening methods for (A) potency of fragment hit and (B) kinases vs non-bromodomain protein–protein interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Differences in fragment screening methods are also observed for different types of targets: for kinases, biochemical assays are used in nearly half of the campaigns, while for protein–protein interactions (aside from bromodomains) they are rarely used (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). This likely reflects the fact that biochemical assays are relatively straightforward to establish for most kinases, whereas protein–protein interactions may require more challenging techniques. The heavy use of biophysical assays could also reflect the fact that hits against non-bromodomain PPIs tend to be slightly weaker and therefore more challenging to detect with biochemical techniques.</p><p>Properties including molecular weight (MW), ClogP, and deviation from planarity (DFP, a measure of shapeliness in which benzene has a DFP = 0 while adamantane has a DFP = 0.88)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> for all 111 fragment-to-lead examples are summarized in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Not surprisingly, and as also observed in previous years, leads are significantly larger, more lipophilic, and less planar than fragments (ΔHAC = +14, ΔMW = +194, ΔClogP = +1.5, ΔDFP = 0.45; <i>p</i> ≪ 0.0001 in all cases).</p><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Properties of fragments and leads from the 111 examples from the 2015–2018 data set: (A) distribution of molecular weight; (B) distribution of ClogP; (C) distribution of DFP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Fragment starting points in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were required to have MW < 300, and most of them also comply with the “‘rule of three’ concept, in which the molecular weight of a fragment is <300, the cLogP is ≤3, the number of hydrogen bond donors is ≤3, and the number of hydrogen bond acceptors is ≤3.”<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Indeed, only two fragments have cLogP > 3. There has been some controversy over how donors and acceptors are precisely defined, but it is probably fair to say that all of the fragments in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> contain three or fewer hydrogens capable of forming classic hydrogen bonds (i.e., excluding C–H hydrogen bonds) and three or fewer good hydrogen bond acceptors.</p><p>As seen last year, ligand efficiencies for fragments and leads span a similar range and can increase or decrease during optimization (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). A widely held belief is that ligand efficiency decreases during lead optimization, but this is not supported by the evidence for successful fragment-to-lead projects from 2015 to 2018. That said, since the leads in all these examples have affinities of 2 μM or better, ligand efficiencies are likely to be higher than for leads with lower affinities.</p><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Ligand efficiency (LE) values for fragments and leads for all examples from the 2015–2018 data set (93 fragments and 104 leads). (B) Distribution of the change in LE on going from fragment to lead for the 87 examples from the 2015–2018 data set for which LE can be calculated for both fragments and leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Notably, only 6 out of 93 fragments with reported affinity have ligand efficiency values worse than 0.25 (kcal/mol)/atom, and just one is worse than 0.20 (kcal/mol)/atom. In contrast, 78 fragments have ligand efficiencies of 0.30 (kcal/mol)/atom or better, as recommended in the publication that defined the concept.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Ligand efficiency has proven surprisingly contentious,<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> but the data compiled over the years 2015–2018 suggest that a very low-LE fragment (≪0.25 kcal/mol/atom) is less likely to lead to a potent lead molecule. Of course, we would never advocate applying strict numerical cut-offs or single metrics for assessing fragments; ligand efficiency is just one useful tool among many.</p><p>Target class differences for the 4-year data set are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, focusing on the same classes as last year (and thus excluding rare classes such as GPCRs and ion channels). As before, the physical properties of fragments are not notably different among the target classes, with the exception of a slight but not statistically significant increase in size (<i>p</i> = 0.2 for HAC) and lipophilicity (<i>p</i> = 0.2 for ClogP) for non-bromodomain protein–protein interaction inhibitors. Deviation from planarity for the fragments in general is small (i.e., fragments tend to be flatter and less shapely than leads) and does not vary significantly with regard to target class (the increase for enzymes and PPIs is not statistically significant). Thus, the data thus far do not support introducing larger numbers of “three-dimensional” fragments into screening collections, though doing so for other reasons, such as novelty or improved physicochemical properties, may be reasonable. Ligand efficiency for non-bromodomain protein–protein interaction inhibitors is lower than for other target classes, and this difference is statistically significant, albeit modestly (<i>p</i> = 0.03). This finding is consistent with the difficult reputation these targets hold, often necessitating starting from weaker binders.</p><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Mean Values of Listed Properties for Fragment Hits from the 4 Year Data Set, Grouped by Target Class</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center"><i>N</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HAC<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">ClogP<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">DFP<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinase</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">0.42 (0.10, <i>N</i> = 24)</td><td class="colsep0 rowsep0" align="left">14.8 (2.6)</td><td class="colsep0 rowsep0" align="left">2.0 (1.0)</td><td class="colsep0 rowsep0" align="left">0.19 (0.17)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protease</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.38 (0.14, <i>N</i> = 9)</td><td class="colsep0 rowsep0" align="left">14.5 (4.6)</td><td class="colsep0 rowsep0" align="left">1.9 (1.4)</td><td class="colsep0 rowsep0" align="left">0.17 (0.16)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">other enzyme</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">0.37 (0.13, <i>N</i> = 33)</td><td class="colsep0 rowsep0" align="left">15.0 (3.3)</td><td class="colsep0 rowsep0" align="left">1.7 (1.2)</td><td class="colsep0 rowsep0" align="left">0.24 (0.25)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPI, bromodomain</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.42 (0.07, <i>N</i> = 12)</td><td class="colsep0 rowsep0" align="left">14.3 (2.3)</td><td class="colsep0 rowsep0" align="left">1.7 (0.6)</td><td class="colsep0 rowsep0" align="left">0.15 (0.17)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPI, other</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">0.33 (0.08, <i>N</i> = 9)</td><td class="colsep0 rowsep0" align="left">15.8 (2.4)</td><td class="colsep0 rowsep0" align="left">2.2 (1.1)</td><td class="colsep0 rowsep0" align="left">0.23 (0.19)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Number of examples in each class.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Only fragments with absolute numerical values have been used for the LE analysis.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Standard deviation for each property shown in parentheses.</p></div></div></div><p>As also observed last year,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> several of the examples have led to clinical candidates, including asciminib (entry 3), eFT508 (entry 7), and ETC-206 (entry 8). Moreover, some of the F2L campaigns highlighted in previous Perspectives have also led to clinical compounds, either directly or through follow-up optimization. These include ABBV-744 (entry 22 for 2017),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> ASTX660 (entry 26 for 2015, follow-up optimization described in two papers),<a onclick="showRef(event, 'ref2 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref2 ref67 ref68">(2,67,68)</a> HTL14242 (entry 27 for 2015, a negative allosteric modulator of the GPCR mGluR5),<a onclick="showRef(event, 'ref2 ref69'); return false;" href="javascript:void(0);" class="ref ref2 ref69">(2,69)</a> and AZD5991 (entry 23 for 2015).<a onclick="showRef(event, 'ref2 ref70'); return false;" href="javascript:void(0);" class="ref ref2 ref70">(2,70)</a> This last case is particularly notable in that the fragment starting point was taken from the literature.</p><p class="last">As the amount of fragment-derived chemical matter continues to increase and with increasing use of FBDD in concert with other lead-finding approaches (as highlighted in the 2017 F2L Miniperspective),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> it will become increasingly difficult to assess the ultimate origins of any given drug. In the end, it is the contribution to drug discovery in general, rather than any sort of scorekeeping for a given approach, that matters most.</p><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01581" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel A. Erlanson</span> - <span class="hlFld-Affiliation affiliation">Frontier
Medicines, 151 Oyster
Point Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8807-4159" title="Orcid link">http://orcid.org/0000-0001-8807-4159</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7115101f18141d5f14031d101f021e1f3117031e1f051814031c1415025f121e1c"><span class="__cf_email__" data-cfemail="ddb9bcb3b4b8b1f3b8afb1bcb3aeb2b39dbbafb2b3a9b4b8afb0b8b9aef3beb2b0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iwan J. P. de Esch</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Vrije Universiteit
Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Jahnke</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for Biomedical Research, Chemical Biology and Therapeutics, 4002 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7003-3305" title="Orcid link">http://orcid.org/0000-0002-7003-3305</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher N. Johnson</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8618-9729" title="Orcid link">http://orcid.org/0000-0001-8618-9729</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul N. Mortenson</span> - <span class="hlFld-Affiliation affiliation">Astex
Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3583-3163" title="Orcid link">http://orcid.org/0000-0002-3583-3163</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): D.A.E. is a shareholder of Carmot Therapeutics Inc. and an employee of Frontier Medicines. W.J. is an employee and shareholder of Novartis. C.N.J. and P.N.M. are employees of Astex Pharmaceuticals.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Daniel A. Erlanson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=BIO-d7e834-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel A. Erlanson</b> is VP of Chemistry at Frontier Medicines. Before that, he cofounded Carmot Therapeutics and co-developed its Chemotype Evolution technology. Dr. Erlanson earned his B.A. in Chemistry from Carleton College and his Ph.D. in Chemistry from Harvard University in the laboratory of Gregory L. Verdine. He was an NIH postdoctoral fellow with James A. Wells at Genentech. From there he joined Sunesis Pharmaceuticals at its inception and went on to develop fragment-based technologies and lead medicinal chemistry programs. As well as coediting two books on fragment-based drug discovery, Dr. Erlanson is editor of Practical Fragments (<a href="http://practicalfragments.blogspot.com/" class="extLink">http://practicalfragments.blogspot.com/</a>).</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Iwan J. P. de Esch</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=BIO-d7e842-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Iwan J. P. de Esch</b> is Professor at the Medicinal Chemistry Division of VU University Amsterdam. After obtaining a Ph.D. in Medicinal Chemistry at VU University, he became Research Associate at the Drug Design Group of the University of Cambridge. The group spun out as De Novo Pharmaceuticals in 1999. Prof. de Esch returned to Amsterdam in 2003 and established a FBDD research line. He is coordinator of the FBDD-focused European training network FRAGNET. He is also cofounder of De Novo Pharmaceuticals Ltd. (1999), IOTA Pharmaceuticals Ltd. (2007), and Griffin Discoveries BV (2009).</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Wolfgang Jahnke</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=BIO-d7e847-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wolfgang Jahnke</b> is a Director for Structural Biology and Biophysics at the Novartis Institutes for Biomedical Research in Basel, Switzerland. He has helped to shape NMR spectroscopy for applications in fragment-based drug discovery and has coedited two books on fragment-based drug discovery. He has successfully led several interdisciplinary project teams and is co-inventor and coauthor of more than 80 patents and scientific publications. Dr. Jahnke earned his Ph.D. in Chemistry from the Technical University of Munich and did a postdoc with Peter Wright at the Scripps Research Institute in La Jolla, CA.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Christopher N. Johnson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=BIO-d7e852-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christopher N. Johnson</b> obtained an M.A. degree at the University of Cambridge and a Ph.D. at the University of Bristol, U.K. Following a number of years working as a medicinal chemist at GSK and legacy companies, he moved to Astex in 2008, where he has worked on fragment-based approaches applied to multiple target classes including PPI antagonists, with particular focus on the oncology disease area. Dr. Johnson is a co-inventor or coauthor on over 100 patents and scientific publications.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Paul N. Mortenson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=BIO-d7e857-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paul N. Mortenson</b> joined Astex in 2006 as a computational chemist. During his time at Astex he has worked on a number of drug discovery projects, including the collaboration with Novartis that led to the discovery of the CDK4 inhibitor ribociclib (Kisqali). Before Astex, he worked for 4 years at Evotec. He has an M.A. in Chemistry and a Ph.D. in Theoretical Chemistry from the University of Cambridge.</p></figure></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ALK2</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase 2</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">BCL6</td><td class="NLM_def"><p class="first last">B-cell lymphoma 6</p></td></tr><tr><td class="NLM_term">BCR-ABL1</td><td class="NLM_def"><p class="first last">breakpoint cluster region Abelson kinase 1</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromo- and extra-terminal domain</p></td></tr><tr><td class="NLM_term">BRD4</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 4</p></td></tr><tr><td class="NLM_term">BTK</td><td class="NLM_def"><p class="first last">Burton’s tyrosine kinase</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">cyclic AMP response element binding protein, binding protein</p></td></tr><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">DFP</td><td class="NLM_def"><p class="first last">deviation from planarity</p></td></tr><tr><td class="NLM_term">DSLS</td><td class="NLM_def"><p class="first last">differential static light scattering</p></td></tr><tr><td class="NLM_term">DYRK1A</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine phosphorylation-regulated kinase 1A</p></td></tr><tr><td class="NLM_term">EED</td><td class="NLM_def"><p class="first last">embryonic ectoderm development</p></td></tr><tr><td class="NLM_term">EP300</td><td class="NLM_def"><p class="first last">histone acetyltransferase p300</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">extracellular signal–regulated kinase 1/2</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HAC</td><td class="NLM_def"><p class="first last">number of non-hydrogen atoms (heavy atom count)</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IMPDH</td><td class="NLM_def"><p class="first last">inosine-5′-monophosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand-lipophilicity efficiency</p></td></tr><tr><td class="NLM_term">LLE<sub>AT</sub></td><td class="NLM_def"><p class="first last">Astex ligand-lipophilicity efficiency</p></td></tr><tr><td class="NLM_term">mGluR5</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor 5</p></td></tr><tr><td class="NLM_term">MNK1/2</td><td class="NLM_def"><p class="first last">MAPK-interacting kinase 1/2</p></td></tr><tr><td class="NLM_term">MTH1</td><td class="NLM_def"><p class="first last">MutT homologue 1</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NAMPT</td><td class="NLM_def"><p class="first last">nicotinamide phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RORγ</td><td class="NLM_def"><p class="first last">RAR-related orphan receptor γ</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">USP2</td><td class="NLM_def"><p class="first last">ubiquitin specific protease 2</p></td></tr><tr><td class="NLM_term">USP7</td><td class="NLM_def"><p class="first last">ubiquitin specific protease 7</p></td></tr><tr><td class="NLM_term">WDR5</td><td class="NLM_def"><p class="first last">WD repeat-containing protein 5</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty Years On: The Impact of Fragments on Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+Years+On%3A+The+Impact+of+Fragments+on+Drug+Discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lhRlOIkNSOo-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520Years%2520On%253A%2520The%2520Impact%2520of%2520Fragments%2520on%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) is now well-established as a technol. for generating new chem. leads and drugs.  This Miniperspective provides a tabulated overview of the fragment-to-lead literature published in the year 2015, together with a commentary on trends obsd. across the FBDD field during this time.  It is hoped that this tabulated summary will provide a useful point of ref. for both FBDD practitioners and the wider medicinal chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojX6ZlmVXQrLVg90H21EOLACvtfcHk0lgfS1HnfqGc8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP&md5=da9d027787d70d4276378cb01f8e0ce2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1774-1784&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=W.+Jahnkeauthor=P.+N.+Mortensonauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2016&doi=10.1021%2Facs.jmedchem.7b01298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Jahnke, Wolfgang; Mortenson, Paul N.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1774-1784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The popularity of fragment-based drug discovery (FBDD) is demonstrated by the no. of recent successful fragment-to-lead (F2L) publications.  This Miniperspective provides a tabulated summary of the F2L literature published in the year 2016, along with discussion of general trends.  It uses the same format as our summary of the 2015 literature and is intended to be a resource for both FBDD practitioners and medicinal chemists in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDiwnepXDgrbVg90H21EOLACvtfcHk0lgfS1HnfqGc8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP&md5=861d9adf1530250a060fc254ca7b493c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202016%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1774%26epage%3D1784%26doi%3D10.1021%2Facs.jmedchem.7b01298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3872</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3857-3872&author=P.+N.+Mortensonauthor=D.+A.+Erlansonauthor=I.+J.+P.+de+Eschauthor=W.+Jahnkeauthor=C.+N.+Johnson&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2017&doi=10.1021%2Facs.jmedchem.8b01472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span></div><div class="casAuthors">Mortenson, Paul N.; Erlanson, Daniel A.; de Esch, Iwan J. P.; Jahnke, Wolfgang; Johnson, Christopher N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3857-3872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Miniperspective is the third in a series reviewing fragment-to-lead publications from a given year.  Following our reviews for 2015 and 2016, this Miniperspective provides tabulated summaries of relevant articles published in 2017 along with some general observations.  In addn., we discuss insights obtained from anal. of the combined data set of 85 examples from all three years of publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakuhiet0qZLVg90H21EOLACvtfcHk0ligId-nnHtR-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK&md5=f755c4768cd2d8f7efaaefa987a16079</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202017%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3857%26epage%3D3872%26doi%3D10.1021%2Facs.jmedchem.8b01472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2604</span>– <span class="NLM_lpage">2610</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00057</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFWnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2604-2610&author=L.+Chenauthor=C.+Zhuangauthor=J.+Luauthor=Y.+Jiangauthor=C.+Sheng&title=Discovery+of+Novel+KRAS-PDE%CE%B4+Inhibitors+by+Fragment-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design</span></div><div class="casAuthors">Chen, Long; Zhuang, Chunlin; Lu, Junjie; Jiang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2604-2610</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting KRAS-PDEδ protein-protein interactions with small mols. represents a promising opportunity for developing novel antitumor agents.  However, current KRAS-PDEδ inhibitors are limited by poor cellular antitumor potency and the druggability of the target remains to be validated by new inhibitors.  To tackle these challenges, herein, novel, highly potent KRAS-PDEδ inhibitors were identified by fragment-based drug design, providing promising lead compds. or chem. probes for investigating the biol. functions and druggability of KRAS-PDEδ interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqayXxD-smS5LVg90H21EOLACvtfcHk0ligId-nnHtR-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFWnsLw%253D&md5=0b1ad029636a14f2794d548235a30360</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Novel%2520KRAS-PDE%25CE%25B4%2520Inhibitors%2520by%2520Fragment-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2604%26epage%3D2610%26doi%3D10.1021%2Facs.jmedchem.8b00057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linhares, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKerell, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain Via NMR-Based Fragment Screening and Computer-Aided Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7573</span>– <span class="NLM_lpage">7588</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kgu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7573-7588&author=H.+Chengauthor=B.+M.+Linharesauthor=W.+Yuauthor=M.+G.+Cardenasauthor=Y.+Aiauthor=W.+Jiangauthor=A.+Winklerauthor=S.+Cohenauthor=A.+Melnickauthor=A.+MacKerellauthor=T.+Cierpickiauthor=F.+Xue&title=Identification+of+Thiourea-Based+Inhibitors+of+the+B-Cell+Lymphoma+6+BTB+Domain+Via+NMR-Based+Fragment+Screening+and+Computer-Aided+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design</span></div><div class="casAuthors">Cheng, Huimin; Linhares, Brian M.; Yu, Wenbo; Cardenas, Mariano G.; Ai, Yong; Jiang, Wenjuan; Winkler, Alyssa; Cohen, Sandra; Melnick, Ari; MacKerell, Alexander; Cierpicki, Tomasz; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7573-7588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPI) between the transcriptional repressor B-cell lymphoma 6 (BCL6) BTB domain (BCL6BTB) and its corepressors have emerged as a promising target for anticancer therapeutics.  However, identification of potent, drug-like inhibitors of BCL6BTB has remained challenging.  Using NMR-based screening of a library of fragment-like small mols., we have identified a thiourea compd. (7CC5) that binds to BCL6BTB.  From this hit, the application of computer-aided drug design (CADD), medicinal chem., NMR spectroscopy, and X-ray crystallog. has yielded an inhibitor, I, that demonstrated over 100-fold improved potency for BCL6BTB.  This gain in potency was achieved by a unique binding mode that mimics the binding mode of the corepressor SMRT in the arom. and the HDCH sites.  The structure-activity relationship based on these new inhibitors will have a significant impact on the rational design of novel BCL6 inhibitors, facilitating the identification of therapeutics for the treatment of BCL6-dependent tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5uAI4SKnigrVg90H21EOLACvtfcHk0livGL2aU1LwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kgu7%252FI&md5=23f132ce17efe5e1787dd6aad5746310</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00040%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLinhares%26aufirst%3DB.%2BM.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCardenas%26aufirst%3DM.%2BG.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DWinkler%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DMacKerell%26aufirst%3DA.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520Thiourea-Based%2520Inhibitors%2520of%2520the%2520B-Cell%2520Lymphoma%25206%2520BTB%2520Domain%2520Via%2520NMR-Based%2520Fragment%2520Screening%2520and%2520Computer-Aided%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7573%26epage%3D7588%26doi%3D10.1021%2Facs.jmedchem.8b00040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidenreich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10929</span>– <span class="NLM_lpage">10934</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01457</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFeju7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10929-10934&author=D.+Heidenreichauthor=M.+Moustakimauthor=J.+Schmidtauthor=D.+Merkauthor=P.+E.+Brennanauthor=O.+Fedorovauthor=A.+Chaikuadauthor=S.+Knapp&title=Structure-Based+Approach+toward+Identification+of+Inhibitory+Fragments+for+Eleven-Nineteen-Leukemia+Protein+%28ENL%29&doi=10.1021%2Facs.jmedchem.8b01457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)</span></div><div class="casAuthors">Heidenreich, David; Moustakim, Moses; Schmidt, Jurema; Merk, Daniel; Brennan, Paul E.; Fedorov, Oleg; Chaikuad, Apirat; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10929-10934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine acetylation is an epigenetic mark that is principally recognized by bromodomains, and recently structurally diverse YEATS domains also emerged as readers of lysine acetyl/acylations.  Here we present a crystallog.-based strategy and the discovery of fragments binding to the ENL YEATS domain, a potential drug target.  Crystal structures combined with synthetic efforts led to the identification of a submicromolar binder, providing first starting points for the development of chem. probes for this reader domain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoRVFoDK77rVg90H21EOLACvtfcHk0livGL2aU1LwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFeju7jI&md5=fdcbbf8b8ec237216478043a6fd9c50f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01457%26sid%3Dliteratum%253Aachs%26aulast%3DHeidenreich%26aufirst%3DD.%26aulast%3DMoustakim%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructure-Based%2520Approach%2520toward%2520Identification%2520of%2520Inhibitory%2520Fragments%2520for%2520Eleven-Nineteen-Leukemia%2520Protein%2520%2528ENL%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10929%26epage%3D10934%26doi%3D10.1021%2Facs.jmedchem.8b01457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowedder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11061</span>– <span class="NLM_lpage">11073</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01556</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11061-11073&author=N.+Bartonauthor=M.+Converyauthor=A.+W.+J.+Cooperauthor=K.+Downauthor=J.+N.+Hamblinauthor=G.+Inglisauthor=S.+Peaceauthor=J.+Rowedderauthor=P.+Rowlandauthor=J.+A.+Taylorauthor=N.+Wellaway&title=Discovery+of+Potent%2C+Efficient%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+through+a+Deconstruction+and+Regrowth+Approach&doi=10.1021%2Facs.jmedchem.8b01556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach</span></div><div class="casAuthors">Barton, Nick; Convery, Maire; Cooper, Anthony W. J.; Down, Kenneth; Hamblin, J. Nicole; Inglis, Graham; Peace, Simon; Rowedder, James; Rowland, Paul; Taylor, Jonathan A.; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11061-11073</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A deconstruction of previously reported phosphoinositide 3-kinase δ (PI3Kδ) inhibitors and subsequent regrowth led to the identification of a privileged fragment for PI3Kδ, which was exploited to deliver a potent, efficient, and selective lead series with a novel binding mode obsd. in the PI3Kδ crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcRf_CeZHdbVg90H21EOLACvtfcHk0lhJ23tPinDB1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsLzI&md5=492b5e5a27690b41aad866ca94f7bc57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01556%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DConvery%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DDown%26aufirst%3DK.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DRowedder%26aufirst%3DJ.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Efficient%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520through%2520a%2520Deconstruction%2520and%2520Regrowth%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11061%26epage%3D11073%26doi%3D10.1021%2Facs.jmedchem.8b01556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Profiling of a 3-Aminopyridin-2-one-Based Kinase Targeted Fragment Library: Identification of 3-Amino-5-(pyridin-4-yl)pyridin-2(1H)-one Scaffold for Monopolar Spindle 1 (MPS1) and Aurora Kinases Inhibition</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmc.2018.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29764757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2ksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3021-3029&author=D.+Fearonauthor=I.+M.+Westwoodauthor=R.+L.+M.+van+Montfortauthor=R.+Baylissauthor=K.+Jonesauthor=V.+Bavetsias&title=Synthesis+and+Profiling+of+a+3-Aminopyridin-2-one-Based+Kinase+Targeted+Fragment+Library%3A+Identification+of+3-Amino-5-%28pyridin-4-yl%29pyridin-2%281H%29-one+Scaffold+for+Monopolar+Spindle+1+%28MPS1%29+and+Aurora+Kinases+Inhibition&doi=10.1016%2Fj.bmc.2018.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition</span></div><div class="casAuthors">Fearon, Daren; Westwood, Isaac M.; van Montfort, Rob L. M.; Bayliss, Richard; Jones, Keith; Bavetsias, Vassilios</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3021-3029</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Screening a 3-aminopyridin-2-one based fragment library against a 26-kinase panel representative of the human kinome identified 3-amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2(1H)-one (2) and 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one (3) as ligand efficient inhibitors of the mitotic kinase Monopolar Spindle 1 (MPS1) and the Aurora kinase family.  These kinases are well recognized as attractive targets for therapeutic intervention for treating cancer.  Elucidation of the binding mode of these fragments and their analogs has been carried out by x-ray crystallog.  Structural studies have identified key interactions with a conserved lysine residue and have highlighted potential regions of MPS1 which could be targeted to improve activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0pJ3yPx3obVg90H21EOLACvtfcHk0lhJ23tPinDB1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2ksro%253D&md5=04edf748bd53820fe6dd9b1f3120eab0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DD.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520Profiling%2520of%2520a%25203-Aminopyridin-2-one-Based%2520Kinase%2520Targeted%2520Fragment%2520Library%253A%2520Identification%2520of%25203-Amino-5-%2528pyridin-4-yl%2529pyridin-2%25281H%2529-one%2520Scaffold%2520for%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%2520and%2520Aurora%2520Kinases%2520Inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3021%26epage%3D3029%26doi%3D10.1016%2Fj.bmc.2018.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span>SciFinder. <a href="https://www.cas.org/products/scifinder" class="extLink">https://www.cas.org/products/scifinder</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SciFinder.+https%3A%2F%2Fwww.cas.org%2Fproducts%2Fscifinder+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">The Rise of Fragment-Based Drug Discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/nchem.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnchem.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=21378847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=187-192&author=C.+W.+Murrayauthor=D.+C.+Rees&title=The+Rise+of+Fragment-Based+Drug+Discovery&doi=10.1038%2Fnchem.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for new drugs is plagued by high attrition rates at all stages in research and development.  Chemists have an opportunity to tackle this problem because attrition can be traced back, in part, to the quality of the chem. leads.  Fragment-based drug discovery (FBDD) is a new approach, increasingly used in the pharmaceutical industry, for reducing attrition and providing leads for previously intractable biol. targets.  FBDD identifies low-mol.-wt. ligands (∼150 Da) that bind to biol. important macromols.  The three-dimensional exptl. binding mode of these fragments is detd. using X-ray crystallog. or NMR spectroscopy, and is used to facilitate their optimization into potent mols. with drug-like properties.  Compared with high-throughput-screening, the fragment approach requires fewer compds. to be screened, and, despite the lower initial potency of the screening hits, offers more efficient and fruitful optimization campaigns.  Here, we review the rise of FBDD, including its application to discovering clin. candidates against targets for which other chem. approaches have struggled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3ip2FKcYJbVg90H21EOLACvtfcHk0lgBn6hiCjbI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D&md5=0bd1a40fd927cce9200f0fa296a7462f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchem.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.217%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DThe%2520Rise%2520of%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D187%26epage%3D192%26doi%3D10.1038%2Fnchem.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span>Practical
Fragments. <a href="http://practicalfragments.blogspot.com/" class="extLink">http://practicalfragments.blogspot.com/</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Practical%0AFragments.+http%3A%2F%2Fpracticalfragments.blogspot.com%2F+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7261</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVClurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7261-7272&author=L.+Hudsonauthor=J.+Muiauthor=S.+Vazquezauthor=D.+M.+Carvalhoauthor=E.+Williamsauthor=C.+Jonesauthor=A.+N.+Bullockauthor=S.+Hoelder&title=Novel+Quinazolinone+Inhibitors+of+ALK2+Flip+between+Alternate+Binding+Modes%3A+Structure-Activity+Relationship%2C+Structural+Characterization%2C+Kinase+Profiling%2C+and+Cellular+Proof+of+Concept&doi=10.1021%2Facs.jmedchem.8b00782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept</span></div><div class="casAuthors">Hudson, Liam; Mui, James; Vazquez, Santiago; Carvalho, Diana M.; Williams, Eleanor; Jones, Chris; Bullock, Alex N.; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7261-7272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationship and crystallog. data revealed that quinazolinone-contg. fragments flip between two distinct modes of binding to activin receptor-like kinase-2 (ALK2).  We explored both binding modes to discover potent inhibitors and characterized the chem. modifications that triggered the flip in binding mode.  We report kinase selectivity and demonstrate that compds. of this series modulate ALK2 in cancer cells.  These inhibitors are attractive starting points for the discovery of more advanced ALK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqae6Cwj4ijKbVg90H21EOLACvtfcHk0lgBn6hiCjbI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVClurjE&md5=a3a04f969265895f79f720d4a312ba57</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00782%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DL.%26aulast%3DMui%26aufirst%3DJ.%26aulast%3DVazquez%26aufirst%3DS.%26aulast%3DCarvalho%26aufirst%3DD.%2BM.%26aulast%3DWilliams%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DNovel%2520Quinazolinone%2520Inhibitors%2520of%2520ALK2%2520Flip%2520between%2520Alternate%2520Binding%2520Modes%253A%2520Structure-Activity%2520Relationship%252C%2520Structural%2520Characterization%252C%2520Kinase%2520Profiling%252C%2520and%2520Cellular%2520Proof%2520of%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7261%26epage%3D7272%26doi%3D10.1021%2Facs.jmedchem.8b00782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drueckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8120</span>– <span class="NLM_lpage">8135</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKru7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8120-8135&author=J.+Schoepferauthor=W.+Jahnkeauthor=G.+Berelliniauthor=S.+Buonamiciauthor=S.+Cotestaauthor=S.+W.+Cowan-Jacobauthor=S.+Doddauthor=P.+Drueckesauthor=D.+Fabbroauthor=T.+Gabrielauthor=J.+M.+Groellauthor=R.+M.+Grotzfeldauthor=A.+Q.+Hassanauthor=C.+Henryauthor=V.+Iyerauthor=D.+Jonesauthor=F.+Lombardoauthor=A.+Looauthor=P.+W.+Manleyauthor=X.+Pelleauthor=G.+Rummelauthor=B.+Salemauthor=M.+Warmuthauthor=A.+A.+Wylieauthor=T.+Zollerauthor=A.+L.+Marzinzikauthor=P.+Furet&title=Discovery+of+Asciminib+%28ABL001%29%2C+an+Allosteric+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+BCR-ABL1&doi=10.1021%2Facs.jmedchem.8b01040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1</span></div><div class="casAuthors">Schoepfer, Joseph; Jahnke, Wolfgang; Berellini, Giuliano; Buonamici, Silvia; Cotesta, Simona; Cowan-Jacob, Sandra W.; Dodd, Stephanie; Drueckes, Peter; Fabbro, Doriano; Gabriel, Tobias; Groell, Jean-Marc; Grotzfeld, Robert M.; Hassan, A. Quamrul; Henry, Chrystele; Iyer, Varsha; Jones, Darryl; Lombardo, Franco; Loo, Alice; Manley, Paul W.; Pelle, Xavier; Rummel, Gabriele; Salem, Bahaa; Warmuth, Markus; Wylie, Andrew A.; Zoller, Thomas; Marzinzik, Andreas L.; Furet, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8120-8135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of asciminib I, an allosteric inhibitor of the BCR-ABL1 kinase for use in treating chronic myelogenous leukemia (CML), is delineated.  I binds to the myristate pocket of BCR-ABL1 and maintains activity against cancer cells possessing ATP-site mutations in BCR-ABL1 that render them resistant to tyrosine kinase inhibitors; cancer cells resistant to myristate-site mutations are likely to be susceptible to ATP-competitive inhibitors so that combinations of I and tyrosine kinase inhibitors should suppress the emergence of resistance.  Fragment-based screening using NMR and X-ray yielded ligands for the myristate pocket, while an NMR-based conformational assay guided the transformation of these inactive ligands into ABL1 inhibitors.  Further structure-based optimization for potency, physicochem., pharmacokinetic, and drug-like properties, culminated in I which is currently undergoing clin. studies in CML patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQbEIXXgRgbVg90H21EOLACvtfcHk0ljnt2GHI-tqvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKru7bN&md5=023a566cdf4faba6dfc05501b8b6a6ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01040%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DT.%26aulast%3DGroell%26aufirst%3DJ.%2BM.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHassan%26aufirst%3DA.%2BQ.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DPelle%26aufirst%3DX.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWylie%26aufirst%3DA.%2BA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DMarzinzik%26aufirst%3DA.%2BL.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Asciminib%2520%2528ABL001%2529%252C%2520an%2520Allosteric%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520BCR-ABL1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8120%26epage%3D8135%26doi%3D10.1021%2Facs.jmedchem.8b01040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Series of Pyridine and Pyrimidine Carboxamides as Potent and Selective Covalent Inhibitors of BTK</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3419</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30290988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3419-3424&author=R.+Caldwellauthor=L.+Liu-Bujalskiauthor=H.+Qiuauthor=I.+Mochalkinauthor=R.+Jonesauthor=C.+Neaguauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=T.+Johnsonauthor=B.+Shererauthor=A.+Gardbergauthor=A.+V.+Follisauthor=F.+Morandiauthor=J.+Head&title=Discovery+of+a+Novel+Series+of+Pyridine+and+Pyrimidine+Carboxamides+as+Potent+and+Selective+Covalent+Inhibitors+of+BTK&doi=10.1016%2Fj.bmcl.2018.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk</span></div><div class="casAuthors">Caldwell, Richard; Liu-Bujalski, Lesley; Qiu, Hui; Mochalkin, Igor; Jones, Reinaldo; Neagu, Constantin; Goutopoulos, Andreas; Grenningloh, Roland; Johnson, Theresa; Sherer, Brian; Gardberg, Anna; Follis, Ariele Viacava; Morandi, Federica; Head, Jared</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3419-3424</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Btk is an attractive target for the treatment of a range of Bcell malignancies as well as several autoimmune diseases such as murine lupus and rheumatoid arthritis.  Several covalent irreversible inhibitors of Btk are currently in development including ibrutinib which was approved for treatment of B-cell malignancies.  Herein, we describe our efforts using X-ray guided structure based design (SBD) to identify a novel chem. series of covalent Btk inhibitors.  The resulting pyridine carboxamides were potent and selective inhibitors of Btk having excellent enzymic and cellular inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxbbu5RIAg8LVg90H21EOLACvtfcHk0liNrf41WNYSMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqt7fE&md5=b5253fa9bf8f1092dbed43bb8a1efd08</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DR.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DSherer%26aufirst%3DB.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DFollis%26aufirst%3DA.%2BV.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DHead%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Series%2520of%2520Pyridine%2520and%2520Pyrimidine%2520Carboxamides%2520as%2520Potent%2520and%2520Selective%2520Covalent%2520Inhibitors%2520of%2520BTK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3419%26epage%3D3424%26doi%3D10.1016%2Fj.bmcl.2018.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3390/molecules23020064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.3390%2Fmolecules23020064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=64&author=R.+Meineauthor=W.+Beckerauthor=H.+Falkeauthor=L.+Preuauthor=N.+Loaecauthor=L.+Meijerauthor=C.+Kunick&title=Indole-3-Carbonitriles+as+DYRK1A+Inhibitors+by+Fragment-Based+Drug+Design&doi=10.3390%2Fmolecules23020064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span></div><div class="casAuthors">Meine, Rosanna; Becker, Walter; Falke, Hannes; Preu, Lutz; Loaeec, Nadege; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">64/1-64/23</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential drug target because of its role in the development of Down syndrome and Alzheimer's disease.  The selective DYRK1A inhibitor 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acid (KuFal194), a large, flat and lipophilic mol., suffers from poor water soly., limiting its use as chem. probe in cellular assays and animal models.  Based on the structure of KuFal194, 7-chloro-1H-indole-3-carbonitrile was selected as fragment template for the development of smaller and less lipophilic DYRK1A inhibitors.  By modification of this fragment, a series of indole-3-carbonitriles was designed and evaluated as potential DYRK1A ligands by mol. docking studies.  Synthesis and in vitro assays on DYRK1A and related protein kinases identified novel double-digit nanomolar inhibitors with submicromolar activity in cell culture assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkYtRPnACcGLVg90H21EOLACvtfcHk0liPRG1RZeKiCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK&md5=3c41761df0f75e3f8a98c1ee3c057ff9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020064%26sid%3Dliteratum%253Aachs%26aulast%3DMeine%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DIndole-3-Carbonitriles%2520as%2520DYRK1A%2520Inhibitors%2520by%2520Fragment-Based%2520Drug%2520Design%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D64%26doi%3D10.3390%2Fmolecules23020064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids are Selective Inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loaecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+Acids+are+Selective+Inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0liPRG1RZeKiCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520Acids%2520are%2520Selective%2520Inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onions, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4978</span>– <span class="NLM_lpage">4992</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4978-4992&author=T.+D.+Heightmanauthor=V.+Berdiniauthor=H.+Braithwaiteauthor=I.+M.+Buckauthor=M.+Cassidyauthor=J.+Castroauthor=A.+Courtinauthor=J.+E.+H.+Dayauthor=C.+Eastauthor=L.+Fazalauthor=B.+Grahamauthor=C.+M.+Griffiths-Jonesauthor=J.+F.+Lyonsauthor=V.+Martinsauthor=S.+Muenchauthor=J.+M.+Munckauthor=D.+Nortonauthor=M.+O%E2%80%99Reillyauthor=N.+Palmerauthor=P.+Pathuriauthor=M.+Readerauthor=D.+C.+Reesauthor=S.+J.+Richauthor=C.+Richardsonauthor=H.+Sainiauthor=N.+T.+Thompsonauthor=N.+G.+Wallisauthor=H.+Waltonauthor=N.+E.+Wilsherauthor=A.+J.+Woolfordauthor=M.+Cookeauthor=D.+Cousinauthor=S.+Onionsauthor=J.+Shannonauthor=J.+Wattsauthor=C.+W.+Murray&title=Fragment-Based+Discovery+of+a+Potent%2C+Orally+Bioavailable+Inhibitor+That+Modulates+the+Phosphorylation+and+Catalytic+Activity+of+ERK1%2F2&doi=10.1021%2Facs.jmedchem.8b00421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2</span></div><div class="casAuthors">Heightman, Tom D.; Berdini, Valerio; Braithwaite, Hannah; Buck, Ildiko M.; Cassidy, Megan; Castro, Juan; Courtin, Aurelie; Day, James E. H.; East, Charlotte; Fazal, Lynsey; Graham, Brent; Griffiths-Jones, Charlotte M.; Lyons, John F.; Martins, Vanessa; Muench, Sandra; Munck, Joanne M.; Norton, David; O'Reilly, Marc; Palmer, Nick; Pathuri, Puja; Reader, Michael; Rees, David C.; Rich, Sharna J.; Richardson, Caroline; Saini, Harpreet; Thompson, Neil T.; Wallis, Nicola G.; Walton, Hugh; Wilsher, Nicola E.; Woolford, Alison J.-A.; Cooke, Michael; Cousin, David; Onions, Stuart; Shannon, Jonathan; Watts, John; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4978-4992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant activation of the MAPK pathway drives cell proliferation in multiple cancers.  Inhibitors of BRAF and MEK kinases are approved for the treatment of BRAF mutant melanoma, but resistance frequently emerges, often mediated by increased signaling through ERK1/2.  Here, we describe the fragment-based generation of ERK1/2 inhibitors that block catalytic phosphorylation of downstream substrates such as RSK but also modulate phosphorylation of ERK1/2 by MEK without directly inhibiting MEK.  X-ray crystallog. and biophys. fragment screening followed by structure-guided optimization and growth from the hinge into a pocket proximal to the C-α helix afforded highly potent ERK1/2 inhibitors with excellent kinome selectivity.  In BRAF mutant cells, the lead compd. suppresses pRSK and pERK levels and inhibits proliferation at low nanomolar concns.  The lead exhibits tumor regression upon oral dosing in BRAF mutant xenograft models, providing a promising basis for further optimization toward clin. pERK1/2 modulating ERK1/2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqstOOt0nyKg7Vg90H21EOLACvtfcHk0lgjRSMJ_libkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsLY%253D&md5=c2bd7c16be85e5f6af5525ce60272aa1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00421%26sid%3Dliteratum%253Aachs%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBraithwaite%26aufirst%3DH.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DCassidy%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DCourtin%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DEast%26aufirst%3DC.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DLyons%26aufirst%3DJ.%2BF.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMuench%26aufirst%3DS.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DN.%26aulast%3DPathuri%26aufirst%3DP.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaini%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWallis%26aufirst%3DN.%2BG.%26aulast%3DWalton%26aufirst%3DH.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DCousin%26aufirst%3DD.%26aulast%3DOnions%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DJ.%26aulast%3DWatts%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Potent%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520That%2520Modulates%2520the%2520Phosphorylation%2520and%2520Catalytic%2520Activity%2520of%2520ERK1%252F2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4978%26epage%3D4992%26doi%3D10.1021%2Facs.jmedchem.8b00421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E. Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaghafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01795</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01795" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3516-3540&author=S.+H.+Reichauthor=P.+A.+Sprengelerauthor=G.+G.+Chiangauthor=J.+R.+Applemanauthor=J.+Chenauthor=J.+Clarineauthor=B.+Eamauthor=J.+T.+Ernstauthor=Q.+Hanauthor=V.+K.+Goelauthor=E.+Z.+R.+Hanauthor=V.+Huangauthor=I.+N.+J.+Hungauthor=A.+Jemisonauthor=K.+A.+Jessenauthor=J.+Molterauthor=D.+Murphyauthor=M.+Nealauthor=G.+S.+Parkerauthor=M.+Shaghafiauthor=S.+Sperryauthor=J.+Stauntonauthor=C.+R.+Stumpfauthor=P.+A.+Thompsonauthor=C.+Tranauthor=S.+E.+Webberauthor=C.+J.+Wegerskiauthor=H.+Zhengauthor=K.+R.+Webster&title=Structure-Based+Design+of+Pyridone-Aminal+eFT508+Targeting+Dysregulated+Translation+by+Selective+Mitogen-Activated+Protein+Kinase+Interacting+Kinases+1+and+2+%28MNK1%2F2%29+Inhibition&doi=10.1021%2Facs.jmedchem.7b01795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span></div><div class="casAuthors">Reich, Siegfried H.; Sprengeler, Paul A.; Chiang, Gary G.; Appleman, James R.; Chen, Joan; Clarine, Jeff; Eam, Boreth; Ernst, Justin T.; Han, Qing; Goel, Vikas K.; Han, Edward Z. R.; Huang, Vera; Hung, Ivy N. J.; Jemison, Adrianna; Jessen, Katti A.; Molter, Jolene; Murphy, Douglas; Neal, Melissa; Parker, Gregory S.; Shaghafi, Michael; Sperry, Samuel; Staunton, Jocelyn; Stumpf, Craig R.; Thompson, Peggy A.; Tran, Chinh; Webber, Stephen E.; Wegerski, Christopher J.; Zheng, Hong; Webster, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3516-3540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulated translation of mRNA plays a major role in tumorigenesis.  Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins.  Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling.  Compd. 23 (eFT508, 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro-[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione hydrochloride), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation.  The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone-aminal structure described for the first time in the kinase literature.  Compd. 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential.  Compd. 23 is currently being evaluated in Phase 2 clin. trials in solid tumors and lymphoma.  Compd. 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAp-3GOuZu8bVg90H21EOLACvtfcHk0lg1ALZz6gp4Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D&md5=1254b674aa7e6d2037a06bc10e64e4da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DClarine%26aufirst%3DJ.%26aulast%3DEam%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHan%26aufirst%3DE.%2BZ.%2BR.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DHung%26aufirst%3DI.%2BN.%2BJ.%26aulast%3DJemison%26aufirst%3DA.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DStumpf%26aufirst%3DC.%2BR.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DStructure-Based%2520Design%2520of%2520Pyridone-Aminal%2520eFT508%2520Targeting%2520Dysregulated%2520Translation%2520by%2520Selective%2520Mitogen-Activated%2520Protein%2520Kinase%2520Interacting%2520Kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3516%26epage%3D3540%26doi%3D10.1021%2Facs.jmedchem.7b01795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamaneni, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuddagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuah, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4348</span>– <span class="NLM_lpage">4369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01714</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01714" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1eqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4348-4369&author=H.+Yangauthor=L.+R.+Chennamaneniauthor=M.+W.+T.+Hoauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=D.+A.+Jeyarajauthor=Y.+S.+Yeapauthor=B.+Liuauthor=E.+H.+Ongauthor=J.+K.+Joyauthor=J.+L.+K.+Weeauthor=P.+Kwekauthor=P.+Retnaauthor=N.+Dinieauthor=T.+T.+H.+Nguyenauthor=S.+J.+Taiauthor=V.+Manoharanauthor=V.+Pendharkarauthor=C.+B.+Lowauthor=Y.+S.+Chewauthor=S.+Vuddagiriauthor=K.+Sangthongpitagauthor=M.+L.+Choongauthor=M.+A.+Leeauthor=S.+Kannanauthor=C.+S.+Vermaauthor=A.+Poulsenauthor=S.+Limauthor=C.+Chuahauthor=T.+S.+Ongauthor=J.+Hillauthor=A.+Matterauthor=K.+Nacro&title=Optimization+of+Selective+Mitogen-Activated+Protein+Kinase+Interacting+Kinases+1+and+2+Inhibitors+for+the+Treatment+of+Blast+Crisis+Leukemia&doi=10.1021%2Facs.jmedchem.7b01714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia</span></div><div class="casAuthors">Yang, Haiyan; Chennamaneni, Lohitha Rao; Ho, Melvyn Wai Tuck; Ang, Shi Hua; Tan, Eldwin Sum Wai; Jeyaraj, Duraiswamy Athisayamani; Yeap, Yoon Sheng; Liu, Boping; Ong, Esther Hq; Joy, Joma Kanikadu; Wee, John Liang Kuan; Kwek, Perlyn; Retna, Priya; Dinie, Nurul; Nguyen, Thuy Thi Hanh; Tai, Shi Jing; Manoharan, Vithya; Pendharkar, Vishal; Low, Choon Bing; Chew, Yun Shan; Vuddagiri, Susmitha; Sangthongpitag, Kanda; Choong, Meng Ling; Lee, May Ann; Kannan, Srinivasaraghavan; Verma, Chandra S.; Poulsen, Anders; Lim, Sharon; Chuah, Charles; Ong, Tiong Sin; Hill, Jeffrey; Matter, Alex; Nacro, Kassoum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4348-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cells (LSCs).  Inhibition of BCR-ABL1 kinase activity offers long-term relief to CML patients.  However, for a proportion of them, BCR-ABL1 inhibition will become ineffective at treating the disease, and CML will progress to blast crisis (BC) CML with poor prognosis.  BC-CML is often assocd. with excessive phosphorylated eukaryotic translation initiation factor 4E (eIF4E), which renders LSCs capable of proliferating via self-renewal, oblivious to BCR-ABL1 inhibition.  In vivo, eIF4E is exclusively phosphorylated on Ser209 by MNK1/2.  Consequently, a selective inhibitor of MNK1/2 should reduce the level of phosphorylated eIF4E and re-sensitize LSCs to BCR-ABL1 inhibition, thus hindering the proliferation of BC LSCs.  We report herein the structure-activity relationships and pharmacokinetic properties of a selective MNK1/2 inhibitor clin. candidate, ETC-206, which in combination with dasatinib prevents BC-CML LSC self-renewal in vitro and enhances dasatinib antitumor activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF5EekxyqUrVg90H21EOLACvtfcHk0ljOWN1H7oMPRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1eqsbw%253D&md5=6818f494dd765080aec49cc11a9c34bb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01714%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChennamaneni%26aufirst%3DL.%2BR.%26aulast%3DHo%26aufirst%3DM.%2BW.%2BT.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DYeap%26aufirst%3DY.%2BS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DWee%26aufirst%3DJ.%2BL.%2BK.%26aulast%3DKwek%26aufirst%3DP.%26aulast%3DRetna%26aufirst%3DP.%26aulast%3DDinie%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%2BH.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DVuddagiri%26aufirst%3DS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DChuah%26aufirst%3DC.%26aulast%3DOng%26aufirst%3DT.%2BS.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DMatter%26aufirst%3DA.%26aulast%3DNacro%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520Selective%2520Mitogen-Activated%2520Protein%2520Kinase%2520Interacting%2520Kinases%25201%2520and%25202%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Blast%2520Crisis%2520Leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4348%26epage%3D4369%26doi%3D10.1021%2Facs.jmedchem.7b01714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tee, D. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N. H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4396</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1eqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4386-4396&author=J.+Kwiatkowskiauthor=B.+Liuauthor=D.+H.+Y.+Teeauthor=G.+Chenauthor=N.+H.+B.+Ahmadauthor=Y.+X.+Wongauthor=Z.+Y.+Pohauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=E.+H.+Ongauthor=N.+Dinieauthor=A.+Poulsenauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=M.+A.+Leeauthor=S.+Sepramaniamauthor=S.+Y.+Hoauthor=J.+Cherianauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+W.+Hung&title=Fragment-Based+Drug+Discovery+of+Potent+Protein+Kinase+C+Iota+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors</span></div><div class="casAuthors">Kwiatkowski, Jacek; Liu, Boping; Tee, Doris Hui Ying; Chen, Guoying; Binte Ahmad, Nur Huda; Wong, Yun Xuan; Poh, Zhi Ying; Ang, Shi Hua; Tan, Eldwin Sum Wai; Ong, Esther H. Q.; Dinie, Nurul; Poulsen, Anders; Pendharkar, Vishal; Sangthongpitag, Kanda; Lee, May Ann; Sepramaniam, Sugunavathi; Ho, Soo Yei; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Hung, Alvin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4396</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinase C iota (PKC-ι) is an atypical kinase implicated in the promotion of different cancer types.  A biochem. screen of a fragment library has identified several hits from which an azaindole-based scaffold was chosen for optimization.  Driven by a structure-activity relationship and supported by mol. modeling, a weakly bound fragment was systematically grown into a potent and selective inhibitor against PKC-ι.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVKGgW092g1bVg90H21EOLACvtfcHk0ljOWN1H7oMPRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1eqtbk%253D&md5=efeeb545b2a8a88ff9d42d246fd2de4c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTee%26aufirst%3DD.%2BH.%2BY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DAhmad%26aufirst%3DN.%2BH.%2BB.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DDinie%26aufirst%3DN.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DSepramaniam%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DHung%26aufirst%3DA.%2BW.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%2520Potent%2520Protein%2520Kinase%2520C%2520Iota%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4386%26epage%3D4396%26doi%3D10.1021%2Facs.jmedchem.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rountree, J. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flasz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkoudis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozycka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odrzywol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feutren-Burton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavory, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span> <span> </span><span class="NLM_article-title">Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=238-243&author=C.+R.+O%E2%80%99Dowdauthor=M.+D.+Helmauthor=J.+S.+S.+Rountreeauthor=J.+T.+Flaszauthor=E.+Arkoudisauthor=H.+Mielauthor=P.+R.+Hewittauthor=L.+Jordanauthor=O.+Barkerauthor=C.+Hughesauthor=E.+Rozyckaauthor=E.+Cassidyauthor=K.+McClellandauthor=E.+Odrzywolauthor=N.+Pageauthor=S.+Feutren-Burtonauthor=S.+Dvorkinauthor=G.+Gavoryauthor=T.+Harrison&title=Identification+and+Structure-Guided+Development+of+Pyrimidinone+Based+USP7+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors</span></div><div class="casAuthors">O'Dowd, Colin R.; Helm, Matthew D.; Rountree, J. S. Shane; Flasz, Jakub T.; Arkoudis, Elias; Miel, Hugues; Hewitt, Peter R.; Jordan, Linda; Barker, Oliver; Hughes, Caroline; Rozycka, Ewelina; Cassidy, Eamon; McClelland, Keeva; Odrzywol, Ewa; Page, Natalie; Feutren-Burton, Stephanie; Dvorkin, Scarlett; Gavory, Gerald; Harrison, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ubiquitin specific protease 7 (USP7, HAUSP) has become an attractive target in drug discovery due to the role it plays in modulating Mdm2 levels and consequently p53.  Increasing interest in USP7 is emerging due to its potential involvement in oncogenic pathways as well as possible roles in both metabolic and immune disorders in addn. to viral infections.  Potent, novel, and selective inhibitors of USP7 have been developed using both rational and structure-guided design enabled by high-resoln. cocrystallog.  Initial hits were identified via fragment-based screening, scaffold-hopping, and hybridization exercises.  Two distinct subseries are described along with assocd. structure-activity relationship trends, as are initial efforts aimed at developing compds. suitable for in vivo expts.  Overall, these discoveries will enable further research into the wider biol. role of USP7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU61uWyWL-_bVg90H21EOLACvtfcHk0liL-n890Ev1kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFOgs78%253D&md5=7035261c011f6381549e43cfc0b4af0c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00512%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DC.%2BR.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DRountree%26aufirst%3DJ.%2BS.%2BS.%26aulast%3DFlasz%26aufirst%3DJ.%2BT.%26aulast%3DArkoudis%26aufirst%3DE.%26aulast%3DMiel%26aufirst%3DH.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DJordan%26aufirst%3DL.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DHughes%26aufirst%3DC.%26aulast%3DRozycka%26aufirst%3DE.%26aulast%3DCassidy%26aufirst%3DE.%26aulast%3DMcClelland%26aufirst%3DK.%26aulast%3DOdrzywol%26aufirst%3DE.%26aulast%3DPage%26aufirst%3DN.%26aulast%3DFeutren-Burton%26aufirst%3DS.%26aulast%3DDvorkin%26aufirst%3DS.%26aulast%3DGavory%26aufirst%3DG.%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Structure-Guided%2520Development%2520of%2520Pyrimidinone%2520Based%2520USP7%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D238%26epage%3D243%26doi%3D10.1021%2Facsmedchemlett.7b00512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Derived Inhibitors of Human N-Myristoyltransferase Block Capsid Assembly and Replication of the Common Cold Virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+Perez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Guedanauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-Derived+Inhibitors+of+Human+N-Myristoyltransferase+Block+Capsid+Assembly+and+Replication+of+the+Common+Cold+Virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0lgjA1vYeZJ8Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DPerez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGuedan%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-Derived%2520Inhibitors%2520of%2520Human%2520N-Myristoyltransferase%2520Block%2520Capsid%2520Assembly%2520and%2520Replication%2520of%2520the%2520Common%2520Cold%2520Virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Approach to Targeting Inosine-5′-Monophosphate Dehydrogenase (IMPDH) from <i>Mycobacterium tuberculosis</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2806-2822&author=A.+Traperoauthor=A.+Pacittoauthor=V.+Singhauthor=M.+Sabbahauthor=A.+G.+Coyneauthor=V.+Mizrahiauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=C.+Abell&title=Fragment-Based+Approach+to+Targeting+Inosine-5%E2%80%B2-Monophosphate+Dehydrogenase+%28IMPDH%29+from+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.7b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span></div><div class="casAuthors">Trapero, Ana; Pacitto, Angela; Singh, Vinayak; Sabbah, Mohamad; Coyne, Anthony G.; Mizrahi, Valerie; Blundell, Tom L.; Ascher, David B.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2806-2822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB) remains a major cause of mortality worldwide, and improved treatments are needed to combat emergence of drug resistance.  IMP dehydrogenase (IMPDH), a crucial enzyme required for de novo synthesis of guanine nucleotides, is an attractive TB drug target.  Herein, we describe the identification of potent IMPDH inhibitors using fragment-based screening and structure-based design techniques.  Screening of a fragment library for Mycobacterium thermoresistible (Mth) IMPDH ΔCBS inhibitors identified a low affinity phenylimidazole deriv.  X-ray crystallog. of the Mth IMPDH ΔCBS-IMP-inhibitor complex revealed that two mols. of the fragment were bound in the NAD binding pocket of IMPDH.  Linking the two mols. of the fragment afforded compds. with more than 1000-fold improvement in IMPDH affinity over the initial fragment hit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIloJxzRRl5bVg90H21EOLACvtfcHk0lgjA1vYeZJ8Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D&md5=a0decf859d321144e41547dda2b38fbf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01622%26sid%3Dliteratum%253Aachs%26aulast%3DTrapero%26aufirst%3DA.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DSabbah%26aufirst%3DM.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-Based%2520Approach%2520to%2520Targeting%2520Inosine-5%25E2%2580%25B2-Monophosphate%2520Dehydrogenase%2520%2528IMPDH%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2806%26epage%3D2822%26doi%3D10.1021%2Facs.jmedchem.7b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talagas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Saez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panagakou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjanacz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M.</span></span> <span> </span><span class="NLM_article-title">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2533-2551&author=F.+Rahmauthor=J.+Viklundauthor=L.+Tresauguesauthor=M.+Ellermannauthor=A.+Gieseauthor=U.+Ericssonauthor=R.+Forsblomauthor=T.+Ginmanauthor=J.+Guntherauthor=K.+Hallbergauthor=J.+Lindstromauthor=L.+B.+Perssonauthor=C.+Silvanderauthor=A.+Talagasauthor=L.+Diaz-Saezauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=I.+Panagakouauthor=P.+Siejkaauthor=M.+Gorjanaczauthor=M.+Bauserauthor=M.+Andersson&title=Creation+of+a+Novel+Class+of+Potent+and+Selective+MutT+Homologue+1+%28MTH1%29+Inhibitors+Using+Fragment-Based+Screening+and+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span></div><div class="casAuthors">Rahm, Fredrik; Viklund, Jenny; Tresaugues, Lionel; Ellermann, Manuel; Giese, Anja; Ericsson, Ulrika; Forsblom, Rickard; Ginman, Tobias; Gunther, Judith; Hallberg, Kenth; Lindstroem, Johan; Persson, Lars Boukharta; Silvander, Camilla; Talagas, Antoine; Diaz-Saez, Laura; Fedorov, Oleg; Huber, Kilian V. M.; Panagakou, Ioanna; Siejka, Paulina; Gorjanacz, Matyas; Bauser, Marcus; Andersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2533-2551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent literature has both suggested and questioned MTH1 as a novel cancer target.  BAY-707 was just published as a target validation small mol. probe for assessing the effects of pharmacol. inhibition of MTH1 on tumor cell survival, both in vitro and in vivo.  In this report, the authors describe the medicinal chem. program creating BAY-707, where fragment-based methods were used to develop a series of highly potent and selective MTH1 inhibitors.  Using structure-based drug design and rational medicinal chem. approaches, the potency was increased over 10,000 times from the fragment starting point while maintaining high ligand efficiency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7pMr__ory7Vg90H21EOLACvtfcHk0lgzMuYZO6DV1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D&md5=5500fe330efef6fdbe5eae95b3d88ab1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01884%26sid%3Dliteratum%253Aachs%26aulast%3DRahm%26aufirst%3DF.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DTresaugues%26aufirst%3DL.%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DEricsson%26aufirst%3DU.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DGunther%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPersson%26aufirst%3DL.%2BB.%26aulast%3DSilvander%26aufirst%3DC.%26aulast%3DTalagas%26aufirst%3DA.%26aulast%3DDiaz-Saez%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DPanagakou%26aufirst%3DI.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DGorjanacz%26aufirst%3DM.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DM.%26atitle%3DCreation%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520MutT%2520Homologue%25201%2520%2528MTH1%2529%2520Inhibitors%2520Using%2520Fragment-Based%2520Screening%2520and%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2533%26epage%3D2551%26doi%3D10.1021%2Facs.jmedchem.7b01884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korepanova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longenecker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Potent NAMPT Inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2017.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29287958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCmtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=437-440&author=A.+Korepanovaauthor=K.+L.+Longeneckerauthor=S.+D.+Prattauthor=S.+C.+Panchalauthor=R.+F.+Clarkauthor=M.+Lakeauthor=S.+M.+Gopalakrishnanauthor=D.+Raichauthor=C.+Sunauthor=A.+M.+Petros&title=Fragment-Based+Discovery+of+a+Potent+NAMPT+Inhibitor&doi=10.1016%2Fj.bmcl.2017.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a potent NAMPT inhibitor</span></div><div class="casAuthors">Korepanova, Alla; Longenecker, Kenton L.; Pratt, Steve D.; Panchal, Sanjay C.; Clark, Richard F.; Lake, Marc; Gopalakrishnan, Sujatha M.; Raich, Diana; Sun, Chaohong; Petros, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-440</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NAMPT expression is elevated in many cancers, making this protein a potential target for anticancer therapy.  The authors have carried out both NMR based and TR-FRET based fragment screens against human NAMPT and identified six novel binders with a range of potencies.  Co-crystal structures were obtained for two of the fragments bound to NAMPT while for the other four fragments force-field driven docking was employed to generate a bound pose.  Based on structural insights arising from comparison of the bound fragment poses to that of bound FK866 the authors were able to synthetically elaborate one of the fragments into a potent NAMPT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-8YrVVMkVcrVg90H21EOLACvtfcHk0lg0os7SONghoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCmtrbP&md5=4a1e76378d5f3a2093887da6a269799e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKorepanova%26aufirst%3DA.%26aulast%3DLongenecker%26aufirst%3DK.%2BL.%26aulast%3DPratt%26aufirst%3DS.%2BD.%26aulast%3DPanchal%26aufirst%3DS.%2BC.%26aulast%3DClark%26aufirst%3DR.%2BF.%26aulast%3DLake%26aufirst%3DM.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DRaich%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Potent%2520NAMPT%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D437%26epage%3D440%26doi%3D10.1016%2Fj.bmcl.2017.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namatame, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honbou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1248/cpb.c17-00836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1248%2Fcpb.c17-00836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29491261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=286-294&author=A.+Chinoauthor=R.+Seoauthor=Y.+Amanoauthor=I.+Namatameauthor=W.+Hamaguchiauthor=K.+Honbouauthor=T.+Miharaauthor=M.+Yamazakiauthor=M.+Tomishimaauthor=N.+Masuda&title=Fragment-Based+Discovery+of+Pyrimido%5B1%2C2-b%5Dindazole+PDE10A+Inhibitors&doi=10.1248%2Fcpb.c17-00836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of Pyrimido[1,2-b]indazole PDE10A inhibitors</span></div><div class="casAuthors">Chino, Ayaka; Seo, Ryushi; Amano, Yasushi; Namatame, Ichiji; Hamaguchi, Wataru; Honbou, Kazuya; Mihara, Takuma; Yamazaki, Mayako; Tomishima, Masaki; Masuda, Naoyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">286-294</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">In this study, we report the identification of potent pyrimidoindazoles as phosphodiesterase10A (PDE10A) inhibitors by using the method of fragment-based drug discovery (FBDD).  The pyrazolopyridine deriv. 2 was found to be a fragment hit compd. which could occupy a part of the binding site of PDE10A enzyme by using the method of the X-ray co-crystal structure anal.  On the basis of the crystal structure of compd. 2 and PDE10A protein, a no. of compds. were synthesized and evaluated, by means of structure-activity relationship (SAR) studies, which culminated in the discovery of a novel pyrimidoindazole deriv. 13 having good physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGkZ7fYLkZeLVg90H21EOLACvtfcHk0lg0os7SONghoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOlu7fO&md5=6dbed6b6fd4d9ddf7e7198ff1ac9a71f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c17-00836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c17-00836%26sid%3Dliteratum%253Aachs%26aulast%3DChino%26aufirst%3DA.%26aulast%3DSeo%26aufirst%3DR.%26aulast%3DAmano%26aufirst%3DY.%26aulast%3DNamatame%26aufirst%3DI.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DHonbou%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DTomishima%26aufirst%3DM.%26aulast%3DMasuda%26aufirst%3DN.%26atitle%3DFragment-Based%2520Discovery%2520of%2520Pyrimido%255B1%252C2-b%255Dindazole%2520PDE10A%2520Inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D286%26epage%3D294%26doi%3D10.1248%2Fcpb.c17-00836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepper, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blechschmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balibar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3309</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01691</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01691" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3309-3324&author=R.+J.+Moreauauthor=C.+K.+Skepperauthor=B.+A.+Appletonauthor=A.+Blechschmidtauthor=C.+J.+Balibarauthor=B.+M.+Bentonauthor=J.+E.+Drummauthor=B.+Y.+Fengauthor=M.+Gengauthor=C.+Liauthor=M.+K.+Lindvallauthor=A.+Lingelauthor=Y.+Luauthor=M.+Mamoauthor=W.+Mergoauthor=V.+Polyakovauthor=T.+M.+Smithauthor=K.+Takeokaauthor=K.+Ueharaauthor=L.+Wangauthor=J.+R.+Weiauthor=A.+H.+Weissauthor=L.+Xieauthor=W.+Xuauthor=Q.+Zhangauthor=J.+de+Vicente&title=Fragment-Based+Drug+Discovery+of+Inhibitors+of+Phosphopantetheine+Adenylyltransferase+from+Gram-Negative+Bacteria&doi=10.1021%2Facs.jmedchem.7b01691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria</span></div><div class="casAuthors">Moreau, Robert J.; Skepper, Colin K.; Appleton, Brent A.; Blechschmidt, Anke; Balibar, Carl J.; Benton, Bret M.; Drumm, Joseph E.; Feng, Brian Y.; Geng, Mei; Li, Cindy; Lindvall, Mika K.; Lingel, Andreas; Lu, Yipin; Mamo, Mulugeta; Mergo, Wosenu; Polyakov, Valery; Smith, Thomas M.; Takeoka, Kenneth; Uehara, Kyoko; Wang, Lisha; Wei, Jun-Rong; Weiss, Andrew H.; Xie, Lili; Xu, Wenjian; Zhang, Qiong; de Vicente, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3309-3324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and development of new antibiotics capable of curing infections due to multidrug-resistant and pandrug-resistant Gram-neg. bacteria is a major challenge with fundamental importance to our global healthcare system.  Part of our broad program at Novartis to address this urgent, unmet need includes the search for new agents that inhibit novel bacterial targets.  Here we report the discovery and hit-to-lead optimization of new inhibitors of phosphopantetheine adenylyltransferase (PPAT) from Gram-neg. bacteria.  Utilizing a fragment-based screening approach, we discovered a no. of unique scaffolds capable of interacting with the pantetheine site of E. coli PPAT and inhibiting enzymic activity, including triazolopyrimidinone.  Structure-based optimization resulted in the identification of two lead compds. as selective, small mol. inhibitors of bacterial PPAT: triazolopyrimidinone I and azabenzimidazole II efficiently inhibited E. coli and P. aeruginosa PPAT and displayed modest cellular potency against the efflux-deficient E. coli ΔtolC mutant strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa07bfbrkvALVg90H21EOLACvtfcHk0ljljNAfk7GOFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgs7Y%253D&md5=9a7b2e05b17b6b2a83f96505de020cf1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01691%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DR.%2BJ.%26aulast%3DSkepper%26aufirst%3DC.%2BK.%26aulast%3DAppleton%26aufirst%3DB.%2BA.%26aulast%3DBlechschmidt%26aufirst%3DA.%26aulast%3DBalibar%26aufirst%3DC.%2BJ.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%2BK.%26aulast%3DLingel%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DT.%2BM.%26aulast%3DTakeoka%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DJ.%2BR.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%2520Inhibitors%2520of%2520Phosphopantetheine%2520Adenylyltransferase%2520from%2520Gram-Negative%2520Bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3309%26epage%3D3324%26doi%3D10.1021%2Facs.jmedchem.7b01691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skepper, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostafavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeoka, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3325</span>– <span class="NLM_lpage">3349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01861</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01861" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3325-3349&author=C.+K.+Skepperauthor=R.+J.+Moreauauthor=B.+A.+Appletonauthor=B.+M.+Bentonauthor=J.+E.+Drummauthor=B.+Y.+Fengauthor=M.+Gengauthor=C.+Huauthor=C.+Liauthor=A.+Lingelauthor=Y.+Luauthor=M.+Mamoauthor=W.+Mergoauthor=M.+Mostafaviauthor=C.+M.+Rathauthor=M.+Steffekauthor=K.+T.+Takeokaauthor=K.+Ueharaauthor=L.+Wangauthor=J.+R.+Weiauthor=L.+Xieauthor=W.+Xuauthor=Q.+Zhangauthor=J.+de+Vicente&title=Discovery+and+Optimization+of+Phosphopantetheine+Adenylyltransferase+Inhibitors+with+Gram-Negative+Antibacterial+Activity&doi=10.1021%2Facs.jmedchem.7b01861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity</span></div><div class="casAuthors">Skepper, Colin K.; Moreau, Robert J.; Appleton, Brent A.; Benton, Bret M.; Drumm, Joseph E.; Feng, Brian Y.; Geng, Mei; Hu, Cheng; Li, Cindy; Lingel, Andreas; Lu, Yipin; Mamo, Mulugeta; Mergo, Wosenu; Mostafavi, Mina; Rath, Christopher M.; Steffek, Micah; Takeoka, Kenneth T.; Uehara, Kyoko; Wang, Lisha; Wei, Jun-Rong; Xie, Lili; Xu, Wenjian; Zhang, Qiong; de Vicente, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3325-3349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the preceding manuscript the authors described a successful fragment-based lead discovery (FBLD) strategy for discovery of bacterial phosphopantetheine adenylyltransferase inhibitors (PPAT, CoaD).  Following several rounds of optimization two promising lead compds. were identified: triazolopyrimidinone (I) and 4-azabenzimidazole (II).  Here the authors disclose the efforts to further optimize these two leads for on-target potency and Gram-neg. cellular activity.  Enabled by a robust x-ray crystallog. system, the authors' structure-based inhibitor design approach delivered compds. with biochem. potencies 4-5 orders of magnitude greater than their resp. fragment starting points.  Addnl. optimization was guided by observations on bacterial permeability and physicochem. properties, which ultimately led to the identification of PPAT inhibitors with cellular activity against wild-type E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSVizQsO4tt7Vg90H21EOLACvtfcHk0lgBDQkvGax5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGltr0%253D&md5=6077c6386bcb76e34f324533bd9cb43c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01861%26sid%3Dliteratum%253Aachs%26aulast%3DSkepper%26aufirst%3DC.%2BK.%26aulast%3DMoreau%26aufirst%3DR.%2BJ.%26aulast%3DAppleton%26aufirst%3DB.%2BA.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLingel%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMostafavi%26aufirst%3DM.%26aulast%3DRath%26aufirst%3DC.%2BM.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DTakeoka%26aufirst%3DK.%2BT.%26aulast%3DUehara%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DJ.%2BR.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Phosphopantetheine%2520Adenylyltransferase%2520Inhibitors%2520with%2520Gram-Negative%2520Antibacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3325%26epage%3D3349%26doi%3D10.1021%2Facs.jmedchem.7b01861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demont, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinjha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4317</span>– <span class="NLM_lpage">4334</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01666</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01666" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Sjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4317-4334&author=R.+P.+Lawauthor=S.+J.+Atkinsonauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=E.+H.+Demontauthor=L.+J.+Gordonauthor=M.+Lindonauthor=R.+K.+Prinjhaauthor=A.+J.+B.+Watsonauthor=D.+J.+Hirst&title=Discovery+of+Tetrahydroquinoxalines+as+Bromodomain+and+Extra-Terminal+Domain+%28BET%29+Inhibitors+with+Selectivity+for+the+Second+Bromodomain&doi=10.1021%2Facs.jmedchem.7b01666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain</span></div><div class="casAuthors">Law, Robert P.; Atkinson, Stephen J.; Bamborough, Paul; Chung, Chun-wa; Demont, Emmanuel H.; Gordon, Laurie J.; Lindon, Matthew; Prinjha, Rab K.; Watson, Allan J. B.; Hirst, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4317-4334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromodomain and extra-terminal domain (BET) family of proteins bind acetylated lysine residues on histone proteins.  The four BET bromodomains-BRD2, BRD3, BRD4, and BRDT-each contain two bromodomain modules.  BET bromodomain inhibition is a potential therapy for various cancers and immunoinflammatory diseases, but few reported inhibitors show selectivity within the BET family.  Inhibitors with selectivity for the first or second bromodomain are desired to aid investigation of the biol. function of these domains.  Focused library screening identified a series of tetrahydroquinoxalines with selectivity for the second bromodomains of the BET family (BD2).  Structure-guided optimization of the template improved potency, selectivity, and physicochem. properties, culminating in potent BET inhibitors with BD2 selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobBKYwu7NyTbVg90H21EOLACvtfcHk0lgBDQkvGax5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Sjtbc%253D&md5=078db91b35feaf1958fa8c33d0544387</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01666%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DR.%2BP.%26aulast%3DAtkinson%26aufirst%3DS.%2BJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520Tetrahydroquinoxalines%2520as%2520Bromodomain%2520and%2520Extra-Terminal%2520Domain%2520%2528BET%2529%2520Inhibitors%2520with%2520Selectivity%2520for%2520the%2520Second%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4317%26epage%3D4334%26doi%3D10.1021%2Facs.jmedchem.7b01666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosario, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betancort, J. M.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Novel 4-Phenylisoquinolinone BET Bromodomain Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29657099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Smsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1811-1816&author=M.+J.+Bennettauthor=Y.+Wuauthor=A.+Boloorauthor=J.+Matuszkiewiczauthor=S.+M.+O%E2%80%99Connellauthor=L.+Shiauthor=R.+K.+Stansfieldauthor=J.+R.+Del+Rosarioauthor=J.+M.+Vealauthor=D.+J.+Hosfieldauthor=J.+Xuauthor=S.+W.+Kaldorauthor=J.+A.+Staffordauthor=J.+M.+Betancort&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+4-Phenylisoquinolinone+BET+Bromodomain+Inhibitors&doi=10.1016%2Fj.bmcl.2018.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors</span></div><div class="casAuthors">Bennett, Michael J.; Wu, Yiqin; Boloor, Amogh; Matuszkiewicz, Jennifer; O'Connell, Shawn M.; Shi, Lihong; Stansfield, Ryan K.; Del Rosario, Joselyn R.; Veal, James M.; Hosfield, David J.; Xu, Jiangchun; Kaldor, Stephen W.; Stafford, Jeffrey A.; Betancort, Juan M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1811-1816</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bromodomain and extra-terminal (BET) family of epigenetic proteins has attracted considerable attention in drug discovery given its involvement in regulating gene transcription.  Screening a focused small mol. library based on the bromodomain pharmacophore resulted in the identification of 2-methylisoquinoline-1-one as a novel BET bromodomain-binding motif.  Structure guided SAR exploration resulted in >10,000-fold potency improvement for the BRD4-BD1 bromodomain.  Lead compds. exhibited excellent potencies in both biochem. and cellular assays in MYC-dependent cell lines.  Compd. 36 demonstrated good physicochem. properties and promising exposure levels in exploratory PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlnVx6qo2COrVg90H21EOLACvtfcHk0lgjKSTRU5lEVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Smsrk%253D&md5=0022a3a3c84c72f7d9a37382df3afd00</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DMatuszkiewicz%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DS.%2BM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%2BK.%26aulast%3DDel%2BRosario%26aufirst%3DJ.%2BR.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DBetancort%26aufirst%3DJ.%2BM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25204-Phenylisoquinolinone%2520BET%2520Bromodomain%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1811%26epage%3D1816%26doi%3D10.1016%2Fj.bmcl.2018.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batiste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unzue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolbois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiliotopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevado, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span> <span> </span><span class="NLM_article-title">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.7b00401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ehu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=180-188&author=L.+Batisteauthor=A.+Unzueauthor=A.+Dolboisauthor=F.+Hasslerauthor=X.+Wangauthor=N.+Deerainauthor=J.+Zhuauthor=D.+Spiliotopoulosauthor=C.+Nevadoauthor=A.+Caflisch&title=Chemical+Space+Expansion+of+Bromodomain+Ligands+Guided+by+in+Silico+Virtual+Couplings+%28AutoCouple%29&doi=10.1021%2Facscentsci.7b00401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)</span></div><div class="casAuthors">Batiste, Laurent; Unzue, Andrea; Dolbois, Aymeric; Hassler, Fabrice; Wang, Xuan; Deerain, Nicholas; Zhu, Jian; Spiliotopoulos, Dimitrios; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-188</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Expanding the chem. space and simultaneously ensuring synthetic accessibility is of upmost importance, not only for the discovery of effective binders for novel protein classes, but more importantly, for the development of compds. against hard-to-drug proteins.  Here, the authors present AutoCouple, a de novo approach to computational ligand design focused on the diversity-oriented generation of chem. entities via virtual couplings.  In a benchmark application, chem. diverse compds. with low-nanomolar potency for the CBP bromodomain and unprecedented selectivity (up to 1500 fold) against the BRD4(1) bromodomain were achieved by the synthesis of ∼50 derivs. of the original fragment.  The binding mode was confirmed by x-ray crystallog., target engagement in cells was demonstrated and anti-proliferative activity showcased in three cancer cell lines.  These results reveal AutoCouple as a useful in silico coupling method to expand the chem. space in hit optimization campaigns resulting in potent, selective and cell permeable bromodomain ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa0J3CCu_dR7Vg90H21EOLACvtfcHk0lgjKSTRU5lEVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ehu7k%253D&md5=92bcfd52911b0f6f07b49569abf2e2e0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00401%26sid%3Dliteratum%253Aachs%26aulast%3DBatiste%26aufirst%3DL.%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DDolbois%26aufirst%3DA.%26aulast%3DHassler%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDeerain%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DChemical%2520Space%2520Expansion%2520of%2520Bromodomain%2520Ligands%2520Guided%2520by%2520in%2520Silico%2520Virtual%2520Couplings%2520%2528AutoCouple%2529%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2018%26volume%3D4%26spage%3D180%26epage%3D188%26doi%3D10.1021%2Facscentsci.7b00401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unzue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiliotopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevado, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1350-1356&author=A.+Unzueauthor=M.+Xuauthor=J.+Dongauthor=L.+Wiedmerauthor=D.+Spiliotopoulosauthor=A.+Caflischauthor=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span></div><div class="casAuthors">Unzue, Andrea; Xu, Min; Dong, Jing; Wiedmer, Lars; Spiliotopoulos, Dimitrios; Caflisch, Amedeo; Nevado, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1350-1356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel ligands of the CREBBP bromodomain were identified by fragment-based docking.  The in silico discovered hits have been optimized by chem. synthesis into selective nanomolar compds., thereby preserving the ligand efficiency.  The selectivity for the CREBBP bromodomain over other human bromodomain subfamilies has achieved by a benzoate moiety which was predicted by docking to be involved in favorable electrostatic interactions with the Arg1173 side chain, a prediction that could be verified a posteriori by the high-resoln. crystal structure of the CREBBP bromodomain in complex with ligand 6 and also by MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy4MHhgfhyu7Vg90H21EOLACvtfcHk0lhoynFCLpOJ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D&md5=aff73b86b04fc4d7243adcba364ca6a6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWiedmer%26aufirst%3DL.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1350%26epage%3D1356%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of 1-(1H-Indol-1-yl)ethanone Derivatives as CBP/EP300 Bromodomain Inhibitors for the Treatment of Castration-Resistant Prostate Cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.01.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.ejmech.2018.01.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29448139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2018&pages=238-252&author=Q.+Xiangauthor=C.+Wangauthor=Y.+Zhangauthor=X.+Xueauthor=M.+Songauthor=C.+Zhangauthor=C.+Liauthor=C.+Wuauthor=K.+Liauthor=X.+Huiauthor=Y.+Zhouauthor=J.+B.+Smaillauthor=A.+V.+Pattersonauthor=D.+Wuauthor=K.+Dingauthor=Y.+Xu&title=Discovery+and+Optimization+of+1-%281H-Indol-1-yl%29ethanone+Derivatives+as+CBP%2FEP300+Bromodomain+Inhibitors+for+the+Treatment+of+Castration-Resistant+Prostate+Cancer&doi=10.1016%2Fj.ejmech.2018.01.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer</span></div><div class="casAuthors">Xiang, Qiuping; Wang, Chao; Zhang, Yan; Xue, Xiaoqian; Song, Ming; Zhang, Cheng; Li, Chenchang; Wu, Chun; Li, Kuai; Hui, Xiaoyan; Zhou, Yulai; Smaill, Jeff B.; Patterson, Adam V.; Wu, Donghai; Ding, Ke; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">238-252</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The CREB (cAMP responsive element binding protein) binding protein (CBP) and its homolog EP300 have emerged as new therapeutic targets for the treatment of cancer and inflammatory diseases.  Here the authors report the identification, optimization and evaluation of 1-(1H-indol-1-yl)ethanone derivs. as CBP/EP300 inhibitors starting from fragment-based virtual screening (FBVS).  A cocrystal structure of the inhibitor (22e, (S)-1-(2-(3-acetyl-1H-indol-1-yl)acetyl)piperidine-3-carboxylic acid) in complex with CBP provides a solid structural basis for further optimization.  The most potent compd. 32h (3-(1-acetyl-5-methoxy-1H-indole-3-carboxamido)-4-fluoro-5-(1-methyl-1H-pyrazol-4-yl)benzoic acid) binds to the CBP bromodomain and has an IC50 value of 0.037 μM in the AlphaScreen assay which was 2 times more potent than the reported CBP bromodomain inhibitor SGC-CBP30 in the authors' hands.  Compd. 32h also exhibit high selectivity for CBP/EP300 over other bromodomain-contg. proteins.  Notably, the ester deriv. (29h) of compd. 32h markedly inhibits cell growth in several prostate cancer cell lines including LNCaP, 22Rv1 and LNCaP derived C4-2B.  Compd. 29h suppresses the mRNA expression of full length AR (AR-FL), AR target genes and other oncogene in LNCaP cells.  Compd. 29h also reduces the expression of PSA, the biomarker of prostate cancer.  CBP/EP300 inhibitor 29h represents a promising lead compd. for the development of new therapeutics for the treatment of castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfhyhecrKteLVg90H21EOLACvtfcHk0lhoynFCLpOJ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCmurc%253D&md5=960cb1e07d8d587d4b0f45eefe92f9af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.01.087%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DHui%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%25201-%25281H-Indol-1-yl%2529ethanone%2520Derivatives%2520as%2520CBP%252FEP300%2520Bromodomain%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Castration-Resistant%2520Prostate%2520Cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D147%26spage%3D238%26epage%3D252%26doi%3D10.1016%2Fj.ejmech.2018.01.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Migoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bery, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataille, C. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulmin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehebauer, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fuentes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbitts, T. H.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of RAS-Effector Protein Interactions Derived Using an Intracellular Antibody Fragment</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3169</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05707-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41467-018-05707-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30093669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ms12mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3169&author=C.+E.+Quevedoauthor=A.+Cruz-Migoniauthor=N.+Beryauthor=A.+Millerauthor=T.+Tanakaauthor=D.+Petchauthor=C.+J.+R.+Batailleauthor=L.+Y.+W.+Leeauthor=P.+S.+Fallonauthor=H.+Tulminauthor=M.+T.+Ehebauerauthor=N.+Fernandez-Fuentesauthor=A.+J.+Russellauthor=S.+B.+Carrauthor=S.+E.+V.+Phillipsauthor=T.+H.+Rabbitts&title=Small+Molecule+Inhibitors+of+RAS-Effector+Protein+Interactions+Derived+Using+an+Intracellular+Antibody+Fragment&doi=10.1038%2Fs41467-018-05707-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment</span></div><div class="casAuthors">Quevedo Camilo E; Cruz-Migoni Abimael; Bery Nicolas; Miller Ami; Tulmin Hanna; Ehebauer Matthias T; Rabbitts Terence H; Cruz-Migoni Abimael; Fernandez-Fuentes Narcis; Carr Stephen B; Phillips Simon E V; Tanaka Tomoyuki; Petch Donna; Tanaka Tomoyuki; Bataille Carole J R; Russell Angela J; Lee Lydia Y W; Fallon Phillip S; Tulmin Hanna; Ehebauer Matthias T; Fernandez-Fuentes Narcis; Carr Stephen B; Phillips Simon E V</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3169</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeting specific protein-protein interactions (PPIs) is an attractive concept for drug development, but hard to implement since intracellular antibodies do not penetrate cells and most small-molecule drugs are considered unsuitable for PPI inhibition.  A potential solution to these problems is to select intracellular antibody fragments to block PPIs, use these antibody fragments for target validation in disease models and finally derive small molecules overlapping the antibody-binding site.  Here, we explore this strategy using an anti-mutant RAS antibody fragment as a competitor in a small-molecule library screen for identifying RAS-binding compounds.  The initial hits are optimized by structure-based design, resulting in potent RAS-binding compounds that interact with RAS inside the cells, prevent RAS-effector interactions and inhibit endogenous RAS-dependent signalling.  Our results may aid RAS-dependent cancer drug development and demonstrate a general concept for developing small compounds to replace intracellular antibody fragments, enabling rational drug development to target validated PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIUnXfwZaCRvxQvRxYU81tfW6udTcc2eZK_2JFv1Uberntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ms12mtQ%253D%253D&md5=79679120c60be8cd9be9fbbfe0c9fdb6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05707-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05707-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuevedo%26aufirst%3DC.%2BE.%26aulast%3DCruz-Migoni%26aufirst%3DA.%26aulast%3DBery%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPetch%26aufirst%3DD.%26aulast%3DBataille%26aufirst%3DC.%2BJ.%2BR.%26aulast%3DLee%26aufirst%3DL.%2BY.%2BW.%26aulast%3DFallon%26aufirst%3DP.%2BS.%26aulast%3DTulmin%26aufirst%3DH.%26aulast%3DEhebauer%26aufirst%3DM.%2BT.%26aulast%3DFernandez-Fuentes%26aufirst%3DN.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DCarr%26aufirst%3DS.%2BB.%26aulast%3DPhillips%26aufirst%3DS.%2BE.%2BV.%26aulast%3DRabbitts%26aufirst%3DT.%2BH.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520RAS-Effector%2520Protein%2520Interactions%2520Derived%2520Using%2520an%2520Intracellular%2520Antibody%2520Fragment%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3169%26doi%3D10.1038%2Fs41467-018-05707-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salovich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogliotti, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tansey, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent 2-Aryl-6,7-dihydro-5 H-pyrrolo[1,2- a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5623</span>– <span class="NLM_lpage">5642</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5623-5642&author=F.+Wangauthor=K.+O.+Jeonauthor=J.+M.+Salovichauthor=J.+D.+Macdonaldauthor=J.+Alvaradoauthor=R.+D.+Gogliottiauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=Q.+Sunauthor=S.+Wangauthor=D.+Camperauthor=J.+P.+Yuhauthor=J.+G.+Shawauthor=J.+Saiauthor=O.+W.+Rossaneseauthor=W.+P.+Tanseyauthor=S.+R.+Staufferauthor=S.+W.+Fesik&title=Discovery+of+Potent+2-Aryl-6%2C7-dihydro-5+H-pyrrolo%5B1%2C2-+a%5Dimidazoles+as+WDR5-WIN-Site+Inhibitors+Using+Fragment-Based+Methods+and+Structure-Based+Design&doi=10.1021%2Facs.jmedchem.8b00375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent 2-Aryl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Wang, Feng; Jeon, Kyu Ok; Salovich, James M.; Macdonald, Jonathan D.; Alvarado, Joseph; Gogliotti, Rocco D.; Phan, Jason; Olejniczak, Edward T.; Sun, Qi; Wang, Shidong; Camper, DeMarco; Yuh, Joannes P.; Shaw, J. Grace; Sai, Jiqing; Rossanese, Olivia W.; Tansey, William P.; Stauffer, Shaun R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5623-5642</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted pyrroloimidazoles such as I [R = 3,4-Cl2C6H3CH2, 3-MeO-4-MeC6H3, 2-Me-4-pyridinyl, 3,5-(MeO)2-4-MeC6H2] were prepd. as inhibitors of the chromatin-regulatory scaffold protein WDR5 WDR5-interaction (WIN) site as lead compds. for development of antitumor agents.  NMR-based screening of a large fragment library identified several chem. distinct hit series that bind to the WIN site within WDR5.  Using a structure-based design approach, pyrroloimidazoles were found with dissocn. consts. < 10 nM for WDR5 and micromolar cellular activity against an AML-leukemia cell line.  The structures of I (R = 3-MeO-4-MeC6H3) and of four other compds. bound to a fragment of WDR5 were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBSZaiiuG6OrVg90H21EOLACvtfcHk0lhIW7_sVhGucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrsLjN&md5=2322c6458b2a060005bf5250a46f5cbd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00375%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DJ.%2BD.%26aulast%3DAlvarado%26aufirst%3DJ.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DYuh%26aufirst%3DJ.%2BP.%26aulast%3DShaw%26aufirst%3DJ.%2BG.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DTansey%26aufirst%3DW.%2BP.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Potent%25202-Aryl-6%252C7-dihydro-5%2520H-pyrrolo%255B1%252C2-%2520a%255Dimidazoles%2520as%2520WDR5-WIN-Site%2520Inhibitors%2520Using%2520Fragment-Based%2520Methods%2520and%2520Structure-Based%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5623%26epage%3D5642%26doi%3D10.1021%2Facs.jmedchem.8b00375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemyn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span> <span> </span><span class="NLM_article-title">Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5295</span>, <span class="refDoi"> DOI: 10.1002/anie.201712581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fanie.201712581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVeiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5292-5295&author=E.+Pardonauthor=C.+Bettiauthor=T.+Laeremansauthor=F.+Chevillardauthor=K.+Guillemynauthor=P.+Kolbauthor=S.+Balletauthor=J.+Steyaert&title=Nanobody-Enabled+Reverse+Pharmacology+on+G-Protein-Coupled+Receptors&doi=10.1002%2Fanie.201712581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors</span></div><div class="casAuthors">Pardon, Els; Betti, Cecilia; Laeremans, Toon; Chevillard, Florent; Guillemyn, Karel; Kolb, Peter; Ballet, Steven; Steyaert, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5292-5295</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The conformational complexity of transmembrane signaling of G-protein-coupled receptors (GPCRs) is a central hurdle for the design of screens for receptor agonists.  In their basal states, GPCRs have lower affinities for agonists compared to their G-protein-bound active state conformations.  Moreover, different agonists can stabilize distinct active receptor conformations and do not uniformly activate all cellular signaling pathways linked to a given receptor (agonist bias).  Comparative fragment screens were performed on a β2-adrenoreceptor-nanobody fusion locked in its active-state conformation by a G-protein-mimicking nanobody, and the same receptor in its basal-state conformation.  This simple biophys. assay allowed the identification and ranking of multiple novel agonists and permitted classification of the efficacy of each hit in agonist, antagonist, or inverse agonist categories, thereby opening doors to nanobody-enabled reverse pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8ltArcxl9PrVg90H21EOLACvtfcHk0lhIW7_sVhGucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVeiu7g%253D&md5=89f5488d7644ed663a97c770bee85cfe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201712581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201712581%26sid%3Dliteratum%253Aachs%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DChevillard%26aufirst%3DF.%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DKolb%26aufirst%3DP.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26atitle%3DNanobody-Enabled%2520Reverse%2520Pharmacology%2520on%2520G-Protein-Coupled%2520Receptors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D5292%26epage%3D5295%26doi%3D10.1002%2Fanie.201712581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drapier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulumaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span> <span> </span><span class="NLM_article-title">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5279</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5279-5291&author=T.+Drapierauthor=P.+Geubelleauthor=C.+Bouckaertauthor=L.+Nielsenauthor=S.+Laulumaaauthor=E.+Goffinauthor=S.+Dillyauthor=P.+Francotteauthor=J.+Hansonauthor=L.+Pochetauthor=J.+S.+Kastrupauthor=B.+Pirotte&title=Enhancing+Action+of+Positive+Allosteric+Modulators+through+the+Design+of+Dimeric+Compounds&doi=10.1021%2Facs.jmedchem.8b00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span></div><div class="casAuthors">Drapier, Thomas; Geubelle, Pierre; Bouckaert, Charlotte; Nielsen, Lise; Laulumaa, Saara; Goffin, Eric; Dilly, Sebastien; Francotte, Pierre; Hanson, Julien; Pochet, Lionel; Kastrup, Jette Sandholm; Pirotte, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5279-5291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study describes the identification of highly potent dimeric 1,2,4-benzothiadiazine 1,1-dioxide (BTD)-type pos. allosteric modulators of the AMPA receptors (AMPApams) obtained by linking two monomeric BTD scaffolds through their resp. 6-positions.  Using previous X-ray data from monomeric BTDs cocrystd. with the GluA2 ligand-binding domain (LBD), a mol. modeling approach was performed to predict the preferred dimeric combinations.  Two 6,6-ethylene-linked dimeric BTD compds. (16 and 22) were prepd. and evaluated as AMPApams on HEK293 cells expressing GluA2o(Q) (calcium flux expt.).  These compds. were found to be about 10,000 times more potent than their resp. monomers, the most active dimeric compd. being the bis-4-cyclopropyl-substituted compd. 22 [6,6'-(ethane-1,2-diyl)bis(4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide], with an EC50 value of 1.4 nM.  As a proof of concept, the bis-4-methyl-substituted dimeric compd. 16 (EC50 = 13 nM) was successfully cocrystd. with the GluA2o-LBD and was found to occupy the two BTD binding sites at the LBD dimer interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6AJCoOPIir7Vg90H21EOLACvtfcHk0ljDO29e2biZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D&md5=d438a5a16c5ab50e72cda5a71f6c5550</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00250%26sid%3Dliteratum%253Aachs%26aulast%3DDrapier%26aufirst%3DT.%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DBouckaert%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLaulumaa%26aufirst%3DS.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DFrancotte%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DEnhancing%2520Action%2520of%2520Positive%2520Allosteric%2520Modulators%2520through%2520the%2520Design%2520of%2520Dimeric%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5279%26epage%3D5291%26doi%3D10.1021%2Facs.jmedchem.8b00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6724</span>– <span class="NLM_lpage">6735</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12jsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6724-6735&author=D.+A.+Carcacheauthor=A.+Vulpettiauthor=J.+Kallenauthor=H.+Mattesauthor=D.+Orainauthor=R.+Stringerauthor=E.+Vangrevelingheauthor=R.+M.+Wolfauthor=K.+Kaupmannauthor=J.+Ottlauthor=J.+Dawsonauthor=N.+G.+Cookeauthor=K.+Hoegenauerauthor=A.+Billichauthor=J.+Wagnerauthor=C.+Guntermannauthor=S.+Hintermann&title=Optimizing+a+Weakly+Binding+Fragment+into+a+Potent+ROR%CE%B3t+Inverse+Agonist+with+Efficacy+in+an+in+Vivo+Inflammation+Model&doi=10.1021%2Facs.jmedchem.8b00529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model</span></div><div class="casAuthors">Carcache, David A.; Vulpetti, Anna; Kallen, Joerg; Mattes, Henri; Orain, David; Stringer, Rowan; Vangrevelinghe, Eric; Wolf, Romain M.; Kaupmann, Klemens; Ottl, Johannes; Dawson, Janet; Cooke, Nigel G.; Hoegenauer, Klemens; Billich, Andreas; Wagner, Juergen; Guntermann, Christine; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6724-6735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor RORγt is an attractive drug-target due to its role in the differentiation of IL-17 producing Th17 cells that play a crit. role in the etiopathol. of several autoimmune diseases.  Identification of starting points for RORγt inverse agonists with good properties has been a challenge.  We report the identification of a fragment hit and its conversion into a potent inverse agonist through fragment optimization, growing and merging efforts.  Further anal. of the binding mode revealed that inverse agonism was achieved by an unusual mechanism.  In contrast to other reported inverse agonists, there is no direct interaction or displacement of helix 12 obsd. in the crystal structure.  Nevertheless, compd. 9 proved to be efficacious in a delayed-type hypersensitivity (DTH) inflammation model in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNfQTVtmUt7Vg90H21EOLACvtfcHk0ljDO29e2biZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12jsbjK&md5=6032c6b6a85377ea247a92314736db06</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00529%26sid%3Dliteratum%253Aachs%26aulast%3DCarcache%26aufirst%3DD.%2BA.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DOptimizing%2520a%2520Weakly%2520Binding%2520Fragment%2520into%2520a%2520Potent%2520ROR%25CE%25B3t%2520Inverse%2520Agonist%2520with%2520Efficacy%2520in%2520an%2520in%2520Vivo%2520Inflammation%2520Model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6724%26epage%3D6735%26doi%3D10.1021%2Facs.jmedchem.8b00529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Miller, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmartin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoute, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">A Hit Deconstruction Approach for the Discovery of Fetal Hemoglobin Inducers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3676</span>– <span class="NLM_lpage">3680</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30554630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVGlt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3676-3680&author=A.+B.+Benowitzauthor=H.+C.+Eberlauthor=C.+L.+Erickson-Millerauthor=A.+G.+Gilmartinauthor=E.+R.+Goreauthor=M.+N.+Montouteauthor=Z.+Wu&title=A+Hit+Deconstruction+Approach+for+the+Discovery+of+Fetal+Hemoglobin+Inducers&doi=10.1016%2Fj.bmcl.2018.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A hit deconstruction approach for the discovery of fetal hemoglobin inducers</span></div><div class="casAuthors">Benowitz, Andrew B.; Eberl, H. Christian; Erickson-Miller, Connie L.; Gilmartin, Aidan G.; Gore, Elizabeth R.; Montoute, Monica N.; Wu, Zining</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">3676-3680</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Beta-hemoglobinopathies such as sickle cell disease represent a major global unmet medical need.  De-repression of fetal Hb in erythrocytes is a clin. validated approach for the management of sickle cell disease, but the only FDA-approved medicine for this purpose has limitations to its use.  We conducted a phenotypic screen in human erythroid progenitor cells to identify mols. with the ability to de-repress fetal Hb, which resulted in the identification of the benzoxaborole-contg. hit compd. 1.  This compd. was found to have modest cellular potency and lead-like pharmacokinetics, but no identifiable SAR to enable optimization.  Systematic deconstruction of a closely related analog of 1 revealed the fragment-like carboxylic acid 12, which was then optimized to provide tetrazole 31, which had approx. 100-fold improved cellular potency compared to 1, high levels of oral exposure in rats, and excellent soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdoiMb2V7dyLVg90H21EOLACvtfcHk0lilxQce0iwvIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVGlt7%252FE&md5=8dcb0533662581a03f4b935fffae848b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DA.%2BB.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DErickson-Miller%26aufirst%3DC.%2BL.%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DGore%26aufirst%3DE.%2BR.%26aulast%3DMontoute%26aufirst%3DM.%2BN.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DA%2520Hit%2520Deconstruction%2520Approach%2520for%2520the%2520Discovery%2520of%2520Fetal%2520Hemoglobin%2520Inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3676%26epage%3D3680%26doi%3D10.1016%2Fj.bmcl.2018.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span>; <span class="NLM_string-name">Weininger, D.</span></span> Clogp Reference Manual, Daylight version 4.9. <a href="http://www.daylight.com/dayhtml/doc/clogp/" class="extLink">http://www.daylight.com/dayhtml/doc/clogp/</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Leo%2C+A.%3B+Weininger%2C+D.+Clogp+Reference+Manual%2C+Daylight+version+4.9.+http%3A%2F%2Fwww.daylight.com%2Fdayhtml%2Fdoc%2Fclogp%2F+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DA.%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebd5X_hGvClp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-Like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lilxQce0iwvIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-Like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span> <span> </span><span class="NLM_article-title">Rapid Assessment of a Novel Series of Selective CB(2) Agonists Using Parallel Synthesis Protocols: A Lipophilic Efficiency (LipE) Analysis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4406</span>– <span class="NLM_lpage">4409</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+Assessment+of+a+Novel+Series+of+Selective+CB%282%29+Agonists+Using+Parallel+Synthesis+Protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+Analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljALQR3CbRdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520Assessment%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%2520CB%25282%2529%2520Agonists%2520Using%2520Parallel%2520Synthesis%2520Protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520Analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Assessing the Lipophilicity of Fragments and Early Hits</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+Lipophilicity+of+Fragments+and+Early+Hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0ljALQR3CbRdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520Lipophilicity%2520of%2520Fragments%2520and%2520Early%2520Hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayotte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descoteaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1386</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fcmdc.201800161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29722149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1377-1386&author=Y.+Ayotteauthor=F.+Bilodeauauthor=A.+Descoteauxauthor=S.+R.+LaPlante&title=Fragment-Based+Phenotypic+Lead+Discovery%3A+Cell-Based+Assay+to+Target+Leishmaniasis&doi=10.1002%2Fcmdc.201800161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis</span></div><div class="casAuthors">Ayotte, Yann; Bilodeau, Francois; Descoteaux, Albert; LaPlante, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1377-1386</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A rapid and practical approach for the discovery of new chem. matter for targeting pathogens and diseases is described.  Fragment-based phenotypic lead discovery (FPLD) combines aspects of traditional fragment-based lead discovery (FBLD), which involves the screening of small-mol. fragment libraries to target specific proteins, with phenotypic lead discovery (PLD), which typically involves the screening of drug-like compds. in cell-based assays.  To enable FPLD, a diverse library of fragments was first designed, assembled, and curated.  This library of sol., low-mol.-wt. compds. was then pooled to expedite screening.  Axenic cultures of Leishmania promastigotes were screened, and single hits were then tested for leishmanicidal activity against intracellular amastigote forms in infected murine bone-marrow-derived macrophages without evidence of toxicity toward mammalian cells.  These studies demonstrate that FPLD can be a rapid and effective means to discover hits that can serve as leads for further medicinal chem. purposes or as tool compds. for identifying known or novel targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC85ixZC9T9bVg90H21EOLACvtfcHk0ljALQR3CbRdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsrjF&md5=6b732097feb3a6f81f0c4d6309fbae63</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800161%26sid%3Dliteratum%253Aachs%26aulast%3DAyotte%26aufirst%3DY.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DDescoteaux%26aufirst%3DA.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26atitle%3DFragment-Based%2520Phenotypic%2520Lead%2520Discovery%253A%2520Cell-Based%2520Assay%2520to%2520Target%2520Leishmaniasis%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D1377%26epage%3D1386%26doi%3D10.1002%2Fcmdc.201800161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1787</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7847-2_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2F978-1-4939-7847-2_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29736714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFOnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1787&publication_year=2018&pages=115-127&author=A.+Galmozziauthor=C.+G.+Parkerauthor=B.+P.+Kokauthor=B.+F.+Cravattauthor=E.+Saez&title=Discovery+of+Modulators+of+Adipocyte+Physiology+Using+Fully+Functionalized+Fragments&doi=10.1007%2F978-1-4939-7847-2_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of modulators of adipocyte physiology using fully functionalized fragments</span></div><div class="casAuthors">Galmozzi, Andrea; Parker, Christopher G.; Kok, Bernard P.; Cravatt, Benjamin F.; Saez, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1787</span>
        (<span class="NLM_cas:issue">Phenotypic Screening</span>),
    <span class="NLM_cas:pages">115-127</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Defects in adipocyte function assocd. with obesity drive the development of systemic insulin resistance and type 2 diabetes.  Agents that correct obesity-linked adipocyte dysfunction serve as useful insulin sensitizers in humans, as is exemplified by the thiazolidinediones (TZDs).  We have developed a new platform that integrates advanced chemoproteomics with phenotypic screening to identify small mols. that promote differentiation and lipid storage in adipocytes, and, in tandem, their mol. target(s).  These mols. mimic the activity of TZDs in culture and thus may also serve as insulin sensitizers in vivo.  Central to this platform is the use of fully functionalized fragment (FFF) probes that consist of a variable, fragment-like recognition element linked to an alkyne-diazirine group that enables the photoactivated capture of probe-bound proteins directly in living cells and subsequent copper-catalyzed azide-alkyne cycloaddn. to reporter tags for enrichment and identification of these probe-bound proteins by mass spectrometry.  This platform, which can be adapted to diverse screens and cell types beyond adipocytes, has the potential to uncover new biol. pathways amenable to pharmacol. modulation that may impact human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZufLOat8ZrVg90H21EOLACvtfcHk0lhzp9LTg6iOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFOnsg%253D%253D&md5=c8eeae1a30e3afc5b1739cb0846eea3e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7847-2_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7847-2_9%26sid%3Dliteratum%253Aachs%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DKok%26aufirst%3DB.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DSaez%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520Modulators%2520of%2520Adipocyte%2520Physiology%2520Using%2520Fully%2520Functionalized%2520Fragments%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2018%26volume%3D1787%26spage%3D115%26epage%3D127%26doi%3D10.1007%2F978-1-4939-7847-2_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joslyn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narvaiza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.cell.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=28111073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=527-541&author=C.+G.+Parkerauthor=A.+Galmozziauthor=Y.+Wangauthor=B.+E.+Correiaauthor=K.+Sasakiauthor=C.+M.+Joslynauthor=A.+S.+Kimauthor=C.+L.+Cavallaroauthor=R.+M.+Lawrenceauthor=S.+R.+Johnsonauthor=I.+Narvaizaauthor=E.+Saezauthor=B.+F.+Cravatt&title=Ligand+and+Target+Discovery+by+Fragment-Based+Screening+in+Human+Cells&doi=10.1016%2Fj.cell.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span></div><div class="casAuthors">Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez, Enrique; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-541.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Advances in the synthesis and screening of small-mol. libraries have accelerated the discovery of chem. probes for studying biol. processes.  Still, only a small fraction of the human proteome has chem. ligands.  Here, we describe a platform that marries fragment-based ligand discovery with quant. chem. proteomics to map thousands of reversible small mol.-protein interactions directly in human cells, many of which can be site-specifically detd.  We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chem. probes.  We further combine fragment-based chem. proteomics with phenotypic screening to identify small mols. that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2.  Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small mols. and their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPk-YJwFlDwbVg90H21EOLACvtfcHk0lhzp9LTg6iOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D&md5=835264291015037ab9b7e446992caba3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DJoslyn%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DCavallaro%26aufirst%3DC.%2BL.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DNarvaiza%26aufirst%3DI.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DLigand%2520and%2520Target%2520Discovery%2520by%2520Fragment-Based%2520Screening%2520in%2520Human%2520Cells%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D527%26epage%3D541%26doi%3D10.1016%2Fj.cell.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istratiy, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjhen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, M. S.</span></span> <span> </span><span class="NLM_article-title">Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5209</span>– <span class="NLM_lpage">5215</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5209-5215&author=M.+Lanierauthor=D.+C.+Coleauthor=Y.+Istratiyauthor=M.+G.+Kleinauthor=P.+A.+Schwartzauthor=R.+Tjhenauthor=A.+Jenningsauthor=M.+S.+Hixon&title=Repurposing+Suzuki+Coupling+Reagents+as+a+Directed+Fragment+Library+Targeting+Serine+Hydrolases+and+Related+Enzymes&doi=10.1021%2Facs.jmedchem.6b01224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes</span></div><div class="casAuthors">Lanier, Marion; Cole, Derek C.; Istratiy, Yelena; Klein, Michael G.; Schwartz, Phillip A.; Tjhen, Richard; Jennings, Andy; Hixon, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5209-5215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are susceptible to potent reversible inhibition by boronic acids.  Large collections of chem. diverse boronic acid fragments are com. available because of their utility in coupling chem.  The authors repurposed the approx. 650 boronic acid reagents in the collection as a directed fragment library targeting serine hydrolases and related enzymes.  Highly efficient hits (LE > 0.6) often result.  The utility of the approach is illustrated with the results against autotaxin, a phospholipase implicated in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofvo73rlh3BbVg90H21EOLACvtfcHk0lhzp9LTg6iOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCjsb8%253D&md5=3aa5885e6b53ece7d230233730bae90c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01224%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DIstratiy%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DM.%2BG.%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DTjhen%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DRepurposing%2520Suzuki%2520Coupling%2520Reagents%2520as%2520a%2520Directed%2520Fragment%2520Library%2520Targeting%2520Serine%2520Hydrolases%2520and%2520Related%2520Enzymes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5209%26epage%3D5215%26doi%3D10.1021%2Facs.jmedchem.6b01224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viacava Follis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Efflux Ratio and Permeability of Covalent Irreversible BTK Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3307</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30243592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3307-3311&author=H.+Qiuauthor=L.+Liu-Bujalskiauthor=R.+D.+Caldwellauthor=A.+Viacava+Follisauthor=A.+Gardbergauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=J.+Headauthor=T.+Johnsonauthor=C.+C.+V.+Jonesauthor=R.+Jonesauthor=I.+Mochalkinauthor=F.+Morandiauthor=C.+Neaguauthor=J.+Potnickauthor=B.+Sherer&title=Optimization+of+the+Efflux+Ratio+and+Permeability+of+Covalent+Irreversible+BTK+Inhibitors&doi=10.1016%2Fj.bmcl.2018.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors</span></div><div class="casAuthors">Qiu, Hui; Liu-Bujalski, Lesley; Caldwell, Richard D.; Viacava Follis, Ariele; Gardberg, Anna; Goutopoulos, Andreas; Grenningloh, Roland; Head, Jared; Johnson, Theresa; Jones, Christopher C. V.; Jones, Reinaldo; Mochalkin, Igor; Morandi, Federica; Neagu, Constantin; Potnick, Justin; Sherer, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3307-3311</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (Btk) is a member of the Tec kinase family that is expressed in cells of hematopoietic lineage (e.g. B cells, macrophages, monocytes, and mast cells).  Small mol. covalent irreversible Btk inhibitors targeting Cys481 within the ATP-binding pocket have been applied in the treatment of B-cell malignancies.  Starting from a fragment, we discovered a novel series of potent covalent irreversible Btk inhibitors that bear N-linked groups occupying the solvent accessible pocket (SAP) of the active site of the Btk kinase domain.  The hit mols., however, displayed high P-gp mediated efflux ratio (ER) and poor A-B permeability in Caco-2 assay.  By decreasing tPSA, installing steric hindrance and adjusting clogP, one top mol. 9 was discovered, which showed a 99% decrease in efflux ratio and a 90-fold increase in A-B permeability compared to hit mol. 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0AD3kgaWRCbVg90H21EOLACvtfcHk0ljg4QHzTxJgpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOltr7I&md5=1152f21924092ac251e1dced388cb8c7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DViacava%2BFollis%26aufirst%3DA.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DHead%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DC.%2BC.%2BV.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DPotnick%26aufirst%3DJ.%26aulast%3DSherer%26aufirst%3DB.%26atitle%3DOptimization%2520of%2520the%2520Efflux%2520Ratio%2520and%2520Permeability%2520of%2520Covalent%2520Irreversible%2520BTK%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3307%26epage%3D3311%26doi%3D10.1016%2Fj.bmcl.2018.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Highly Selective Covalent Irreversible BTK Inhibitors from a Fragment Hit</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2939</span>– <span class="NLM_lpage">2944</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30122225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2939-2944&author=H.+Qiuauthor=L.+Liu-Bujalskiauthor=R.+D.+Caldwellauthor=A.+V.+Follisauthor=A.+Gardbergauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=J.+Headauthor=T.+Johnsonauthor=R.+Jonesauthor=I.+Mochalkinauthor=F.+Morandiauthor=C.+Neaguauthor=B.+Sherer&title=Discovery+of+Potent%2C+Highly+Selective+Covalent+Irreversible+BTK+Inhibitors+from+a+Fragment+Hit&doi=10.1016%2Fj.bmcl.2018.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit</span></div><div class="casAuthors">Qiu, Hui; Liu-Bujalski, Lesley; Caldwell, Richard D.; Follis, Ariele Viacava; Gardberg, Anna; Goutopoulos, Andreas; Grenningloh, Roland; Head, Jared; Johnson, Theresa; Jones, Reinaldo; Mochalkin, Igor; Morandi, Federica; Neagu, Constantin; Sherer, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2939-2944</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bruton's Tyrosine Kinase (BTK) is a member of the TEC kinase family that is expressed in cells of hematopoietic lineage (e.g., in B cells, macrophages, monocytes, and mast cells).  Small mol. covalent irreversible BTK inhibitor targeting Cys481 within the ATP-binding pocket, for example ibrutinib, has been applied in the treatment of B-cell malignancies.  Starting from a fragment hit, we discovered a novel series of potent covalent irreversible BTK inhibitors that occupy selectivity pocket of the active site of the BTK kinase domain.  Guided by x-ray structures and a fragment-based drug design (FBDD) approach, we generated mols. showing comparable cellular potency to ibrutinib and higher kinome selectivity against undesirable off-targets like EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUzH2Fde_MUbVg90H21EOLACvtfcHk0ljg4QHzTxJgpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfJ&md5=f4019ea46ab1a06cab875c0b7af5b1fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DFollis%26aufirst%3DA.%2BV.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DHead%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DSherer%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Highly%2520Selective%2520Covalent%2520Irreversible%2520BTK%2520Inhibitors%2520from%2520a%2520Fragment%2520Hit%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2939%26epage%3D2944%26doi%3D10.1016%2Fj.bmcl.2018.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottschalk, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Hafez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farag, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span> <span> </span><span class="NLM_article-title">Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1218-1230&author=R.+Schulzauthor=A.+Atefauthor=D.+Beckerauthor=F.+Gottschalkauthor=C.+Tauberauthor=S.+Wagnerauthor=C.+Arkonaauthor=A.+A.+Abdel-Hafezauthor=H.+H.+Faragauthor=J.+Rademannauthor=G.+Wolber&title=Phenylthiomethyl+Ketone-Based+Fragments+Show+Selective+and+Irreversible+Inhibition+of+Enteroviral+3C+Proteases&doi=10.1021%2Facs.jmedchem.7b01440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases</span></div><div class="casAuthors">Schulz, Robert; Atef, Amira; Becker, Daniel; Gottschalk, Franziska; Tauber, Carolin; Wagner, Stefan; Arkona, Christoph; Abdel-Hafez, Atef A.; Farag, Hassan H.; Rademann, Joerg; Wolber, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1218-1230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead structure discovery mainly focuses on the identification of noncovalently binding ligands.  Covalent linkage, however, is an essential binding mechanism for a multitude of successfully marketed drugs, although discovered by serendipity in most cases.  The authors present a concept for the design of fragments covalently binding to proteases.  Covalent linkage enables fragment binding unrelated to affinity to shallow protein binding sites and at the same time allows differentiated targeted hit verification and binding location verification through mass spectrometry.  The authors describe a systematic and rational computational approach for the identification of covalently binding fragments from compd. collections inhibiting enteroviral 3C protease, a target with high therapeutic potential.  By implementing reactive groups potentially forming covalent bonds as a chem. feature in the authors' 3D pharmacophore methodol., covalent binders were discovered by high-throughput virtual screening.  The authors present careful exptl. validation of the virtual hits using enzymic assays and mass spectrometry unraveling a novel, previously unknown irreversible inhibition of the 3C protease by phenylthiomethyl ketone-based fragments.  Subsequent synthetic optimization through fragment growing and reactivity anal. against catalytic and noncatalytic cysteines revealed specific irreversible 3C protease inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wUZEbIFMZbVg90H21EOLACvtfcHk0ljg4QHzTxJgpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gtg%253D%253D&md5=82d13071a89ce3e06a55090c0c1ff19a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01440%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DAtef%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DD.%26aulast%3DGottschalk%26aufirst%3DF.%26aulast%3DTauber%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DArkona%26aufirst%3DC.%26aulast%3DAbdel-Hafez%26aufirst%3DA.%2BA.%26aulast%3DFarag%26aufirst%3DH.%2BH.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DWolber%26aufirst%3DG.%26atitle%3DPhenylthiomethyl%2520Ketone-Based%2520Fragments%2520Show%2520Selective%2520and%2520Irreversible%2520Inhibition%2520of%2520Enteroviral%25203C%2520Proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1218%26epage%3D1230%26doi%3D10.1021%2Facs.jmedchem.7b01440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craven, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affron, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. J.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5257</span>– <span class="NLM_lpage">5261</span>, <span class="refDoi"> DOI: 10.1002/anie.201711825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fanie.201711825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5257-5261&author=G.+B.+Cravenauthor=D.+P.+Affronauthor=C.+E.+Allenauthor=S.+Matthiesauthor=J.+G.+Greenerauthor=R.+M.+L.+Morganauthor=E.+W.+Tateauthor=A.+Armstrongauthor=D.+J.+Mann&title=High-Throughput+Kinetic+Analysis+for+Target-Directed+Covalent+Ligand+Discovery&doi=10.1002%2Fanie.201711825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery</span></div><div class="casAuthors">Craven, Gregory B.; Affron, Dominic P.; Allen, Charlotte E.; Matthies, Stefan; Greener, Joe G.; Morgan, Rhodri M. L.; Tate, Edward W.; Armstrong, Alan; Mann, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5257-5261</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cysteine-reactive small mols. are used as chem. probes of biol. systems and as medicines.  Identifying high-quality covalent ligands requires comprehensive kinetic anal. to distinguish selective binders from pan-reactive compds.  Quant. irreversible tethering (qIT), a general method for screening cysteine-reactive small mols. based upon the maximization of kinetic selectivity, is described.  This method was applied prospectively to discover covalent fragments that target the clin. important cell cycle regulator Cdk2.  Crystal structures of the inhibitor complexes validate the approach and guide further optimization.  The power of this technique is highlighted by the identification of a Cdk2-selective allosteric (type IV) kinase inhibitor whose novel mode-of-action could be exploited therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Cxjlad3Kq7Vg90H21EOLACvtfcHk0lhzUrXqj8x4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOlsLc%253D&md5=58c46f4d3ee87791fe857d186127b923</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fanie.201711825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201711825%26sid%3Dliteratum%253Aachs%26aulast%3DCraven%26aufirst%3DG.%2BB.%26aulast%3DAffron%26aufirst%3DD.%2BP.%26aulast%3DAllen%26aufirst%3DC.%2BE.%26aulast%3DMatthies%26aufirst%3DS.%26aulast%3DGreener%26aufirst%3DJ.%2BG.%26aulast%3DMorgan%26aufirst%3DR.%2BM.%2BL.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DD.%2BJ.%26atitle%3DHigh-Throughput%2520Kinetic%2520Analysis%2520for%2520Target-Directed%2520Covalent%2520Ligand%2520Discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D5257%26epage%3D5261%26doi%3D10.1002%2Fanie.201711825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomala, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiera-Mularz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzanik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zieba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musielak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalniak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holak, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of Small-Molecule Inhibitors of USP2a</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.ejmech.2018.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29529503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=261-267&author=M.+D.+Tomalaauthor=K.+Magiera-Mularzauthor=K.+Kubicaauthor=S.+Krzanikauthor=B.+Ziebaauthor=B.+Musielakauthor=M.+Pustulaauthor=G.+M.+Popowiczauthor=M.+Sattlerauthor=G.+Dubinauthor=L.+Skalniakauthor=T.+A.+Holak&title=Identification+of+Small-Molecule+Inhibitors+of+USP2a&doi=10.1016%2Fj.ejmech.2018.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of USP2a</span></div><div class="casAuthors">Tomala, Marcin D.; Magiera-Mularz, Katarzyna; Kubica, Katarzyna; Krzanik, Sylwia; Zieba, Bartosz; Musielak, Bogdan; Pustula, Marcin; Popowicz, Grzegorz M.; Sattler, Michael; Dubin, Grzegorz; Skalniak, Lukasz; Holak, Tad A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-267</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">USP2a is a deubiquitinating protease that rescues its target proteins from destruction by the proteasome by reversing the process of protein ubiquitination.  USP2a shows oncogenic properties in vivo and has been found to be a specific activator of cyclin D1.  Many types of cancers are addicted to cyclin D1 expression.  Targeting USP2a is a promising strategy for cancer therapy but little progress has been made in the field of inhibition of USP2a.  Using NMR-based fragment screening and biophys. binding assays, the authors have discovered small mols. that bind to USP2a.  Iterations of fragment combination and structure-driven design identified two 5-(2-thienyl)-3-isoxazoles as the inhibitors of the USP2a-ubiquitin protein-protein interaction.  The affinity of these mols. for the catalytic domain of USP2a parallels their ability to interfere with USP2a binding to ubiquitin in vitro.  Altogether, the results establish the 5-(2-thienyl)-3-isoxazole pharmacophore as an attractive starting point for lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve1h82GTItrVg90H21EOLACvtfcHk0lhzUrXqj8x4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlylsLc%253D&md5=737e41f0a0b5574839ad6a3cc4d2f70a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DTomala%26aufirst%3DM.%2BD.%26aulast%3DMagiera-Mularz%26aufirst%3DK.%26aulast%3DKubica%26aufirst%3DK.%26aulast%3DKrzanik%26aufirst%3DS.%26aulast%3DZieba%26aufirst%3DB.%26aulast%3DMusielak%26aufirst%3DB.%26aulast%3DPustula%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DDubin%26aufirst%3DG.%26aulast%3DSkalniak%26aufirst%3DL.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520USP2a%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D261%26epage%3D267%26doi%3D10.1016%2Fj.ejmech.2018.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span>; <span class="NLM_string-name">Jahnke, W.</span></span> <i>Fragment-Based Drug Discovery: Lessons and Outlook</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2F9783527683604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Erlanson&author=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Lessons+and+Outlook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F9783527683604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527683604%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26btitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Lessons%2520and%2520Outlook%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Penzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basse, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deboves, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschkinat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, A. D.</span></span> <span> </span><span class="NLM_article-title">Insight into Small Molecule Binding to the Neonatal Fc Receptor by X-Ray Crystallography and 100 kHz Magic-Angle-Spinning NMR</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">e2006192</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.2006192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1371%2Fjournal.pbio.2006192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29782488" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=e2006192&author=D.+Stopplerauthor=A.+Macphersonauthor=S.+Smith-Penzelauthor=N.+Basseauthor=F.+Lecomteauthor=H.+Debovesauthor=R.+D.+Taylorauthor=T.+Normanauthor=J.+Porterauthor=L.+C.+Watersauthor=M.+Westwoodauthor=B.+Cossinsauthor=K.+Cainauthor=J.+Whiteauthor=R.+Griffinauthor=C.+Prosserauthor=S.+Kelmauthor=A.+H.+Sullivanauthor=D.+Foxauthor=M.+D.+Carrauthor=A.+Henryauthor=R.+Taylorauthor=B.+H.+Meierauthor=H.+Oschkinatauthor=A.+D.+Lawson&title=Insight+into+Small+Molecule+Binding+to+the+Neonatal+Fc+Receptor+by+X-Ray+Crystallography+and+100+kHz+Magic-Angle-Spinning+NMR&doi=10.1371%2Fjournal.pbio.2006192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.2006192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.2006192%26sid%3Dliteratum%253Aachs%26aulast%3DStoppler%26aufirst%3DD.%26aulast%3DMacpherson%26aufirst%3DA.%26aulast%3DSmith-Penzel%26aufirst%3DS.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DDeboves%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26aulast%3DNorman%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DWaters%26aufirst%3DL.%2BC.%26aulast%3DWestwood%26aufirst%3DM.%26aulast%3DCossins%26aufirst%3DB.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DProsser%26aufirst%3DC.%26aulast%3DKelm%26aufirst%3DS.%26aulast%3DSullivan%26aufirst%3DA.%2BH.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DCarr%26aufirst%3DM.%2BD.%26aulast%3DHenry%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26aulast%3DOschkinat%26aufirst%3DH.%26aulast%3DLawson%26aufirst%3DA.%2BD.%26atitle%3DInsight%2520into%2520Small%2520Molecule%2520Binding%2520to%2520the%2520Neonatal%2520Fc%2520Receptor%2520by%2520X-Ray%2520Crystallography%2520and%2520100%2520kHz%2520Magic-Angle-Spinning%2520NMR%26jtitle%3DPLoS%2520Biol.%26date%3D2018%26volume%3D16%26spage%3De2006192%26doi%3D10.1371%2Fjournal.pbio.2006192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derviaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collette, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span> <span> </span><span class="NLM_article-title">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5719</span>– <span class="NLM_lpage">5732</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00653</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5719-5732&author=L.+Hofferauthor=Y.+V.+Voitovichauthor=B.+Rauxauthor=K.+Carrascoauthor=C.+Mullerauthor=A.+Y.+Fedorovauthor=C.+Derviauxauthor=A.+Amouricauthor=S.+Betziauthor=D.+Horvathauthor=A.+Varnekauthor=Y.+Colletteauthor=S.+Combesauthor=P.+Rocheauthor=X.+Morelli&title=Integrated+Strategy+for+Lead+Optimization+Based+on+Fragment+Growing%3A+The+Diversity-Oriented-Target-Focused-Synthesis+Approach&doi=10.1021%2Facs.jmedchem.8b00653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span></div><div class="casAuthors">Hoffer, Laurent; Voitovich, Yuliia V.; Raux, Brigitt; Carrasco, Kendall; Muller, Christophe; Fedorov, Aleksey Y.; Derviaux, Carine; Amouric, Agnes; Betzi, Stephane; Horvath, Dragos; Varnek, Alexandre; Collette, Yves; Combes, Sebastien; Roche, Philippe; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5719-5732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past few decades, hit identification has been greatly facilitated by advances in high-throughput and fragment-based screenings.  One major hurdle remaining in drug discovery is process automation of hit-to-lead (H2L) optimization.  Here, we report a time- and cost-efficient integrated strategy for H2L optimization as well as a partially automated design of potent chem. probes consisting of a focused-chem.-library design and virtual screening coupled with robotic diversity-oriented de novo synthesis and automated in vitro evaluation.  The virtual library is generated by combining an activated fragment, corresponding to the substructure binding to the target, with a collection of functionalized building blocks using in silico encoded chem. reactions carefully chosen from a list of one-step org. transformations relevant in medicinal chem.  The proof of concept was demonstrated using the optimization of bromodomain inhibitors as a test case, leading to the validation of several compds. with improved affinity by several orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocVtdmg7D67Vg90H21EOLACvtfcHk0ljqqq678Vt_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK&md5=0e5f18636e2b1df24314efa81e67e2b5</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00653%26sid%3Dliteratum%253Aachs%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DAmouric%26aufirst%3DA.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DVarnek%26aufirst%3DA.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DIntegrated%2520Strategy%2520for%2520Lead%2520Optimization%2520Based%2520on%2520Fragment%2520Growing%253A%2520The%2520Diversity-Oriented-Target-Focused-Synthesis%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5719%26epage%3D5732%26doi%3D10.1021%2Facs.jmedchem.8b00653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chevillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hilten, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, P.</span></span> <span> </span><span class="NLM_article-title">Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1118</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01558</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01558" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1118-1129&author=F.+Chevillardauthor=H.+Rimmerauthor=C.+Bettiauthor=E.+Pardonauthor=S.+Balletauthor=N.+van+Hiltenauthor=J.+Steyaertauthor=W.+E.+Diederichauthor=P.+Kolb&title=Binding-Site+Compatible+Fragment+Growing+Applied+to+the+Design+of+%CE%B22-Adrenergic+Receptor+Ligands&doi=10.1021%2Facs.jmedchem.7b01558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands</span></div><div class="casAuthors">Chevillard, Florent; Rimmer, Helena; Betti, Cecilia; Pardon, Els; Ballet, Steven; van Hilten, Niek; Steyaert, Jan; Diederich, Wibke E.; Kolb, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1118-1129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery is intimately linked to fragment extension approaches that can be accelerated using software for de novo design.  Although computers allow for the facile generation of millions of suggestions, synthetic feasibility is however often neglected.  In this study the authors computationally extended, chem. synthesized, and exptl. assayed new ligands for the β2-adrenergic receptor (β2AR) by growing fragment-sized ligands.  To address the synthetic tractability issue, the authors' in silico work-flow aims at derivatized products based on robust org. reactions.  The study started from the predicted binding modes of five fragments.  The authors suggested a total of eight diverse extensions that were easily synthesized, and further assays showed that four products had an improved affinity (up to 40-fold) compared to their resp. initial fragment.  The described work-flow, which the authors call "growing via merging" and for which the key tools are available online, can improve early fragment-based drug discovery projects, making it a useful creative tool for medicinal chemists during structure-activity relationship (SAR) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNVNIASFV5LVg90H21EOLACvtfcHk0ljqqq678Vt_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKnu7s%253D&md5=f915fcba6096ec506f49274a2b628b97</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01558%26sid%3Dliteratum%253Aachs%26aulast%3DChevillard%26aufirst%3DF.%26aulast%3DRimmer%26aufirst%3DH.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3Dvan%2BHilten%26aufirst%3DN.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26aulast%3DKolb%26aufirst%3DP.%26atitle%3DBinding-Site%2520Compatible%2520Fragment%2520Growing%2520Applied%2520to%2520the%2520Design%2520of%2520%25CE%25B22-Adrenergic%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1118%26epage%3D1129%26doi%3D10.1021%2Facs.jmedchem.7b01558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raju, T. N.</span></span> <span> </span><span class="NLM_article-title">The Nobel Chronicles. 1988: James Whyte Black, (B 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98)</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1022</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)74775-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2FS0140-6736%2805%2974775-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10768469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ivV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2000&pages=1022&author=T.+N.+Raju&title=The+Nobel+Chronicles.+1988%3A+James+Whyte+Black%2C+%28B+1924%29%2C+Gertrude+Elion+%281918-99%29%2C+and+George+H+Hitchings+%281905-98%29&doi=10.1016%2FS0140-6736%2805%2974775-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The Nobel chronicles. 1988: James Whyte Black, (b 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98)</span></div><div class="casAuthors">Raju T N</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">9208</span>),
    <span class="NLM_cas:pages">1022</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTWLVzWjiD66qcneEtCi92fW6udTcc2eYqA3LToHoGarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ivV2mtA%253D%253D&md5=c89d64b40317d0d0cb4a76c1cceecb58</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2974775-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252974775-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaju%26aufirst%3DT.%2BN.%26atitle%3DThe%2520Nobel%2520Chronicles.%25201988%253A%2520James%2520Whyte%2520Black%252C%2520%2528B%25201924%2529%252C%2520Gertrude%2520Elion%2520%25281918-99%2529%252C%2520and%2520George%2520H%2520Hitchings%2520%25281905-98%2529%26jtitle%3DLancet%26date%3D2000%26volume%3D355%26spage%3D1022%26doi%3D10.1016%2FS0140-6736%2805%2974775-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drwal, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bret, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquemard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desaphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellenberger, E.</span></span> <span> </span><span class="NLM_article-title">Structural Insights on Fragment Binding Mode Conservation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5963</span>– <span class="NLM_lpage">5973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCnu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5963-5973&author=M.+N.+Drwalauthor=G.+Bretauthor=C.+Perezauthor=C.+Jacquemardauthor=J.+Desaphyauthor=E.+Kellenberger&title=Structural+Insights+on+Fragment+Binding+Mode+Conservation&doi=10.1021%2Facs.jmedchem.8b00256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights on Fragment Binding Mode Conservation</span></div><div class="casAuthors">Drwal, Malgorzata N.; Bret, Guillaume; Perez, Carlos; Jacquemard, Celien; Desaphy, Jeremy; Kellenberger, Esther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5963-5973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aiming at a deep understanding of fragment binding to ligandable targets, we performed a large scale anal. of the Protein Data Bank.  Binding modes of 1832 drug-like ligands and 1079 fragments to 235 proteins were compared.  We obsd. that the binding modes of fragments and their drug-like superstructures binding to the same protein are mostly conserved, thereby providing exptl. evidence for the preservation of fragment binding modes during mol. growing.  Furthermore, small chem. changes in the fragment are tolerated without alteration of the fragment binding mode.  The exceptions to this observation generally involve conformational variability of the mols.  Our data anal. also suggests that, provided enough fragments have been crystd. within a protein, good interaction coverage of the binding pocket is achieved.  Last, we extended our study to 126 crystn. additives and discuss in which cases they provide information relevant to structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQaTwivC9OA7Vg90H21EOLACvtfcHk0lghdfF0GiFapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCnu7bL&md5=60541171c9cc385735c2ba9ea6e107de</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00256%26sid%3Dliteratum%253Aachs%26aulast%3DDrwal%26aufirst%3DM.%2BN.%26aulast%3DBret%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DJacquemard%26aufirst%3DC.%26aulast%3DDesaphy%26aufirst%3DJ.%26aulast%3DKellenberger%26aufirst%3DE.%26atitle%3DStructural%2520Insights%2520on%2520Fragment%2520Binding%2520Mode%2520Conservation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5963%26epage%3D5973%26doi%3D10.1021%2Facs.jmedchem.8b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.chembiol.2018.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30482678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=9-15&author=D.+A.+Erlansonauthor=B.+J.+Davisauthor=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Advancing+Fragments+in+the+Absence+of+Crystal+Structures&doi=10.1016%2Fj.chembiol.2018.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures</span></div><div class="casAuthors">Erlanson, Daniel A.; Davis, Ben J.; Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fragment-based drug discovery typically requires an interplay between screening methods, structural methods, and medicinal chem.  X-ray crystallog. is generally the method of choice to obtain three-dimensional structures of the bound ligand/protein complex, but this can sometimes be difficult, particularly for early, low-affinity fragment hits.  In this Perspective, we discuss strategies to advance and evolve fragments in the absence of crystal structures of protein-fragment complexes, although the structure of the unliganded protein may be available.  The strategies can involve other structural techniques, such as NMR spectroscopy, mol. modeling, or a variety of chem. approaches.  Often, these strategies are aimed at guiding evolution of initial fragment hits to a stage where crystal structures can be obtained for further structure-based optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmStmkIpx6bLVg90H21EOLACvtfcHk0lghdfF0GiFapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzI&md5=2f5fb9d063b7ccabb4f7eb611c00ce30</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DDavis%26aufirst%3DB.%2BJ.%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Advancing%2520Fragments%2520in%2520the%2520Absence%2520of%2520Crystal%2520Structures%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D9%26epage%3D15%26doi%3D10.1016%2Fj.chembiol.2018.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span> <span> </span><span class="NLM_article-title">Learning from Our Mistakes: The ’Unknown Knowns’ in Fragment Screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2844</span>– <span class="NLM_lpage">2852</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2013.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=23562240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltlOns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2844-2852&author=B.+J.+Davisauthor=D.+A.+Erlanson&title=Learning+from+Our+Mistakes%3A+The+%E2%80%99Unknown+Knowns%E2%80%99+in+Fragment+Screening&doi=10.1016%2Fj.bmcl.2013.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from our mistakes: The 'unknown knowns' in fragment screening</span></div><div class="casAuthors">Davis, Ben J.; Erlanson, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2844-2852</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past 15 years, fragment-based lead discovery (FBLD) has been adopted widely throughout academia and industry.  The approach entails discovering very small mol. fragments and growing, merging, or linking them to produce drug leads.  Because the affinities of the initial fragments are often low, detection methods are pushed to their limits, leading to a variety of artifacts, false positives, and false negatives that too often go unrecognized.  This Digest discusses some of these problems and offers suggestions to avoid them.  Although the primary focus is on FBLD, many of the lessons also apply to more established approaches such as high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFRxp9cNiurVg90H21EOLACvtfcHk0lghdfF0GiFapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltlOns7s%253D&md5=823da57ab8f5c433e4a123bebf16666f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DB.%2BJ.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26atitle%3DLearning%2520from%2520Our%2520Mistakes%253A%2520The%2520%25E2%2580%2599Unknown%2520Knowns%25E2%2580%2599%2520in%2520Fragment%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2844%26epage%3D2852%26doi%3D10.1016%2Fj.bmcl.2013.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Firth, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2516</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/ci300293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2516-2525&author=N.+C.+Firthauthor=N.+Brownauthor=J.+Blagg&title=Plane+of+Best+Fit%3A+A+Novel+Method+to+Characterize+the+Three-Dimensionality+of+Molecules&doi=10.1021%2Fci300293f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules</span></div><div class="casAuthors">Firth, Nicholas C.; Brown, Nathan; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2516-2525</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a computational method, plane of best fit (PBF), to quantify and characterize the 3D character of mols.  This method is rapid and amenable to anal. of large diverse data sets.  We compare PBF with alternative literature methods used to assess 3D character and apply the method to diverse data sets of fragment-like, drug-like, and natural product compd. libraries.  We show that exemplar fragment libraries underexploit the potential of 3D character in fragment-like chem. space and that drug-like mols. in the libraries examd. are predominantly 2D in character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszhZRQVuP0LVg90H21EOLACvtfcHk0li_cEb_L7SY3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rt7zP&md5=747bb9c5fb38eb34af4e1047f83633e8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fci300293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300293f%26sid%3Dliteratum%253Aachs%26aulast%3DFirth%26aufirst%3DN.%2BC.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DPlane%2520of%2520Best%2520Fit%253A%2520A%2520Novel%2520Method%2520to%2520Characterize%2520the%2520Three-Dimensionality%2520of%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2516%26epage%3D2525%26doi%3D10.1021%2Fci300293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">The ’Rule of Three’ for Fragment-Based Drug Discovery: Where Are We Now?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1038/nrd3926-c1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd3926-c1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=23845999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ks7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=644-645&author=H.+Jhotiauthor=G.+Williamsauthor=D.+C.+Reesauthor=C.+W.+Murray&title=The+%E2%80%99Rule+of+Three%E2%80%99+for+Fragment-Based+Drug+Discovery%3A+Where+Are+We+Now%3F&doi=10.1038%2Fnrd3926-c1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The 'rule of three' for fragment-based drug discovery: where are we now?</span></div><div class="casAuthors">Jhoti, Harren; Williams, Glyn; Rees, David C.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The value of using the RO3 in FBDD is being (correctly) challenged as many useful fragment hits do not adhere to its restrictions (see the Practical Fragments blog website).  We have always believed that the RO3 concept has limitations and, like other rules related to desirable physicochem. properties, such as the 'rule of five' guidelines, it is simply a guideline that should not be overemphasized.  Nevertheless, we believe that the RO3 has been useful in ensuring that fragment libraries really do consist of compds. with fragment-like properties, although reports of 'fragment' hits that actually resemble lead-like compds. - particularly considering their substantial mol. mass - do still appear.  The fundamental concept of fragment screening is to use simpler mols. so that the chem. space can be sampled much more efficiently than is possible when using mols. of greater complexity.  One consequence of screening smaller, simpler fragments is that their affinity is expected to be relatively low (>1 mM), given the limited nos. of potential interactions that they can make with the protein.  Although weak in potency, fragment hits make high-quality interactions with the protein as they must overcome a substantial entropic barrier to binding, relative to their size.  The detection of low-potency fragment hits presents substantial tech. challenges, but to avoid these challenges and succumb to the temptation to screen larger, more complex mols. runs counter to the whole raison d'être of fragment screening.  We now have experience of over 30 fragment screens against a broad range of protein classes, and our results support the view that less complex mols. give a higher hit rate.  Consequently, our fragment library now almost exclusively contains mols. with fewer than 17 non-hydrogen atoms (mol. mass <230 Da).  As such, we believe the RO3 concept has assisted in limiting the mol. complexity in our fragment libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Jd0pJhvtnbVg90H21EOLACvtfcHk0li_cEb_L7SY3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ks7zP&md5=36ee69ae9c183b59da9afb8cb07c2c48</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnrd3926-c1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3926-c1%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DThe%2520%25E2%2580%2599Rule%2520of%2520Three%25E2%2580%2599%2520for%2520Fragment-Based%2520Drug%2520Discovery%253A%2520Where%2520Are%2520We%2520Now%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D644%26epage%3D645%26doi%3D10.1038%2Fnrd3926-c1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand Efficiency Metrics Considered Harmful</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9757-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2Fs10822-014-9757-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=24899110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2ksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=699-710&author=P.+W.+Kennyauthor=A.+Leitaoauthor=C.+A.+Montanari&title=Ligand+Efficiency+Metrics+Considered+Harmful&doi=10.1007%2Fs10822-014-9757-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency metrics considered harmful</span></div><div class="casAuthors">Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ligand efficiency metrics are used in drug discovery to normalize biol. activity or affinity with respect to physicochem. properties such as lipophilicity and mol. size.  This Perspective provides an overview of ligand efficiency metrics and summarizes thermodn. of protein-ligand binding.  Different classes of ligand efficiency metric are critically examd. and the study concludes with suggestions for alternative ways to account for physicochem. properties when prioritizing and optimizing leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWFJmrjl6YXrVg90H21EOLACvtfcHk0li_cEb_L7SY3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2ksLw%253D&md5=48885bcd2fcc646577ef78a5e7037494</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9757-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9757-8%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520Efficiency%2520Metrics%2520Considered%2520Harmful%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D699%26epage%3D710%26doi%3D10.1007%2Fs10822-014-9757-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of Ligand Efficiency Metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+Ligand+Efficiency+Metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0lhZgciD-rmExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520Ligand%2520Efficiency%2520Metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4611-4625&author=E.+Tamaniniauthor=I.+M.+Buckauthor=G.+Chessariauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=M.+Fredericksonauthor=C.+M.+Griffiths-Jonesauthor=K.+Hearnauthor=T.+D.+Heightmanauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsher&title=Discovery+of+a+Potent+Nonpeptidomimetic%2C+Small-Molecule+Antagonist+of+Cellular+Inhibitor+of+Apoptosis+Protein+1+%28cIAP1%29+and+X-Linked+Inhibitor+of+Apoptosis+Protein+%28XIAP%29&doi=10.1021%2Facs.jmedchem.6b01877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Tamanini, Emiliano; Buck, Ildiko M.; Chessari, Gianni; Chiarparin, Elisabetta; Day, James E. H.; Frederickson, Martyn; Griffiths-Jones, Charlotte M.; Hearn, Keisha; Heightman, Tom D.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP and cIAP1 are members of the inhibitor of apoptosis protein (IAP) family and are key regulators of anti-apoptotic and pro-survival signaling pathways.  Overexpression of IAPs occurs in various cancers and has been assocd. with tumor progression and resistance to treatment.  Structure-based drug design (SBDD) guided by structural information from X-ray crystallog., computational studies, and NMR soln. conformational anal. was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chem. probe for IAP biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIPJYPfW1ubVg90H21EOLACvtfcHk0lhZgciD-rmExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D&md5=2e00e53298df3ebe16bc02ad7cd7bf65</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01877%26sid%3Dliteratum%253Aachs%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Nonpeptidomimetic%252C%2520Small-Molecule%2520Antagonist%2520of%2520Cellular%2520Inhibitor%2520of%2520Apoptosis%2520Protein%25201%2520%2528cIAP1%2529%2520and%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4611%26epage%3D4625%26doi%3D10.1021%2Facs.jmedchem.6b01877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millemaggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7314</span>– <span class="NLM_lpage">7329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7314-7329&author=C.+N.+Johnsonauthor=J.+S.+Ahnauthor=I.+M.+Buckauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=A.+Hopkinsauthor=S.+Howardauthor=E.+J.+Lewisauthor=V.+Martinsauthor=A.+Millemaggiauthor=J.+M.+Munckauthor=L.+W.+Pageauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+Saxtyauthor=T.+Smythauthor=N.+T.+Thompsonauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=G.+Chessari&title=A+Fragment-Derived+Clinical+Candidate+for+Antagonism+of+X-Linked+and+Cellular+Inhibitor+of+Apoptosis+Proteins%3A+1-%286-%5B%284-Fluorophenyl%29methyl%5D-5-%28hydroxymethyl%29-3%2C3-dimethyl-1+H%2C2+H%2C3+H-pyrrolo%5B3%2C2-+b%5Dpyridin-1-yl%29-2-%5B%282+R%2C5+R%29-5-methyl-2-%28%5B%283R%29-3-methylmorpholin-4-yl%5Dmethyl%29piperazin-1-yl%5Dethan-1-one+%28ASTX660%29&doi=10.1021%2Facs.jmedchem.8b00900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span></div><div class="casAuthors">Johnson, Christopher N.; Ahn, Jong Sook; Buck, Ildiko M.; Chiarparin, Elisabetta; Day, James E. H.; Hopkins, Anna; Howard, Steven; Lewis, Edward J.; Martins, Vanessa; Millemaggi, Alessia; Munck, Joanne M.; Page, Lee W.; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Saxty, Gordon; Smyth, Tomoko; Thompson, Neil T.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7314-7329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are promising anticancer targets, given their roles in the evasion of apoptosis.  Several peptidomimetic IAP antagonists, with inherent selectivity for cellular IAP (cIAP) over X-linked IAP (XIAP), have been tested in the clinic.  A fragment screening approach followed by structure-based optimization has previously been reported that resulted in a low-nanomolar cIAP1 and XIAP antagonist lead mol. with a more balanced cIAP-XIAP profile.  We now report the further structure-guided optimization of the lead, with a view to improving the metabolic stability and cardiac safety profile, to give the nonpeptidomimetic antagonist clin. candidate (ASTX660), currently being tested in a phase 1/2 clin. trial (NCT02503423).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBj2OOs5EG-7Vg90H21EOLACvtfcHk0lhZgciD-rmExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P&md5=9c7ca5775f42441c971ad8459bb129c2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00900%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DHopkins%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMillemaggi%26aufirst%3DA.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DA%2520Fragment-Derived%2520Clinical%2520Candidate%2520for%2520Antagonism%2520of%2520X-Linked%2520and%2520Cellular%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%253A%25201-%25286-%255B%25284-Fluorophenyl%2529methyl%255D-5-%2528hydroxymethyl%2529-3%252C3-dimethyl-1%2520H%252C2%2520H%252C3%2520H-pyrrolo%255B3%252C2-%2520b%255Dpyridin-1-yl%2529-2-%255B%25282%2520R%252C5%2520R%2529-5-methyl-2-%2528%255B%25283R%2529-3-methylmorpholin-4-yl%255Dmethyl%2529piperazin-1-yl%255Dethan-1-one%2520%2528ASTX660%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7314%26epage%3D7329%26doi%3D10.1021%2Facs.jmedchem.8b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span>Sosei
Heptares <a href="https://soseiheptares.com/our-pipeline/rd-pipeline/in-house-programs.html" class="extLink">https://soseiheptares.com/our-pipeline/rd-pipeline/in-house-programs.html</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sosei%0AHeptares+https%3A%2F%2Fsoseiheptares.com%2Four-pipeline%2Frd-pipeline%2Fin-house-programs.html+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tron, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricks, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Mcl-1-Specific Inhibitor AZD5991 and Preclinical Activity in Multiple Myeloma and Acute Myeloid Leukemia</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5341</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07551-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41467-018-07551-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30559424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5341&author=A.+E.+Tronauthor=M.+A.+Belmonteauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+H.+Boiseauthor=E.+Chiarparinauthor=J.+Cidadoauthor=K.+J.+Embreyauthor=E.+Ganglauthor=F.+D.+Gibbonsauthor=G.+P.+Gregoryauthor=D.+Hargreavesauthor=J.+A.+Hendricksauthor=J.+W.+Johannesauthor=R.+W.+Johnstoneauthor=S.+L.+Kazmirskiauthor=J.+G.+Kettleauthor=M.+L.+Lambauthor=S.+M.+Matulisauthor=A.+K.+Nookaauthor=M.+J.+Packerauthor=B.+Pengauthor=P.+B.+Rawlinsauthor=D.+W.+Robbinsauthor=A.+G.+Schullerauthor=N.+Suauthor=W.+Yangauthor=Q.+Yeauthor=X.+Zhengauthor=J.+P.+Secristauthor=E.+A.+Clarkauthor=D.+M.+Wilsonauthor=S.+E.+Fawellauthor=A.+W.+Hird&title=Discovery+of+Mcl-1-Specific+Inhibitor+AZD5991+and+Preclinical+Activity+in+Multiple+Myeloma+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fs41467-018-07551-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span></div><div class="casAuthors">Tron, Adriana E.; Belmonte, Matthew A.; Adam, Ammar; Aquila, Brian M.; Boise, Lawrence H.; Chiarparin, Elisabetta; Cidado, Justin; Embrey, Kevin J.; Gangl, Eric; Gibbons, Francis D.; Gregory, Gareth P.; Hargreaves, David; Hendricks, J. Adam; Johannes, Jeffrey W.; Johnstone, Ricky W.; Kazmirski, Steven L.; Kettle, Jason G.; Lamb, Michelle L.; Matulis, Shannon M.; Nooka, Ajay K.; Packer, Martin J.; Peng, Bo; Rawlins, Philip B.; Robbins, Daniel W.; Schuller, Alwin G.; Su, Nancy; Yang, Wenzhan; Ye, Qing; Zheng, Xiaolan; Secrist, J. Paul; Clark, Edwin A.; Wilson, David M.; Fawell, Stephen E.; Hird, Alexander W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5341</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers.  High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 inhibitors as anticancer drugs.  Here, we describe AZD5991, a rationally designed macrocyclic mol. with high selectivity and affinity for Mcl-1 currently in clin. development.  Our studies demonstrate that AZD5991 binds directly to Mcl-1 and induces rapid apoptosis in cancer cells, most notably myeloma and acute myeloid leukemia, by activating the Bak-dependent mitochondrial apoptotic pathway.  AZD5991 shows potent antitumor activity in vivo with complete tumor regression in several models of multiple myeloma and acute myeloid leukemia after a single tolerated dose as monotherapy or in combination with bortezomib or venetoclax.  Based on these promising data, a Phase I clin. trial has been launched for evaluation of AZD5991 in patients with hematol. malignancies (NCT03218683).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLv1vdwF2TY7Vg90H21EOLACvtfcHk0lhTxzFjJidCrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK&md5=10ccf1fda947aca212bede3927eaabfa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07551-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07551-w%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DA.%2BE.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHendricks%26aufirst%3DJ.%2BA.%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DKazmirski%26aufirst%3DS.%2BL.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMatulis%26aufirst%3DS.%2BM.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobbins%26aufirst%3DD.%2BW.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DClark%26aufirst%3DE.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DHird%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520Mcl-1-Specific%2520Inhibitor%2520AZD5991%2520and%2520Preclinical%2520Activity%2520in%2520Multiple%2520Myeloma%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D5341%26doi%3D10.1038%2Fs41467-018-07551-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arthur Lebrêne, Thomas Martzel, Laura Gouriou, Morgane Sanselme, Vincent Levacher, Sylvain Oudeyer, Carlos Afonso, Corinne Loutelier-Bourhis, <span class="NLM_string-name hlFld-ContribAuthor">Jean-François Brière</span>. </span><span class="cited-content_cbyCitation_article-title">The Catalytic Regio- and Stereoselective Synthesis of 1,6-Diazabicyclo[4.3.0]nonane-2,7-diones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (13)
                                     , 8600-8609. <a href="https://doi.org/10.1021/acs.joc.1c00252" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00252%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThe%252BCatalytic%252BRegio-%252Band%252BStereoselective%252BSynthesis%252Bof%252B1%25252C6-Diazabicyclo%25255B4.3.0%25255Dnonane-2%25252C7-diones%26aulast%3DLebr%25C3%25AAne%26aufirst%3DArthur%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D14062021%26volume%3D86%26issue%3D13%26spage%3D8600%26epage%3D8609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul D. Leeson, A. Patricia Bento, Anna Gaulton, Anne Hersey, Emma J. Manners, Chris J. Radoux, <span class="NLM_string-name hlFld-ContribAuthor">Andrew R. Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7210-7230. <a href="https://doi.org/10.1021/acs.jmedchem.1c00416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTarget-Based%252BEvaluation%252Bof%252B%2525E2%252580%25259CDrug-Like%2525E2%252580%25259D%252BProperties%252Band%252BLigand%252BEfficiencies%26aulast%3DLeeson%26aufirst%3DPaul%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D13052021%26volume%3D64%26issue%3D11%26spage%3D7210%26epage%3D7230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dominique Sydow, Paula Schmiel, Jérémie Mortier, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Volkamer</span>. </span><span class="cited-content_cbyCitation_article-title">KinFragLib: Exploring the Kinase Inhibitor Space Using Subpocket-Focused Fragmentation and Recombination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6081-6094. <a href="https://doi.org/10.1021/acs.jcim.0c00839" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DKinFragLib%25253A%252BExploring%252Bthe%252BKinase%252BInhibitor%252BSpace%252BUsing%252BSubpocket-Focused%252BFragmentation%252Band%252BRecombination%26aulast%3DSydow%26aufirst%3DDominique%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23072020%26date%3D06112020%26volume%3D60%26issue%3D12%26spage%3D6081%26epage%3D6094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wolfgang Jahnke, Daniel A. Erlanson, Iwan J. P. de Esch, Christopher N. Johnson, Paul N. Mortenson, Yuji Ochi, <span class="NLM_string-name hlFld-ContribAuthor">Tatsuya Urushima</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2019. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15494-15507. <a href="https://doi.org/10.1021/acs.jmedchem.0c01608" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2019%26aulast%3DJahnke%26aufirst%3DWolfgang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14092020%26date%3D23112020%26volume%3D63%26issue%3D24%26spage%3D15494%26epage%3D15507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua Li, Meng-Qi Gao, Yan Chen, Yu-Xia Wang, Xiao-Lei Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Guang-Fu Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyrazine-Carboxamide-Diphenyl-Ethers as Novel Succinate Dehydrogenase Inhibitors via Fragment Recombination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (47)
                                     , 14001-14008. <a href="https://doi.org/10.1021/acs.jafc.0c05646" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c05646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c05646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c05646%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyrazine-Carboxamide-Diphenyl-Ethers%252Bas%252BNovel%252BSuccinate%252BDehydrogenase%252BInhibitors%252Bvia%252BFragment%252BRecombination%26aulast%3DLi%26aufirst%3DHua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01092020%26date%3D04112020%26date%3D29102020%26date%3D13112020%26volume%3D68%26issue%3D47%26spage%3D14001%26epage%3D14008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Levente  Kollár</span>, <span class="hlFld-ContribAuthor ">Martina  Gobec</span>, <span class="hlFld-ContribAuthor ">Bence  Szilágyi</span>, <span class="hlFld-ContribAuthor ">Matic  Proj</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi-Balogh</span>, <span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Tímea  Imre</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>, <span class="hlFld-ContribAuthor ">Izidor  Sosič</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective fragment-sized immunoproteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113455. <a href="https://doi.org/10.1016/j.ejmech.2021.113455" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113455%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bselective%252Bfragment-sized%252Bimmunoproteasome%252Binhibitors%26aulast%3DKoll%25C3%25A1r%26aufirst%3DLevente%26date%3D2021%26volume%3D219%26spage%3D113455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Shi</span>, <span class="hlFld-ContribAuthor ">Guang-Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based drug design facilitates selective kinase inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 551-565. <a href="https://doi.org/10.1016/j.tips.2021.04.001" title="DOI URL">https://doi.org/10.1016/j.tips.2021.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFragment-based%252Bdrug%252Bdesign%252Bfacilitates%252Bselective%252Bkinase%252Binhibitor%252Bdiscovery%26aulast%3DWang%26aufirst%3DZhi-Zheng%26date%3D2021%26volume%3D42%26issue%3D7%26spage%3D551%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Tom  Dekker</span>, <span class="hlFld-ContribAuthor ">Hanna F.  Klein</span>, <span class="hlFld-ContribAuthor ">Guido V.  Janssen</span>, <span class="hlFld-ContribAuthor ">Maikel  Wijtmans</span>, <span class="hlFld-ContribAuthor ">Peter  O’Brien</span>, <span class="hlFld-ContribAuthor ">Iwan J.P.  de Esch</span>. </span><span class="cited-content_cbyCitation_article-title">Escape from planarity in fragment-based drug discovery: A physicochemical and 3D property analysis of synthetic 3D fragment libraries. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2021,</strong> <em>61 </em><a href="https://doi.org/10.1016/j.ddtec.2021.05.001" title="DOI URL">https://doi.org/10.1016/j.ddtec.2021.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2021.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2021.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DEscape%252Bfrom%252Bplanarity%252Bin%252Bfragment-based%252Bdrug%252Bdiscovery%25253A%252BA%252Bphysicochemical%252Band%252B3D%252Bproperty%252Banalysis%252Bof%252Bsynthetic%252B3D%252Bfragment%252Blibraries%26aulast%3DHamilton%26aufirst%3DDavid%2BJ.%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José T.  Moreira-Filho</span>, <span class="hlFld-ContribAuthor ">Arthur C.  Silva</span>, <span class="hlFld-ContribAuthor ">Rafael F.  Dantas</span>, <span class="hlFld-ContribAuthor ">Barbara F.  Gomes</span>, <span class="hlFld-ContribAuthor ">Lauro R.  Souza Neto</span>, <span class="hlFld-ContribAuthor ">Jose  Brandao-Neto</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Owens</span>, <span class="hlFld-ContribAuthor ">Nicholas  Furnham</span>, <span class="hlFld-ContribAuthor ">Bruno J.  Neves</span>, <span class="hlFld-ContribAuthor ">Floriano P.  Silva-Junior</span>, <span class="hlFld-ContribAuthor ">Carolina H.  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.642383" title="DOI URL">https://doi.org/10.3389/fimmu.2021.642383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.642383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.642383%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSchistosomiasis%252BDrug%252BDiscovery%252Bin%252Bthe%252BEra%252Bof%252BAutomation%252Band%252BArtificial%252BIntelligence%26aulast%3DMoreira-Filho%26aufirst%3DJos%25C3%25A9%2BT.%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Maksims  Yevglevskis</span>, <span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Tony D.  James</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Woodman</span>. </span><span class="cited-content_cbyCitation_article-title">Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (10)
                                     , 5952-5984. <a href="https://doi.org/10.1039/D0CS00540A" title="DOI URL">https://doi.org/10.1039/D0CS00540A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00540A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00540A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DRacemases%252Band%252Bepimerases%252Boperating%252Bthrough%252Ba%252B1%25252C1-proton%252Btransfer%252Bmechanism%25253A%252Breactivity%25252C%252Bmechanism%252Band%252Binhibition%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D10%26spage%3D5952%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Davoine</span>, <span class="hlFld-ContribAuthor ">M.  Fillet</span>, <span class="hlFld-ContribAuthor ">L.  Pochet</span>. </span><span class="cited-content_cbyCitation_article-title">Capillary electrophoresis as a fragment screening tool to cross-validate hits from chromogenic assay: Application to FXIIa. </span><span class="cited-content_cbyCitation_journal-name">Talanta</span><span> <strong>2021,</strong> <em>226 </em>, 122163. <a href="https://doi.org/10.1016/j.talanta.2021.122163" title="DOI URL">https://doi.org/10.1016/j.talanta.2021.122163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.talanta.2021.122163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.talanta.2021.122163%26sid%3Dliteratum%253Aachs%26jtitle%3DTalanta%26atitle%3DCapillary%252Belectrophoresis%252Bas%252Ba%252Bfragment%252Bscreening%252Btool%252Bto%252Bcross-validate%252Bhits%252Bfrom%252Bchromogenic%252Bassay%25253A%252BApplication%252Bto%252BFXIIa%26aulast%3DDavoine%26aufirst%3DC.%26date%3D2021%26volume%3D226%26spage%3D122163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah L.  Mueller</span>, <span class="hlFld-ContribAuthor ">Panagiotis K.  Chrysanthopoulos</span>, <span class="hlFld-ContribAuthor ">Maria A.  Halili</span>, <span class="hlFld-ContribAuthor ">Caryn  Hepburn</span>, <span class="hlFld-ContribAuthor ">Tom  Nebl</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Thomas S.  Peat</span>, <span class="hlFld-ContribAuthor ">Sally-Ann  Poulsen</span>. </span><span class="cited-content_cbyCitation_article-title">The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 3010. <a href="https://doi.org/10.3390/molecules26103010" title="DOI URL">https://doi.org/10.3390/molecules26103010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26103010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26103010%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BGlitazone%252BClass%252Bof%252BDrugs%252Bas%252BCarbonic%252BAnhydrase%252BInhibitors%2525E2%252580%252594A%252BSpin-Off%252BDiscovery%252Bfrom%252BFragment%252BScreening%26aulast%3DMueller%26aufirst%3DSarah%2BL.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D3010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey D.  St. Denis</span>, <span class="hlFld-ContribAuthor ">Richard J.  Hall</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Tom D.  Heightman</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based drug discovery: opportunities for organic synthesis. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 321-329. <a href="https://doi.org/10.1039/D0MD00375A" title="DOI URL">https://doi.org/10.1039/D0MD00375A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00375A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00375A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DFragment-based%252Bdrug%252Bdiscovery%25253A%252Bopportunities%252Bfor%252Borganic%252Bsynthesis%26aulast%3DSt.%2BDenis%26aufirst%3DJeffrey%2BD.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D3%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Modular Click Chemistry Library: Searching for Better Functions. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1025-1027. <a href="https://doi.org/10.1002/cjoc.202000596" title="DOI URL">https://doi.org/10.1002/cjoc.202000596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000596%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DModular%252BClick%252BChemistry%252BLibrary%25253A%252BSearching%252Bfor%252BBetter%252BFunctions%26aulast%3DZhang%26aufirst%3DJiong%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D4%26spage%3D1025%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgi K  Kanev</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Bart A  Westerman</span>, <span class="hlFld-ContribAuthor ">Iwan J P  de Esch</span>, <span class="hlFld-ContribAuthor ">Albert J  Kooistra</span>. </span><span class="cited-content_cbyCitation_article-title">KLIFS: an overhaul after the first 5 years of supporting kinase research. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (D1)
                                     , D562-D569. <a href="https://doi.org/10.1093/nar/gkaa895" title="DOI URL">https://doi.org/10.1093/nar/gkaa895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa895%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DKLIFS%25253A%252Ban%252Boverhaul%252Bafter%252Bthe%252Bfirst%252B5%252Byears%252Bof%252Bsupporting%252Bkinase%252Bresearch%26aulast%3DKanev%26aufirst%3DGeorgi%2BK%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3DD1%26spage%3DD562%26epage%3DD569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Oebbeke</span>, <span class="hlFld-ContribAuthor ">Christof  Siefker</span>, <span class="hlFld-ContribAuthor ">Björn  Wagner</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Bindung an die Kinase‐Scharnier‐Region: Wenn Ladungsverteilung und lokale p
              K
              a
              ‐Verschiebungen etablierte Bioisosterie‐Konzepte fehlleiten. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (1)
                                     , 256-262. <a href="https://doi.org/10.1002/ange.202011295" title="DOI URL">https://doi.org/10.1002/ange.202011295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202011295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202011295%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DFragment%2525E2%252580%252590Bindung%252Ban%252Bdie%252BKinase%2525E2%252580%252590Scharnier%2525E2%252580%252590Region%25253A%252BWenn%252BLadungsverteilung%252Bund%252Blokale%252Bp%252BK%252Ba%252B%2525E2%252580%252590Verschiebungen%252Betablierte%252BBioisosterie%2525E2%252580%252590Konzepte%252Bfehlleiten%26aulast%3DOebbeke%26aufirst%3DMatthias%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D1%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Oebbeke</span>, <span class="hlFld-ContribAuthor ">Christof  Siefker</span>, <span class="hlFld-ContribAuthor ">Björn  Wagner</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment Binding to Kinase Hinge: If Charge Distribution and Local p
              K
              a
              Shifts Mislead Popular Bioisosterism Concepts. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (1)
                                     , 252-258. <a href="https://doi.org/10.1002/anie.202011295" title="DOI URL">https://doi.org/10.1002/anie.202011295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202011295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202011295%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DFragment%252BBinding%252Bto%252BKinase%252BHinge%25253A%252BIf%252BCharge%252BDistribution%252Band%252BLocal%252Bp%252BK%252Ba%252BShifts%252BMislead%252BPopular%252BBioisosterism%252BConcepts%26aulast%3DOebbeke%26aufirst%3DMatthias%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D1%26spage%3D252%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sailu  Sarvagalla</span>, <span class="hlFld-ContribAuthor ">Sree Karani  Kondapuram</span>, <span class="hlFld-ContribAuthor ">R. Vasundhara  Devi</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>. </span><span class="cited-content_cbyCitation_article-title">Resources for Docking-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 179-203. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00002-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00002-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00002-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00002-3%26sid%3Dliteratum%253Aachs%26atitle%3DResources%252Bfor%252BDocking-Based%252BVirtual%252BScreening%26aulast%3DSarvagalla%26aufirst%3DSailu%26date%3D2021%26spage%3D179%26epage%3D203%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Max J.  Caplin</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Foley</span>. </span><span class="cited-content_cbyCitation_article-title">Emergent synthetic methods for the modular advancement of sp
              3
              -rich fragments. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.1039/D1SC00161B" title="DOI URL">https://doi.org/10.1039/D1SC00161B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC00161B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC00161B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DEmergent%252Bsynthetic%252Bmethods%252Bfor%252Bthe%252Bmodular%252Badvancement%252Bof%252Bsp%252B3%252B-rich%252Bfragments%26aulast%3DCaplin%26aufirst%3DMax%2BJ.%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Hoarau</span>, <span class="hlFld-ContribAuthor ">Jarunee  Vanichtanankul</span>, <span class="hlFld-ContribAuthor ">Nitipol  Srimongkolpithak</span>, <span class="hlFld-ContribAuthor ">Danoo  Vitsupakorn</span>, <span class="hlFld-ContribAuthor ">Yongyuth  Yuthavong</span>, <span class="hlFld-ContribAuthor ">Sumalee  Kamchonwongpaisan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new non-pyrimidine scaffolds as
              Plasmodium falciparum
              DHFR inhibitors by fragment-based screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 198-206. <a href="https://doi.org/10.1080/14756366.2020.1854244" title="DOI URL">https://doi.org/10.1080/14756366.2020.1854244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1854244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1854244%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bnon-pyrimidine%252Bscaffolds%252Bas%252BPlasmodium%252Bfalciparum%252BDHFR%252Binhibitors%252Bby%252Bfragment-based%252Bscreening%26aulast%3DHoarau%26aufirst%3DMarie%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D198%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmut  Oschkinat</span>, <span class="hlFld-ContribAuthor ">Nestor  Kamdem</span>. </span><span class="cited-content_cbyCitation_article-title">SAR-by-NMR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-4. <a href="https://doi.org/10.1007/978-3-030-21573-6_154-1" title="DOI URL">https://doi.org/10.1007/978-3-030-21573-6_154-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-21573-6_154-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-21573-6_154-1%26sid%3Dliteratum%253Aachs%26atitle%3DSAR-by-NMR%26aulast%3DOschkinat%26aufirst%3DHartmut%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D4%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BPharmacology%26aulast%3DOffermanns%26aufirst%3DStefan%26date%3D2020%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Erlanson</span>. </span><span class="cited-content_cbyCitation_article-title">Many small steps towards a COVID-19 drug. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-18710-3" title="DOI URL">https://doi.org/10.1038/s41467-020-18710-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-18710-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-18710-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMany%252Bsmall%252Bsteps%252Btowards%252Ba%252BCOVID-19%252Bdrug%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana Pelizzari  Raymundo</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Doultsinos</span>, <span class="hlFld-ContribAuthor ">Xavier  Guillory</span>, <span class="hlFld-ContribAuthor ">Antonio  Carlesso</span>, <span class="hlFld-ContribAuthor ">Leif A.  Eriksson</span>, <span class="hlFld-ContribAuthor ">Eric  Chevet</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Targeting of IRE1 in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Trends in Cancer</span><span> <strong>2020,</strong> <em>6 </em>
                                    (12)
                                     , 1018-1030. <a href="https://doi.org/10.1016/j.trecan.2020.07.006" title="DOI URL">https://doi.org/10.1016/j.trecan.2020.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trecan.2020.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trecan.2020.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Cancer%26atitle%3DPharmacological%252BTargeting%252Bof%252BIRE1%252Bin%252BCancer%26aulast%3DRaymundo%26aufirst%3DDiana%2BPelizzari%26date%3D2020%26volume%3D6%26issue%3D12%26spage%3D1018%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Keiffer</span>, <span class="hlFld-ContribAuthor ">Marta G.  Carneiro</span>, <span class="hlFld-ContribAuthor ">Johan  Hollander</span>, <span class="hlFld-ContribAuthor ">Masakazu  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Denys  Pogoryelev</span>, <span class="hlFld-ContribAuthor ">Eiso  AB</span>, <span class="hlFld-ContribAuthor ">Stephan  Theisgen</span>, <span class="hlFld-ContribAuthor ">Gerhard  Müller</span>, <span class="hlFld-ContribAuthor ">Gregg  Siegal</span>. </span><span class="cited-content_cbyCitation_article-title">NMR in target driven drug discovery: why not?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (10-11)
                                     , 521-529. <a href="https://doi.org/10.1007/s10858-020-00343-9" title="DOI URL">https://doi.org/10.1007/s10858-020-00343-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-020-00343-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-020-00343-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DNMR%252Bin%252Btarget%252Bdriven%252Bdrug%252Bdiscovery%25253A%252Bwhy%252Bnot%25253F%26aulast%3DKeiffer%26aufirst%3DS%25C3%25A9bastien%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D10-11%26spage%3D521%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raymond S.  Norton</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Jahnke</span>. </span><span class="cited-content_cbyCitation_article-title">NMR in pharmaceutical discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (10-11)
                                     , 473-476. <a href="https://doi.org/10.1007/s10858-020-00345-7" title="DOI URL">https://doi.org/10.1007/s10858-020-00345-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-020-00345-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-020-00345-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DNMR%252Bin%252Bpharmaceutical%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DNorton%26aufirst%3DRaymond%2BS.%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D10-11%26spage%3D473%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sridhar  Sreeramulu</span>, <span class="hlFld-ContribAuthor ">Christian  Richter</span>, <span class="hlFld-ContribAuthor ">Till  Kuehn</span>, <span class="hlFld-ContribAuthor ">Kamal  Azzaoui</span>, <span class="hlFld-ContribAuthor ">Marcel Jules José  Blommers</span>, <span class="hlFld-ContribAuthor ">Rebecca  Del Conte</span>, <span class="hlFld-ContribAuthor ">Marco  Fragai</span>, <span class="hlFld-ContribAuthor ">Nils  Trieloff</span>, <span class="hlFld-ContribAuthor ">Peter  Schmieder</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>, <span class="hlFld-ContribAuthor ">Edgar  Specker</span>, <span class="hlFld-ContribAuthor ">Vladimir  Ivanov</span>, <span class="hlFld-ContribAuthor ">Hartmut  Oschkinat</span>, <span class="hlFld-ContribAuthor ">Lucia  Banci</span>, <span class="hlFld-ContribAuthor ">Harald  Schwalbe</span>. </span><span class="cited-content_cbyCitation_article-title">NMR quality control of fragment libraries for screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (10-11)
                                     , 555-563. <a href="https://doi.org/10.1007/s10858-020-00327-9" title="DOI URL">https://doi.org/10.1007/s10858-020-00327-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-020-00327-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-020-00327-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DNMR%252Bquality%252Bcontrol%252Bof%252Bfragment%252Blibraries%252Bfor%252Bscreening%26aulast%3DSreeramulu%26aufirst%3DSridhar%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D10-11%26spage%3D555%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaj S.  Troelsen</span>, <span class="hlFld-ContribAuthor ">Mads H.  Clausen</span>. </span><span class="cited-content_cbyCitation_article-title">Library Design Strategies To Accelerate Fragment‐Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (50)
                                     , 11391-11403. <a href="https://doi.org/10.1002/chem.202000584" title="DOI URL">https://doi.org/10.1002/chem.202000584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202000584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202000584%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DLibrary%252BDesign%252BStrategies%252BTo%252BAccelerate%252BFragment%2525E2%252580%252590Based%252BDrug%252BDiscovery%26aulast%3DTroelsen%26aufirst%3DNikolaj%2BS.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D50%26spage%3D11391%26epage%3D11403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bogdan  Musielak</span>, <span class="hlFld-ContribAuthor ">Weronika  Janczyk</span>, <span class="hlFld-ContribAuthor ">Ismael  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Jacek  Plewka</span>, <span class="hlFld-ContribAuthor ">Dominik  Sala</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Magiera-Mularz</span>, <span class="hlFld-ContribAuthor ">Tad  Holak</span>. </span><span class="cited-content_cbyCitation_article-title">Competition NMR for Detection of Hit/Lead Inhibitors of Protein–Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (13)
                                     , 3017. <a href="https://doi.org/10.3390/molecules25133017" title="DOI URL">https://doi.org/10.3390/molecules25133017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25133017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25133017%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCompetition%252BNMR%252Bfor%252BDetection%252Bof%252BHit%25252FLead%252BInhibitors%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%26aulast%3DMusielak%26aufirst%3DBogdan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D13%26spage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Distribution of target class for the F2L examples from each year reviewed (27 in 2015, 28 in 2016, 30 in 2017, and 26 in 2018), as well as the total for all 111 examples from 2015 to 2018.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Distribution of screening methods for the F2L examples from each year reviewed as well as the total for all 111 examples. Where multiple screening techniques were used in an example, each individual screen has been counted separately, so the sum of all methods is greater than 100%: Tm, thermal shift; SPR, surface plasmon resonance; DSLS, differential static light scattering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of screening methods for (A) potency of fragment hit and (B) kinases vs non-bromodomain protein–protein interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Properties of fragments and leads from the 111 examples from the 2015–2018 data set: (A) distribution of molecular weight; (B) distribution of ClogP; (C) distribution of DFP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/medium/jm9b01581_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Ligand efficiency (LE) values for fragments and leads for all examples from the 2015–2018 data set (93 fragments and 104 leads). (B) Distribution of the change in LE on going from fragment to lead for the 87 examples from the 2015–2018 data set for which LE can be calculated for both fragments and leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01581/20200507/images/large/jm9b01581_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01581&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty Years On: The Impact of Fragments on Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+Years+On%3A+The+Impact+of+Fragments+on+Drug+Discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lggR0KYQCbbYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520Years%2520On%253A%2520The%2520Impact%2520of%2520Fragments%2520on%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2015</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) is now well-established as a technol. for generating new chem. leads and drugs.  This Miniperspective provides a tabulated overview of the fragment-to-lead literature published in the year 2015, together with a commentary on trends obsd. across the FBDD field during this time.  It is hoped that this tabulated summary will provide a useful point of ref. for both FBDD practitioners and the wider medicinal chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojX6ZlmVXQrLVg90H21EOLACvtfcHk0liVGoK0H5ZQ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1KlsbnP&md5=da9d027787d70d4276378cb01f8e0ce2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1774-1784&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=W.+Jahnkeauthor=P.+N.+Mortensonauthor=D.+C.+Rees&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2016&doi=10.1021%2Facs.jmedchem.7b01298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Jahnke, Wolfgang; Mortenson, Paul N.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1774-1784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The popularity of fragment-based drug discovery (FBDD) is demonstrated by the no. of recent successful fragment-to-lead (F2L) publications.  This Miniperspective provides a tabulated summary of the F2L literature published in the year 2016, along with discussion of general trends.  It uses the same format as our summary of the 2015 literature and is intended to be a resource for both FBDD practitioners and medicinal chemists in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDiwnepXDgrbVg90H21EOLACvtfcHk0ljM1FWzDIB2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP&md5=861d9adf1530250a060fc254ca7b493c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202016%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1774%26epage%3D1784%26doi%3D10.1021%2Facs.jmedchem.7b01298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3872</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3857-3872&author=P.+N.+Mortensonauthor=D.+A.+Erlansonauthor=I.+J.+P.+de+Eschauthor=W.+Jahnkeauthor=C.+N.+Johnson&title=Fragment-to-Lead+Medicinal+Chemistry+Publications+in+2017&doi=10.1021%2Facs.jmedchem.8b01472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2017</span></div><div class="casAuthors">Mortenson, Paul N.; Erlanson, Daniel A.; de Esch, Iwan J. P.; Jahnke, Wolfgang; Johnson, Christopher N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3857-3872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Miniperspective is the third in a series reviewing fragment-to-lead publications from a given year.  Following our reviews for 2015 and 2016, this Miniperspective provides tabulated summaries of relevant articles published in 2017 along with some general observations.  In addn., we discuss insights obtained from anal. of the combined data set of 85 examples from all three years of publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakuhiet0qZLVg90H21EOLACvtfcHk0ljM1FWzDIB2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CqsrbK&md5=f755c4768cd2d8f7efaaefa987a16079</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26atitle%3DFragment-to-Lead%2520Medicinal%2520Chemistry%2520Publications%2520in%25202017%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3857%26epage%3D3872%26doi%3D10.1021%2Facs.jmedchem.8b01472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2604</span>– <span class="NLM_lpage">2610</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00057</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFWnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2604-2610&author=L.+Chenauthor=C.+Zhuangauthor=J.+Luauthor=Y.+Jiangauthor=C.+Sheng&title=Discovery+of+Novel+KRAS-PDE%CE%B4+Inhibitors+by+Fragment-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design</span></div><div class="casAuthors">Chen, Long; Zhuang, Chunlin; Lu, Junjie; Jiang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2604-2610</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting KRAS-PDEδ protein-protein interactions with small mols. represents a promising opportunity for developing novel antitumor agents.  However, current KRAS-PDEδ inhibitors are limited by poor cellular antitumor potency and the druggability of the target remains to be validated by new inhibitors.  To tackle these challenges, herein, novel, highly potent KRAS-PDEδ inhibitors were identified by fragment-based drug design, providing promising lead compds. or chem. probes for investigating the biol. functions and druggability of KRAS-PDEδ interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqayXxD-smS5LVg90H21EOLACvtfcHk0lhA7yALOIltIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFWnsLw%253D&md5=0b1ad029636a14f2794d548235a30360</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Novel%2520KRAS-PDE%25CE%25B4%2520Inhibitors%2520by%2520Fragment-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2604%26epage%3D2610%26doi%3D10.1021%2Facs.jmedchem.8b00057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linhares, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKerell, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain Via NMR-Based Fragment Screening and Computer-Aided Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7573</span>– <span class="NLM_lpage">7588</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kgu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7573-7588&author=H.+Chengauthor=B.+M.+Linharesauthor=W.+Yuauthor=M.+G.+Cardenasauthor=Y.+Aiauthor=W.+Jiangauthor=A.+Winklerauthor=S.+Cohenauthor=A.+Melnickauthor=A.+MacKerellauthor=T.+Cierpickiauthor=F.+Xue&title=Identification+of+Thiourea-Based+Inhibitors+of+the+B-Cell+Lymphoma+6+BTB+Domain+Via+NMR-Based+Fragment+Screening+and+Computer-Aided+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design</span></div><div class="casAuthors">Cheng, Huimin; Linhares, Brian M.; Yu, Wenbo; Cardenas, Mariano G.; Ai, Yong; Jiang, Wenjuan; Winkler, Alyssa; Cohen, Sandra; Melnick, Ari; MacKerell, Alexander; Cierpicki, Tomasz; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7573-7588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPI) between the transcriptional repressor B-cell lymphoma 6 (BCL6) BTB domain (BCL6BTB) and its corepressors have emerged as a promising target for anticancer therapeutics.  However, identification of potent, drug-like inhibitors of BCL6BTB has remained challenging.  Using NMR-based screening of a library of fragment-like small mols., we have identified a thiourea compd. (7CC5) that binds to BCL6BTB.  From this hit, the application of computer-aided drug design (CADD), medicinal chem., NMR spectroscopy, and X-ray crystallog. has yielded an inhibitor, I, that demonstrated over 100-fold improved potency for BCL6BTB.  This gain in potency was achieved by a unique binding mode that mimics the binding mode of the corepressor SMRT in the arom. and the HDCH sites.  The structure-activity relationship based on these new inhibitors will have a significant impact on the rational design of novel BCL6 inhibitors, facilitating the identification of therapeutics for the treatment of BCL6-dependent tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5uAI4SKnigrVg90H21EOLACvtfcHk0lhA7yALOIltIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kgu7%252FI&md5=23f132ce17efe5e1787dd6aad5746310</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00040%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLinhares%26aufirst%3DB.%2BM.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCardenas%26aufirst%3DM.%2BG.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DWinkler%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DMacKerell%26aufirst%3DA.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520Thiourea-Based%2520Inhibitors%2520of%2520the%2520B-Cell%2520Lymphoma%25206%2520BTB%2520Domain%2520Via%2520NMR-Based%2520Fragment%2520Screening%2520and%2520Computer-Aided%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7573%26epage%3D7588%26doi%3D10.1021%2Facs.jmedchem.8b00040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidenreich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10929</span>– <span class="NLM_lpage">10934</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01457</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFeju7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10929-10934&author=D.+Heidenreichauthor=M.+Moustakimauthor=J.+Schmidtauthor=D.+Merkauthor=P.+E.+Brennanauthor=O.+Fedorovauthor=A.+Chaikuadauthor=S.+Knapp&title=Structure-Based+Approach+toward+Identification+of+Inhibitory+Fragments+for+Eleven-Nineteen-Leukemia+Protein+%28ENL%29&doi=10.1021%2Facs.jmedchem.8b01457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)</span></div><div class="casAuthors">Heidenreich, David; Moustakim, Moses; Schmidt, Jurema; Merk, Daniel; Brennan, Paul E.; Fedorov, Oleg; Chaikuad, Apirat; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10929-10934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine acetylation is an epigenetic mark that is principally recognized by bromodomains, and recently structurally diverse YEATS domains also emerged as readers of lysine acetyl/acylations.  Here we present a crystallog.-based strategy and the discovery of fragments binding to the ENL YEATS domain, a potential drug target.  Crystal structures combined with synthetic efforts led to the identification of a submicromolar binder, providing first starting points for the development of chem. probes for this reader domain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoRVFoDK77rVg90H21EOLACvtfcHk0lgnc3Qj1FPgtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFeju7jI&md5=fdcbbf8b8ec237216478043a6fd9c50f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01457%26sid%3Dliteratum%253Aachs%26aulast%3DHeidenreich%26aufirst%3DD.%26aulast%3DMoustakim%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructure-Based%2520Approach%2520toward%2520Identification%2520of%2520Inhibitory%2520Fragments%2520for%2520Eleven-Nineteen-Leukemia%2520Protein%2520%2528ENL%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10929%26epage%3D10934%26doi%3D10.1021%2Facs.jmedchem.8b01457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowedder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11061</span>– <span class="NLM_lpage">11073</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01556</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11061-11073&author=N.+Bartonauthor=M.+Converyauthor=A.+W.+J.+Cooperauthor=K.+Downauthor=J.+N.+Hamblinauthor=G.+Inglisauthor=S.+Peaceauthor=J.+Rowedderauthor=P.+Rowlandauthor=J.+A.+Taylorauthor=N.+Wellaway&title=Discovery+of+Potent%2C+Efficient%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+through+a+Deconstruction+and+Regrowth+Approach&doi=10.1021%2Facs.jmedchem.8b01556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach</span></div><div class="casAuthors">Barton, Nick; Convery, Maire; Cooper, Anthony W. J.; Down, Kenneth; Hamblin, J. Nicole; Inglis, Graham; Peace, Simon; Rowedder, James; Rowland, Paul; Taylor, Jonathan A.; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11061-11073</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A deconstruction of previously reported phosphoinositide 3-kinase δ (PI3Kδ) inhibitors and subsequent regrowth led to the identification of a privileged fragment for PI3Kδ, which was exploited to deliver a potent, efficient, and selective lead series with a novel binding mode obsd. in the PI3Kδ crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcRf_CeZHdbVg90H21EOLACvtfcHk0lgnc3Qj1FPgtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsLzI&md5=492b5e5a27690b41aad866ca94f7bc57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01556%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DConvery%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DDown%26aufirst%3DK.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DRowedder%26aufirst%3DJ.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Efficient%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520through%2520a%2520Deconstruction%2520and%2520Regrowth%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11061%26epage%3D11073%26doi%3D10.1021%2Facs.jmedchem.8b01556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Profiling of a 3-Aminopyridin-2-one-Based Kinase Targeted Fragment Library: Identification of 3-Amino-5-(pyridin-4-yl)pyridin-2(1H)-one Scaffold for Monopolar Spindle 1 (MPS1) and Aurora Kinases Inhibition</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmc.2018.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29764757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2ksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3021-3029&author=D.+Fearonauthor=I.+M.+Westwoodauthor=R.+L.+M.+van+Montfortauthor=R.+Baylissauthor=K.+Jonesauthor=V.+Bavetsias&title=Synthesis+and+Profiling+of+a+3-Aminopyridin-2-one-Based+Kinase+Targeted+Fragment+Library%3A+Identification+of+3-Amino-5-%28pyridin-4-yl%29pyridin-2%281H%29-one+Scaffold+for+Monopolar+Spindle+1+%28MPS1%29+and+Aurora+Kinases+Inhibition&doi=10.1016%2Fj.bmc.2018.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition</span></div><div class="casAuthors">Fearon, Daren; Westwood, Isaac M.; van Montfort, Rob L. M.; Bayliss, Richard; Jones, Keith; Bavetsias, Vassilios</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3021-3029</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Screening a 3-aminopyridin-2-one based fragment library against a 26-kinase panel representative of the human kinome identified 3-amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2(1H)-one (2) and 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one (3) as ligand efficient inhibitors of the mitotic kinase Monopolar Spindle 1 (MPS1) and the Aurora kinase family.  These kinases are well recognized as attractive targets for therapeutic intervention for treating cancer.  Elucidation of the binding mode of these fragments and their analogs has been carried out by x-ray crystallog.  Structural studies have identified key interactions with a conserved lysine residue and have highlighted potential regions of MPS1 which could be targeted to improve activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0pJ3yPx3obVg90H21EOLACvtfcHk0lh7jP5S2a4CPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2ksro%253D&md5=04edf748bd53820fe6dd9b1f3120eab0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DD.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520Profiling%2520of%2520a%25203-Aminopyridin-2-one-Based%2520Kinase%2520Targeted%2520Fragment%2520Library%253A%2520Identification%2520of%25203-Amino-5-%2528pyridin-4-yl%2529pyridin-2%25281H%2529-one%2520Scaffold%2520for%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%2520and%2520Aurora%2520Kinases%2520Inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3021%26epage%3D3029%26doi%3D10.1016%2Fj.bmc.2018.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span>SciFinder. <a href="https://www.cas.org/products/scifinder" class="extLink">https://www.cas.org/products/scifinder</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SciFinder.+https%3A%2F%2Fwww.cas.org%2Fproducts%2Fscifinder+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">The Rise of Fragment-Based Drug Discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/nchem.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnchem.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=21378847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=187-192&author=C.+W.+Murrayauthor=D.+C.+Rees&title=The+Rise+of+Fragment-Based+Drug+Discovery&doi=10.1038%2Fnchem.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for new drugs is plagued by high attrition rates at all stages in research and development.  Chemists have an opportunity to tackle this problem because attrition can be traced back, in part, to the quality of the chem. leads.  Fragment-based drug discovery (FBDD) is a new approach, increasingly used in the pharmaceutical industry, for reducing attrition and providing leads for previously intractable biol. targets.  FBDD identifies low-mol.-wt. ligands (∼150 Da) that bind to biol. important macromols.  The three-dimensional exptl. binding mode of these fragments is detd. using X-ray crystallog. or NMR spectroscopy, and is used to facilitate their optimization into potent mols. with drug-like properties.  Compared with high-throughput-screening, the fragment approach requires fewer compds. to be screened, and, despite the lower initial potency of the screening hits, offers more efficient and fruitful optimization campaigns.  Here, we review the rise of FBDD, including its application to discovering clin. candidates against targets for which other chem. approaches have struggled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3ip2FKcYJbVg90H21EOLACvtfcHk0lh7jP5S2a4CPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rs78%253D&md5=0bd1a40fd927cce9200f0fa296a7462f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchem.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.217%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DThe%2520Rise%2520of%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D187%26epage%3D192%26doi%3D10.1038%2Fnchem.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span>Practical
Fragments. <a href="http://practicalfragments.blogspot.com/" class="extLink">http://practicalfragments.blogspot.com/</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Practical%0AFragments.+http%3A%2F%2Fpracticalfragments.blogspot.com%2F+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7261</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVClurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7261-7272&author=L.+Hudsonauthor=J.+Muiauthor=S.+Vazquezauthor=D.+M.+Carvalhoauthor=E.+Williamsauthor=C.+Jonesauthor=A.+N.+Bullockauthor=S.+Hoelder&title=Novel+Quinazolinone+Inhibitors+of+ALK2+Flip+between+Alternate+Binding+Modes%3A+Structure-Activity+Relationship%2C+Structural+Characterization%2C+Kinase+Profiling%2C+and+Cellular+Proof+of+Concept&doi=10.1021%2Facs.jmedchem.8b00782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept</span></div><div class="casAuthors">Hudson, Liam; Mui, James; Vazquez, Santiago; Carvalho, Diana M.; Williams, Eleanor; Jones, Chris; Bullock, Alex N.; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7261-7272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationship and crystallog. data revealed that quinazolinone-contg. fragments flip between two distinct modes of binding to activin receptor-like kinase-2 (ALK2).  We explored both binding modes to discover potent inhibitors and characterized the chem. modifications that triggered the flip in binding mode.  We report kinase selectivity and demonstrate that compds. of this series modulate ALK2 in cancer cells.  These inhibitors are attractive starting points for the discovery of more advanced ALK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqae6Cwj4ijKbVg90H21EOLACvtfcHk0liPklUhmkTRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVClurjE&md5=a3a04f969265895f79f720d4a312ba57</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00782%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DL.%26aulast%3DMui%26aufirst%3DJ.%26aulast%3DVazquez%26aufirst%3DS.%26aulast%3DCarvalho%26aufirst%3DD.%2BM.%26aulast%3DWilliams%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DNovel%2520Quinazolinone%2520Inhibitors%2520of%2520ALK2%2520Flip%2520between%2520Alternate%2520Binding%2520Modes%253A%2520Structure-Activity%2520Relationship%252C%2520Structural%2520Characterization%252C%2520Kinase%2520Profiling%252C%2520and%2520Cellular%2520Proof%2520of%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7261%26epage%3D7272%26doi%3D10.1021%2Facs.jmedchem.8b00782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drueckes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8120</span>– <span class="NLM_lpage">8135</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKru7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8120-8135&author=J.+Schoepferauthor=W.+Jahnkeauthor=G.+Berelliniauthor=S.+Buonamiciauthor=S.+Cotestaauthor=S.+W.+Cowan-Jacobauthor=S.+Doddauthor=P.+Drueckesauthor=D.+Fabbroauthor=T.+Gabrielauthor=J.+M.+Groellauthor=R.+M.+Grotzfeldauthor=A.+Q.+Hassanauthor=C.+Henryauthor=V.+Iyerauthor=D.+Jonesauthor=F.+Lombardoauthor=A.+Looauthor=P.+W.+Manleyauthor=X.+Pelleauthor=G.+Rummelauthor=B.+Salemauthor=M.+Warmuthauthor=A.+A.+Wylieauthor=T.+Zollerauthor=A.+L.+Marzinzikauthor=P.+Furet&title=Discovery+of+Asciminib+%28ABL001%29%2C+an+Allosteric+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+BCR-ABL1&doi=10.1021%2Facs.jmedchem.8b01040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1</span></div><div class="casAuthors">Schoepfer, Joseph; Jahnke, Wolfgang; Berellini, Giuliano; Buonamici, Silvia; Cotesta, Simona; Cowan-Jacob, Sandra W.; Dodd, Stephanie; Drueckes, Peter; Fabbro, Doriano; Gabriel, Tobias; Groell, Jean-Marc; Grotzfeld, Robert M.; Hassan, A. Quamrul; Henry, Chrystele; Iyer, Varsha; Jones, Darryl; Lombardo, Franco; Loo, Alice; Manley, Paul W.; Pelle, Xavier; Rummel, Gabriele; Salem, Bahaa; Warmuth, Markus; Wylie, Andrew A.; Zoller, Thomas; Marzinzik, Andreas L.; Furet, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8120-8135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of asciminib I, an allosteric inhibitor of the BCR-ABL1 kinase for use in treating chronic myelogenous leukemia (CML), is delineated.  I binds to the myristate pocket of BCR-ABL1 and maintains activity against cancer cells possessing ATP-site mutations in BCR-ABL1 that render them resistant to tyrosine kinase inhibitors; cancer cells resistant to myristate-site mutations are likely to be susceptible to ATP-competitive inhibitors so that combinations of I and tyrosine kinase inhibitors should suppress the emergence of resistance.  Fragment-based screening using NMR and X-ray yielded ligands for the myristate pocket, while an NMR-based conformational assay guided the transformation of these inactive ligands into ABL1 inhibitors.  Further structure-based optimization for potency, physicochem., pharmacokinetic, and drug-like properties, culminated in I which is currently undergoing clin. studies in CML patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQbEIXXgRgbVg90H21EOLACvtfcHk0liPklUhmkTRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKru7bN&md5=023a566cdf4faba6dfc05501b8b6a6ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01040%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DT.%26aulast%3DGroell%26aufirst%3DJ.%2BM.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHassan%26aufirst%3DA.%2BQ.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DPelle%26aufirst%3DX.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWylie%26aufirst%3DA.%2BA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DMarzinzik%26aufirst%3DA.%2BL.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Asciminib%2520%2528ABL001%2529%252C%2520an%2520Allosteric%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520BCR-ABL1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8120%26epage%3D8135%26doi%3D10.1021%2Facs.jmedchem.8b01040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Series of Pyridine and Pyrimidine Carboxamides as Potent and Selective Covalent Inhibitors of BTK</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3419</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30290988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3419-3424&author=R.+Caldwellauthor=L.+Liu-Bujalskiauthor=H.+Qiuauthor=I.+Mochalkinauthor=R.+Jonesauthor=C.+Neaguauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=T.+Johnsonauthor=B.+Shererauthor=A.+Gardbergauthor=A.+V.+Follisauthor=F.+Morandiauthor=J.+Head&title=Discovery+of+a+Novel+Series+of+Pyridine+and+Pyrimidine+Carboxamides+as+Potent+and+Selective+Covalent+Inhibitors+of+BTK&doi=10.1016%2Fj.bmcl.2018.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk</span></div><div class="casAuthors">Caldwell, Richard; Liu-Bujalski, Lesley; Qiu, Hui; Mochalkin, Igor; Jones, Reinaldo; Neagu, Constantin; Goutopoulos, Andreas; Grenningloh, Roland; Johnson, Theresa; Sherer, Brian; Gardberg, Anna; Follis, Ariele Viacava; Morandi, Federica; Head, Jared</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3419-3424</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Btk is an attractive target for the treatment of a range of Bcell malignancies as well as several autoimmune diseases such as murine lupus and rheumatoid arthritis.  Several covalent irreversible inhibitors of Btk are currently in development including ibrutinib which was approved for treatment of B-cell malignancies.  Herein, we describe our efforts using X-ray guided structure based design (SBD) to identify a novel chem. series of covalent Btk inhibitors.  The resulting pyridine carboxamides were potent and selective inhibitors of Btk having excellent enzymic and cellular inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxbbu5RIAg8LVg90H21EOLACvtfcHk0lgVJ_fkp45vRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqt7fE&md5=b5253fa9bf8f1092dbed43bb8a1efd08</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DR.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DSherer%26aufirst%3DB.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DFollis%26aufirst%3DA.%2BV.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DHead%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Series%2520of%2520Pyridine%2520and%2520Pyrimidine%2520Carboxamides%2520as%2520Potent%2520and%2520Selective%2520Covalent%2520Inhibitors%2520of%2520BTK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3419%26epage%3D3424%26doi%3D10.1016%2Fj.bmcl.2018.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3390/molecules23020064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.3390%2Fmolecules23020064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=64&author=R.+Meineauthor=W.+Beckerauthor=H.+Falkeauthor=L.+Preuauthor=N.+Loaecauthor=L.+Meijerauthor=C.+Kunick&title=Indole-3-Carbonitriles+as+DYRK1A+Inhibitors+by+Fragment-Based+Drug+Design&doi=10.3390%2Fmolecules23020064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span></div><div class="casAuthors">Meine, Rosanna; Becker, Walter; Falke, Hannes; Preu, Lutz; Loaeec, Nadege; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">64/1-64/23</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential drug target because of its role in the development of Down syndrome and Alzheimer's disease.  The selective DYRK1A inhibitor 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acid (KuFal194), a large, flat and lipophilic mol., suffers from poor water soly., limiting its use as chem. probe in cellular assays and animal models.  Based on the structure of KuFal194, 7-chloro-1H-indole-3-carbonitrile was selected as fragment template for the development of smaller and less lipophilic DYRK1A inhibitors.  By modification of this fragment, a series of indole-3-carbonitriles was designed and evaluated as potential DYRK1A ligands by mol. docking studies.  Synthesis and in vitro assays on DYRK1A and related protein kinases identified novel double-digit nanomolar inhibitors with submicromolar activity in cell culture assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkYtRPnACcGLVg90H21EOLACvtfcHk0lgVJ_fkp45vRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK&md5=3c41761df0f75e3f8a98c1ee3c057ff9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020064%26sid%3Dliteratum%253Aachs%26aulast%3DMeine%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DIndole-3-Carbonitriles%2520as%2520DYRK1A%2520Inhibitors%2520by%2520Fragment-Based%2520Drug%2520Design%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D64%26doi%3D10.3390%2Fmolecules23020064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids are Selective Inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loaecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+Acids+are+Selective+Inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0lgVJ_fkp45vRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520Acids%2520are%2520Selective%2520Inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onions, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4978</span>– <span class="NLM_lpage">4992</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4978-4992&author=T.+D.+Heightmanauthor=V.+Berdiniauthor=H.+Braithwaiteauthor=I.+M.+Buckauthor=M.+Cassidyauthor=J.+Castroauthor=A.+Courtinauthor=J.+E.+H.+Dayauthor=C.+Eastauthor=L.+Fazalauthor=B.+Grahamauthor=C.+M.+Griffiths-Jonesauthor=J.+F.+Lyonsauthor=V.+Martinsauthor=S.+Muenchauthor=J.+M.+Munckauthor=D.+Nortonauthor=M.+O%E2%80%99Reillyauthor=N.+Palmerauthor=P.+Pathuriauthor=M.+Readerauthor=D.+C.+Reesauthor=S.+J.+Richauthor=C.+Richardsonauthor=H.+Sainiauthor=N.+T.+Thompsonauthor=N.+G.+Wallisauthor=H.+Waltonauthor=N.+E.+Wilsherauthor=A.+J.+Woolfordauthor=M.+Cookeauthor=D.+Cousinauthor=S.+Onionsauthor=J.+Shannonauthor=J.+Wattsauthor=C.+W.+Murray&title=Fragment-Based+Discovery+of+a+Potent%2C+Orally+Bioavailable+Inhibitor+That+Modulates+the+Phosphorylation+and+Catalytic+Activity+of+ERK1%2F2&doi=10.1021%2Facs.jmedchem.8b00421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2</span></div><div class="casAuthors">Heightman, Tom D.; Berdini, Valerio; Braithwaite, Hannah; Buck, Ildiko M.; Cassidy, Megan; Castro, Juan; Courtin, Aurelie; Day, James E. H.; East, Charlotte; Fazal, Lynsey; Graham, Brent; Griffiths-Jones, Charlotte M.; Lyons, John F.; Martins, Vanessa; Muench, Sandra; Munck, Joanne M.; Norton, David; O'Reilly, Marc; Palmer, Nick; Pathuri, Puja; Reader, Michael; Rees, David C.; Rich, Sharna J.; Richardson, Caroline; Saini, Harpreet; Thompson, Neil T.; Wallis, Nicola G.; Walton, Hugh; Wilsher, Nicola E.; Woolford, Alison J.-A.; Cooke, Michael; Cousin, David; Onions, Stuart; Shannon, Jonathan; Watts, John; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4978-4992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant activation of the MAPK pathway drives cell proliferation in multiple cancers.  Inhibitors of BRAF and MEK kinases are approved for the treatment of BRAF mutant melanoma, but resistance frequently emerges, often mediated by increased signaling through ERK1/2.  Here, we describe the fragment-based generation of ERK1/2 inhibitors that block catalytic phosphorylation of downstream substrates such as RSK but also modulate phosphorylation of ERK1/2 by MEK without directly inhibiting MEK.  X-ray crystallog. and biophys. fragment screening followed by structure-guided optimization and growth from the hinge into a pocket proximal to the C-α helix afforded highly potent ERK1/2 inhibitors with excellent kinome selectivity.  In BRAF mutant cells, the lead compd. suppresses pRSK and pERK levels and inhibits proliferation at low nanomolar concns.  The lead exhibits tumor regression upon oral dosing in BRAF mutant xenograft models, providing a promising basis for further optimization toward clin. pERK1/2 modulating ERK1/2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqstOOt0nyKg7Vg90H21EOLACvtfcHk0liPKvSl88tEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsLY%253D&md5=c2bd7c16be85e5f6af5525ce60272aa1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00421%26sid%3Dliteratum%253Aachs%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBraithwaite%26aufirst%3DH.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DCassidy%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DCourtin%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DEast%26aufirst%3DC.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DLyons%26aufirst%3DJ.%2BF.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMuench%26aufirst%3DS.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DN.%26aulast%3DPathuri%26aufirst%3DP.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaini%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWallis%26aufirst%3DN.%2BG.%26aulast%3DWalton%26aufirst%3DH.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DCousin%26aufirst%3DD.%26aulast%3DOnions%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DJ.%26aulast%3DWatts%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Potent%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520That%2520Modulates%2520the%2520Phosphorylation%2520and%2520Catalytic%2520Activity%2520of%2520ERK1%252F2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4978%26epage%3D4992%26doi%3D10.1021%2Facs.jmedchem.8b00421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E. Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaghafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01795</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01795" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3516-3540&author=S.+H.+Reichauthor=P.+A.+Sprengelerauthor=G.+G.+Chiangauthor=J.+R.+Applemanauthor=J.+Chenauthor=J.+Clarineauthor=B.+Eamauthor=J.+T.+Ernstauthor=Q.+Hanauthor=V.+K.+Goelauthor=E.+Z.+R.+Hanauthor=V.+Huangauthor=I.+N.+J.+Hungauthor=A.+Jemisonauthor=K.+A.+Jessenauthor=J.+Molterauthor=D.+Murphyauthor=M.+Nealauthor=G.+S.+Parkerauthor=M.+Shaghafiauthor=S.+Sperryauthor=J.+Stauntonauthor=C.+R.+Stumpfauthor=P.+A.+Thompsonauthor=C.+Tranauthor=S.+E.+Webberauthor=C.+J.+Wegerskiauthor=H.+Zhengauthor=K.+R.+Webster&title=Structure-Based+Design+of+Pyridone-Aminal+eFT508+Targeting+Dysregulated+Translation+by+Selective+Mitogen-Activated+Protein+Kinase+Interacting+Kinases+1+and+2+%28MNK1%2F2%29+Inhibition&doi=10.1021%2Facs.jmedchem.7b01795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span></div><div class="casAuthors">Reich, Siegfried H.; Sprengeler, Paul A.; Chiang, Gary G.; Appleman, James R.; Chen, Joan; Clarine, Jeff; Eam, Boreth; Ernst, Justin T.; Han, Qing; Goel, Vikas K.; Han, Edward Z. R.; Huang, Vera; Hung, Ivy N. J.; Jemison, Adrianna; Jessen, Katti A.; Molter, Jolene; Murphy, Douglas; Neal, Melissa; Parker, Gregory S.; Shaghafi, Michael; Sperry, Samuel; Staunton, Jocelyn; Stumpf, Craig R.; Thompson, Peggy A.; Tran, Chinh; Webber, Stephen E.; Wegerski, Christopher J.; Zheng, Hong; Webster, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3516-3540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulated translation of mRNA plays a major role in tumorigenesis.  Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins.  Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling.  Compd. 23 (eFT508, 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro-[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione hydrochloride), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation.  The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone-aminal structure described for the first time in the kinase literature.  Compd. 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential.  Compd. 23 is currently being evaluated in Phase 2 clin. trials in solid tumors and lymphoma.  Compd. 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAp-3GOuZu8bVg90H21EOLACvtfcHk0liPKvSl88tEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D&md5=1254b674aa7e6d2037a06bc10e64e4da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DClarine%26aufirst%3DJ.%26aulast%3DEam%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHan%26aufirst%3DE.%2BZ.%2BR.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DHung%26aufirst%3DI.%2BN.%2BJ.%26aulast%3DJemison%26aufirst%3DA.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DStumpf%26aufirst%3DC.%2BR.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DStructure-Based%2520Design%2520of%2520Pyridone-Aminal%2520eFT508%2520Targeting%2520Dysregulated%2520Translation%2520by%2520Selective%2520Mitogen-Activated%2520Protein%2520Kinase%2520Interacting%2520Kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3516%26epage%3D3540%26doi%3D10.1021%2Facs.jmedchem.7b01795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamaneni, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuddagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuah, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4348</span>– <span class="NLM_lpage">4369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01714</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01714" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1eqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4348-4369&author=H.+Yangauthor=L.+R.+Chennamaneniauthor=M.+W.+T.+Hoauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=D.+A.+Jeyarajauthor=Y.+S.+Yeapauthor=B.+Liuauthor=E.+H.+Ongauthor=J.+K.+Joyauthor=J.+L.+K.+Weeauthor=P.+Kwekauthor=P.+Retnaauthor=N.+Dinieauthor=T.+T.+H.+Nguyenauthor=S.+J.+Taiauthor=V.+Manoharanauthor=V.+Pendharkarauthor=C.+B.+Lowauthor=Y.+S.+Chewauthor=S.+Vuddagiriauthor=K.+Sangthongpitagauthor=M.+L.+Choongauthor=M.+A.+Leeauthor=S.+Kannanauthor=C.+S.+Vermaauthor=A.+Poulsenauthor=S.+Limauthor=C.+Chuahauthor=T.+S.+Ongauthor=J.+Hillauthor=A.+Matterauthor=K.+Nacro&title=Optimization+of+Selective+Mitogen-Activated+Protein+Kinase+Interacting+Kinases+1+and+2+Inhibitors+for+the+Treatment+of+Blast+Crisis+Leukemia&doi=10.1021%2Facs.jmedchem.7b01714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia</span></div><div class="casAuthors">Yang, Haiyan; Chennamaneni, Lohitha Rao; Ho, Melvyn Wai Tuck; Ang, Shi Hua; Tan, Eldwin Sum Wai; Jeyaraj, Duraiswamy Athisayamani; Yeap, Yoon Sheng; Liu, Boping; Ong, Esther Hq; Joy, Joma Kanikadu; Wee, John Liang Kuan; Kwek, Perlyn; Retna, Priya; Dinie, Nurul; Nguyen, Thuy Thi Hanh; Tai, Shi Jing; Manoharan, Vithya; Pendharkar, Vishal; Low, Choon Bing; Chew, Yun Shan; Vuddagiri, Susmitha; Sangthongpitag, Kanda; Choong, Meng Ling; Lee, May Ann; Kannan, Srinivasaraghavan; Verma, Chandra S.; Poulsen, Anders; Lim, Sharon; Chuah, Charles; Ong, Tiong Sin; Hill, Jeffrey; Matter, Alex; Nacro, Kassoum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4348-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cells (LSCs).  Inhibition of BCR-ABL1 kinase activity offers long-term relief to CML patients.  However, for a proportion of them, BCR-ABL1 inhibition will become ineffective at treating the disease, and CML will progress to blast crisis (BC) CML with poor prognosis.  BC-CML is often assocd. with excessive phosphorylated eukaryotic translation initiation factor 4E (eIF4E), which renders LSCs capable of proliferating via self-renewal, oblivious to BCR-ABL1 inhibition.  In vivo, eIF4E is exclusively phosphorylated on Ser209 by MNK1/2.  Consequently, a selective inhibitor of MNK1/2 should reduce the level of phosphorylated eIF4E and re-sensitize LSCs to BCR-ABL1 inhibition, thus hindering the proliferation of BC LSCs.  We report herein the structure-activity relationships and pharmacokinetic properties of a selective MNK1/2 inhibitor clin. candidate, ETC-206, which in combination with dasatinib prevents BC-CML LSC self-renewal in vitro and enhances dasatinib antitumor activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF5EekxyqUrVg90H21EOLACvtfcHk0lgjIgtLc05OsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1eqsbw%253D&md5=6818f494dd765080aec49cc11a9c34bb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01714%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChennamaneni%26aufirst%3DL.%2BR.%26aulast%3DHo%26aufirst%3DM.%2BW.%2BT.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DYeap%26aufirst%3DY.%2BS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DWee%26aufirst%3DJ.%2BL.%2BK.%26aulast%3DKwek%26aufirst%3DP.%26aulast%3DRetna%26aufirst%3DP.%26aulast%3DDinie%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%2BH.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DVuddagiri%26aufirst%3DS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DChuah%26aufirst%3DC.%26aulast%3DOng%26aufirst%3DT.%2BS.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DMatter%26aufirst%3DA.%26aulast%3DNacro%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520Selective%2520Mitogen-Activated%2520Protein%2520Kinase%2520Interacting%2520Kinases%25201%2520and%25202%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Blast%2520Crisis%2520Leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4348%26epage%3D4369%26doi%3D10.1021%2Facs.jmedchem.7b01714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tee, D. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N. H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4396</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1eqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4386-4396&author=J.+Kwiatkowskiauthor=B.+Liuauthor=D.+H.+Y.+Teeauthor=G.+Chenauthor=N.+H.+B.+Ahmadauthor=Y.+X.+Wongauthor=Z.+Y.+Pohauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=E.+H.+Ongauthor=N.+Dinieauthor=A.+Poulsenauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=M.+A.+Leeauthor=S.+Sepramaniamauthor=S.+Y.+Hoauthor=J.+Cherianauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+W.+Hung&title=Fragment-Based+Drug+Discovery+of+Potent+Protein+Kinase+C+Iota+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors</span></div><div class="casAuthors">Kwiatkowski, Jacek; Liu, Boping; Tee, Doris Hui Ying; Chen, Guoying; Binte Ahmad, Nur Huda; Wong, Yun Xuan; Poh, Zhi Ying; Ang, Shi Hua; Tan, Eldwin Sum Wai; Ong, Esther H. Q.; Dinie, Nurul; Poulsen, Anders; Pendharkar, Vishal; Sangthongpitag, Kanda; Lee, May Ann; Sepramaniam, Sugunavathi; Ho, Soo Yei; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Hung, Alvin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4396</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinase C iota (PKC-ι) is an atypical kinase implicated in the promotion of different cancer types.  A biochem. screen of a fragment library has identified several hits from which an azaindole-based scaffold was chosen for optimization.  Driven by a structure-activity relationship and supported by mol. modeling, a weakly bound fragment was systematically grown into a potent and selective inhibitor against PKC-ι.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVKGgW092g1bVg90H21EOLACvtfcHk0lgjIgtLc05OsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1eqtbk%253D&md5=efeeb545b2a8a88ff9d42d246fd2de4c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTee%26aufirst%3DD.%2BH.%2BY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DAhmad%26aufirst%3DN.%2BH.%2BB.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DDinie%26aufirst%3DN.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DSepramaniam%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DHung%26aufirst%3DA.%2BW.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%2520Potent%2520Protein%2520Kinase%2520C%2520Iota%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4386%26epage%3D4396%26doi%3D10.1021%2Facs.jmedchem.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rountree, J. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flasz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkoudis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozycka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odrzywol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feutren-Burton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavory, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span> <span> </span><span class="NLM_article-title">Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=238-243&author=C.+R.+O%E2%80%99Dowdauthor=M.+D.+Helmauthor=J.+S.+S.+Rountreeauthor=J.+T.+Flaszauthor=E.+Arkoudisauthor=H.+Mielauthor=P.+R.+Hewittauthor=L.+Jordanauthor=O.+Barkerauthor=C.+Hughesauthor=E.+Rozyckaauthor=E.+Cassidyauthor=K.+McClellandauthor=E.+Odrzywolauthor=N.+Pageauthor=S.+Feutren-Burtonauthor=S.+Dvorkinauthor=G.+Gavoryauthor=T.+Harrison&title=Identification+and+Structure-Guided+Development+of+Pyrimidinone+Based+USP7+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors</span></div><div class="casAuthors">O'Dowd, Colin R.; Helm, Matthew D.; Rountree, J. S. Shane; Flasz, Jakub T.; Arkoudis, Elias; Miel, Hugues; Hewitt, Peter R.; Jordan, Linda; Barker, Oliver; Hughes, Caroline; Rozycka, Ewelina; Cassidy, Eamon; McClelland, Keeva; Odrzywol, Ewa; Page, Natalie; Feutren-Burton, Stephanie; Dvorkin, Scarlett; Gavory, Gerald; Harrison, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ubiquitin specific protease 7 (USP7, HAUSP) has become an attractive target in drug discovery due to the role it plays in modulating Mdm2 levels and consequently p53.  Increasing interest in USP7 is emerging due to its potential involvement in oncogenic pathways as well as possible roles in both metabolic and immune disorders in addn. to viral infections.  Potent, novel, and selective inhibitors of USP7 have been developed using both rational and structure-guided design enabled by high-resoln. cocrystallog.  Initial hits were identified via fragment-based screening, scaffold-hopping, and hybridization exercises.  Two distinct subseries are described along with assocd. structure-activity relationship trends, as are initial efforts aimed at developing compds. suitable for in vivo expts.  Overall, these discoveries will enable further research into the wider biol. role of USP7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU61uWyWL-_bVg90H21EOLACvtfcHk0lgjIgtLc05OsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFOgs78%253D&md5=7035261c011f6381549e43cfc0b4af0c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00512%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DC.%2BR.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DRountree%26aufirst%3DJ.%2BS.%2BS.%26aulast%3DFlasz%26aufirst%3DJ.%2BT.%26aulast%3DArkoudis%26aufirst%3DE.%26aulast%3DMiel%26aufirst%3DH.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DJordan%26aufirst%3DL.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DHughes%26aufirst%3DC.%26aulast%3DRozycka%26aufirst%3DE.%26aulast%3DCassidy%26aufirst%3DE.%26aulast%3DMcClelland%26aufirst%3DK.%26aulast%3DOdrzywol%26aufirst%3DE.%26aulast%3DPage%26aufirst%3DN.%26aulast%3DFeutren-Burton%26aufirst%3DS.%26aulast%3DDvorkin%26aufirst%3DS.%26aulast%3DGavory%26aufirst%3DG.%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Structure-Guided%2520Development%2520of%2520Pyrimidinone%2520Based%2520USP7%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D238%26epage%3D243%26doi%3D10.1021%2Facsmedchemlett.7b00512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Derived Inhibitors of Human N-Myristoyltransferase Block Capsid Assembly and Replication of the Common Cold Virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+Perez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Guedanauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-Derived+Inhibitors+of+Human+N-Myristoyltransferase+Block+Capsid+Assembly+and+Replication+of+the+Common+Cold+Virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0lg6C6_XsPqAPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DPerez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGuedan%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-Derived%2520Inhibitors%2520of%2520Human%2520N-Myristoyltransferase%2520Block%2520Capsid%2520Assembly%2520and%2520Replication%2520of%2520the%2520Common%2520Cold%2520Virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Approach to Targeting Inosine-5′-Monophosphate Dehydrogenase (IMPDH) from <i>Mycobacterium tuberculosis</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2806-2822&author=A.+Traperoauthor=A.+Pacittoauthor=V.+Singhauthor=M.+Sabbahauthor=A.+G.+Coyneauthor=V.+Mizrahiauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=C.+Abell&title=Fragment-Based+Approach+to+Targeting+Inosine-5%E2%80%B2-Monophosphate+Dehydrogenase+%28IMPDH%29+from+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.7b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis</span></div><div class="casAuthors">Trapero, Ana; Pacitto, Angela; Singh, Vinayak; Sabbah, Mohamad; Coyne, Anthony G.; Mizrahi, Valerie; Blundell, Tom L.; Ascher, David B.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2806-2822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB) remains a major cause of mortality worldwide, and improved treatments are needed to combat emergence of drug resistance.  IMP dehydrogenase (IMPDH), a crucial enzyme required for de novo synthesis of guanine nucleotides, is an attractive TB drug target.  Herein, we describe the identification of potent IMPDH inhibitors using fragment-based screening and structure-based design techniques.  Screening of a fragment library for Mycobacterium thermoresistible (Mth) IMPDH ΔCBS inhibitors identified a low affinity phenylimidazole deriv.  X-ray crystallog. of the Mth IMPDH ΔCBS-IMP-inhibitor complex revealed that two mols. of the fragment were bound in the NAD binding pocket of IMPDH.  Linking the two mols. of the fragment afforded compds. with more than 1000-fold improvement in IMPDH affinity over the initial fragment hit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIloJxzRRl5bVg90H21EOLACvtfcHk0lg6C6_XsPqAPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGksb0%253D&md5=a0decf859d321144e41547dda2b38fbf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01622%26sid%3Dliteratum%253Aachs%26aulast%3DTrapero%26aufirst%3DA.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DSabbah%26aufirst%3DM.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-Based%2520Approach%2520to%2520Targeting%2520Inosine-5%25E2%2580%25B2-Monophosphate%2520Dehydrogenase%2520%2528IMPDH%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2806%26epage%3D2822%26doi%3D10.1021%2Facs.jmedchem.7b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talagas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Saez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panagakou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjanacz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M.</span></span> <span> </span><span class="NLM_article-title">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2533-2551&author=F.+Rahmauthor=J.+Viklundauthor=L.+Tresauguesauthor=M.+Ellermannauthor=A.+Gieseauthor=U.+Ericssonauthor=R.+Forsblomauthor=T.+Ginmanauthor=J.+Guntherauthor=K.+Hallbergauthor=J.+Lindstromauthor=L.+B.+Perssonauthor=C.+Silvanderauthor=A.+Talagasauthor=L.+Diaz-Saezauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=I.+Panagakouauthor=P.+Siejkaauthor=M.+Gorjanaczauthor=M.+Bauserauthor=M.+Andersson&title=Creation+of+a+Novel+Class+of+Potent+and+Selective+MutT+Homologue+1+%28MTH1%29+Inhibitors+Using+Fragment-Based+Screening+and+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span></div><div class="casAuthors">Rahm, Fredrik; Viklund, Jenny; Tresaugues, Lionel; Ellermann, Manuel; Giese, Anja; Ericsson, Ulrika; Forsblom, Rickard; Ginman, Tobias; Gunther, Judith; Hallberg, Kenth; Lindstroem, Johan; Persson, Lars Boukharta; Silvander, Camilla; Talagas, Antoine; Diaz-Saez, Laura; Fedorov, Oleg; Huber, Kilian V. M.; Panagakou, Ioanna; Siejka, Paulina; Gorjanacz, Matyas; Bauser, Marcus; Andersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2533-2551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent literature has both suggested and questioned MTH1 as a novel cancer target.  BAY-707 was just published as a target validation small mol. probe for assessing the effects of pharmacol. inhibition of MTH1 on tumor cell survival, both in vitro and in vivo.  In this report, the authors describe the medicinal chem. program creating BAY-707, where fragment-based methods were used to develop a series of highly potent and selective MTH1 inhibitors.  Using structure-based drug design and rational medicinal chem. approaches, the potency was increased over 10,000 times from the fragment starting point while maintaining high ligand efficiency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7pMr__ory7Vg90H21EOLACvtfcHk0lhfaNhVQEmsAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D&md5=5500fe330efef6fdbe5eae95b3d88ab1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01884%26sid%3Dliteratum%253Aachs%26aulast%3DRahm%26aufirst%3DF.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DTresaugues%26aufirst%3DL.%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DEricsson%26aufirst%3DU.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DGunther%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPersson%26aufirst%3DL.%2BB.%26aulast%3DSilvander%26aufirst%3DC.%26aulast%3DTalagas%26aufirst%3DA.%26aulast%3DDiaz-Saez%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DPanagakou%26aufirst%3DI.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DGorjanacz%26aufirst%3DM.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DM.%26atitle%3DCreation%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520MutT%2520Homologue%25201%2520%2528MTH1%2529%2520Inhibitors%2520Using%2520Fragment-Based%2520Screening%2520and%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2533%26epage%3D2551%26doi%3D10.1021%2Facs.jmedchem.7b01884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korepanova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longenecker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Potent NAMPT Inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2017.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29287958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCmtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=437-440&author=A.+Korepanovaauthor=K.+L.+Longeneckerauthor=S.+D.+Prattauthor=S.+C.+Panchalauthor=R.+F.+Clarkauthor=M.+Lakeauthor=S.+M.+Gopalakrishnanauthor=D.+Raichauthor=C.+Sunauthor=A.+M.+Petros&title=Fragment-Based+Discovery+of+a+Potent+NAMPT+Inhibitor&doi=10.1016%2Fj.bmcl.2017.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a potent NAMPT inhibitor</span></div><div class="casAuthors">Korepanova, Alla; Longenecker, Kenton L.; Pratt, Steve D.; Panchal, Sanjay C.; Clark, Richard F.; Lake, Marc; Gopalakrishnan, Sujatha M.; Raich, Diana; Sun, Chaohong; Petros, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-440</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NAMPT expression is elevated in many cancers, making this protein a potential target for anticancer therapy.  The authors have carried out both NMR based and TR-FRET based fragment screens against human NAMPT and identified six novel binders with a range of potencies.  Co-crystal structures were obtained for two of the fragments bound to NAMPT while for the other four fragments force-field driven docking was employed to generate a bound pose.  Based on structural insights arising from comparison of the bound fragment poses to that of bound FK866 the authors were able to synthetically elaborate one of the fragments into a potent NAMPT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-8YrVVMkVcrVg90H21EOLACvtfcHk0lhfaNhVQEmsAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCmtrbP&md5=4a1e76378d5f3a2093887da6a269799e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKorepanova%26aufirst%3DA.%26aulast%3DLongenecker%26aufirst%3DK.%2BL.%26aulast%3DPratt%26aufirst%3DS.%2BD.%26aulast%3DPanchal%26aufirst%3DS.%2BC.%26aulast%3DClark%26aufirst%3DR.%2BF.%26aulast%3DLake%26aufirst%3DM.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DRaich%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Potent%2520NAMPT%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D437%26epage%3D440%26doi%3D10.1016%2Fj.bmcl.2017.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namatame, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honbou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1248/cpb.c17-00836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1248%2Fcpb.c17-00836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29491261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=286-294&author=A.+Chinoauthor=R.+Seoauthor=Y.+Amanoauthor=I.+Namatameauthor=W.+Hamaguchiauthor=K.+Honbouauthor=T.+Miharaauthor=M.+Yamazakiauthor=M.+Tomishimaauthor=N.+Masuda&title=Fragment-Based+Discovery+of+Pyrimido%5B1%2C2-b%5Dindazole+PDE10A+Inhibitors&doi=10.1248%2Fcpb.c17-00836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of Pyrimido[1,2-b]indazole PDE10A inhibitors</span></div><div class="casAuthors">Chino, Ayaka; Seo, Ryushi; Amano, Yasushi; Namatame, Ichiji; Hamaguchi, Wataru; Honbou, Kazuya; Mihara, Takuma; Yamazaki, Mayako; Tomishima, Masaki; Masuda, Naoyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">286-294</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">In this study, we report the identification of potent pyrimidoindazoles as phosphodiesterase10A (PDE10A) inhibitors by using the method of fragment-based drug discovery (FBDD).  The pyrazolopyridine deriv. 2 was found to be a fragment hit compd. which could occupy a part of the binding site of PDE10A enzyme by using the method of the X-ray co-crystal structure anal.  On the basis of the crystal structure of compd. 2 and PDE10A protein, a no. of compds. were synthesized and evaluated, by means of structure-activity relationship (SAR) studies, which culminated in the discovery of a novel pyrimidoindazole deriv. 13 having good physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGkZ7fYLkZeLVg90H21EOLACvtfcHk0lhfaNhVQEmsAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOlu7fO&md5=6dbed6b6fd4d9ddf7e7198ff1ac9a71f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c17-00836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c17-00836%26sid%3Dliteratum%253Aachs%26aulast%3DChino%26aufirst%3DA.%26aulast%3DSeo%26aufirst%3DR.%26aulast%3DAmano%26aufirst%3DY.%26aulast%3DNamatame%26aufirst%3DI.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DHonbou%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DTomishima%26aufirst%3DM.%26aulast%3DMasuda%26aufirst%3DN.%26atitle%3DFragment-Based%2520Discovery%2520of%2520Pyrimido%255B1%252C2-b%255Dindazole%2520PDE10A%2520Inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D286%26epage%3D294%26doi%3D10.1248%2Fcpb.c17-00836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepper, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blechschmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balibar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3309</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01691</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01691" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3309-3324&author=R.+J.+Moreauauthor=C.+K.+Skepperauthor=B.+A.+Appletonauthor=A.+Blechschmidtauthor=C.+J.+Balibarauthor=B.+M.+Bentonauthor=J.+E.+Drummauthor=B.+Y.+Fengauthor=M.+Gengauthor=C.+Liauthor=M.+K.+Lindvallauthor=A.+Lingelauthor=Y.+Luauthor=M.+Mamoauthor=W.+Mergoauthor=V.+Polyakovauthor=T.+M.+Smithauthor=K.+Takeokaauthor=K.+Ueharaauthor=L.+Wangauthor=J.+R.+Weiauthor=A.+H.+Weissauthor=L.+Xieauthor=W.+Xuauthor=Q.+Zhangauthor=J.+de+Vicente&title=Fragment-Based+Drug+Discovery+of+Inhibitors+of+Phosphopantetheine+Adenylyltransferase+from+Gram-Negative+Bacteria&doi=10.1021%2Facs.jmedchem.7b01691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria</span></div><div class="casAuthors">Moreau, Robert J.; Skepper, Colin K.; Appleton, Brent A.; Blechschmidt, Anke; Balibar, Carl J.; Benton, Bret M.; Drumm, Joseph E.; Feng, Brian Y.; Geng, Mei; Li, Cindy; Lindvall, Mika K.; Lingel, Andreas; Lu, Yipin; Mamo, Mulugeta; Mergo, Wosenu; Polyakov, Valery; Smith, Thomas M.; Takeoka, Kenneth; Uehara, Kyoko; Wang, Lisha; Wei, Jun-Rong; Weiss, Andrew H.; Xie, Lili; Xu, Wenjian; Zhang, Qiong; de Vicente, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3309-3324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and development of new antibiotics capable of curing infections due to multidrug-resistant and pandrug-resistant Gram-neg. bacteria is a major challenge with fundamental importance to our global healthcare system.  Part of our broad program at Novartis to address this urgent, unmet need includes the search for new agents that inhibit novel bacterial targets.  Here we report the discovery and hit-to-lead optimization of new inhibitors of phosphopantetheine adenylyltransferase (PPAT) from Gram-neg. bacteria.  Utilizing a fragment-based screening approach, we discovered a no. of unique scaffolds capable of interacting with the pantetheine site of E. coli PPAT and inhibiting enzymic activity, including triazolopyrimidinone.  Structure-based optimization resulted in the identification of two lead compds. as selective, small mol. inhibitors of bacterial PPAT: triazolopyrimidinone I and azabenzimidazole II efficiently inhibited E. coli and P. aeruginosa PPAT and displayed modest cellular potency against the efflux-deficient E. coli ΔtolC mutant strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa07bfbrkvALVg90H21EOLACvtfcHk0lhPNN_fnX0xEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgs7Y%253D&md5=9a7b2e05b17b6b2a83f96505de020cf1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01691%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DR.%2BJ.%26aulast%3DSkepper%26aufirst%3DC.%2BK.%26aulast%3DAppleton%26aufirst%3DB.%2BA.%26aulast%3DBlechschmidt%26aufirst%3DA.%26aulast%3DBalibar%26aufirst%3DC.%2BJ.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%2BK.%26aulast%3DLingel%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DT.%2BM.%26aulast%3DTakeoka%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DJ.%2BR.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%2520Inhibitors%2520of%2520Phosphopantetheine%2520Adenylyltransferase%2520from%2520Gram-Negative%2520Bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3309%26epage%3D3324%26doi%3D10.1021%2Facs.jmedchem.7b01691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skepper, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drumm, J. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostafavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeoka, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3325</span>– <span class="NLM_lpage">3349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01861</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01861" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3325-3349&author=C.+K.+Skepperauthor=R.+J.+Moreauauthor=B.+A.+Appletonauthor=B.+M.+Bentonauthor=J.+E.+Drummauthor=B.+Y.+Fengauthor=M.+Gengauthor=C.+Huauthor=C.+Liauthor=A.+Lingelauthor=Y.+Luauthor=M.+Mamoauthor=W.+Mergoauthor=M.+Mostafaviauthor=C.+M.+Rathauthor=M.+Steffekauthor=K.+T.+Takeokaauthor=K.+Ueharaauthor=L.+Wangauthor=J.+R.+Weiauthor=L.+Xieauthor=W.+Xuauthor=Q.+Zhangauthor=J.+de+Vicente&title=Discovery+and+Optimization+of+Phosphopantetheine+Adenylyltransferase+Inhibitors+with+Gram-Negative+Antibacterial+Activity&doi=10.1021%2Facs.jmedchem.7b01861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity</span></div><div class="casAuthors">Skepper, Colin K.; Moreau, Robert J.; Appleton, Brent A.; Benton, Bret M.; Drumm, Joseph E.; Feng, Brian Y.; Geng, Mei; Hu, Cheng; Li, Cindy; Lingel, Andreas; Lu, Yipin; Mamo, Mulugeta; Mergo, Wosenu; Mostafavi, Mina; Rath, Christopher M.; Steffek, Micah; Takeoka, Kenneth T.; Uehara, Kyoko; Wang, Lisha; Wei, Jun-Rong; Xie, Lili; Xu, Wenjian; Zhang, Qiong; de Vicente, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3325-3349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the preceding manuscript the authors described a successful fragment-based lead discovery (FBLD) strategy for discovery of bacterial phosphopantetheine adenylyltransferase inhibitors (PPAT, CoaD).  Following several rounds of optimization two promising lead compds. were identified: triazolopyrimidinone (I) and 4-azabenzimidazole (II).  Here the authors disclose the efforts to further optimize these two leads for on-target potency and Gram-neg. cellular activity.  Enabled by a robust x-ray crystallog. system, the authors' structure-based inhibitor design approach delivered compds. with biochem. potencies 4-5 orders of magnitude greater than their resp. fragment starting points.  Addnl. optimization was guided by observations on bacterial permeability and physicochem. properties, which ultimately led to the identification of PPAT inhibitors with cellular activity against wild-type E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSVizQsO4tt7Vg90H21EOLACvtfcHk0lhPNN_fnX0xEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGltr0%253D&md5=6077c6386bcb76e34f324533bd9cb43c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01861%26sid%3Dliteratum%253Aachs%26aulast%3DSkepper%26aufirst%3DC.%2BK.%26aulast%3DMoreau%26aufirst%3DR.%2BJ.%26aulast%3DAppleton%26aufirst%3DB.%2BA.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLingel%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMamo%26aufirst%3DM.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMostafavi%26aufirst%3DM.%26aulast%3DRath%26aufirst%3DC.%2BM.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DTakeoka%26aufirst%3DK.%2BT.%26aulast%3DUehara%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DJ.%2BR.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Phosphopantetheine%2520Adenylyltransferase%2520Inhibitors%2520with%2520Gram-Negative%2520Antibacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3325%26epage%3D3349%26doi%3D10.1021%2Facs.jmedchem.7b01861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demont, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinjha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4317</span>– <span class="NLM_lpage">4334</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01666</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01666" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Sjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4317-4334&author=R.+P.+Lawauthor=S.+J.+Atkinsonauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=E.+H.+Demontauthor=L.+J.+Gordonauthor=M.+Lindonauthor=R.+K.+Prinjhaauthor=A.+J.+B.+Watsonauthor=D.+J.+Hirst&title=Discovery+of+Tetrahydroquinoxalines+as+Bromodomain+and+Extra-Terminal+Domain+%28BET%29+Inhibitors+with+Selectivity+for+the+Second+Bromodomain&doi=10.1021%2Facs.jmedchem.7b01666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain</span></div><div class="casAuthors">Law, Robert P.; Atkinson, Stephen J.; Bamborough, Paul; Chung, Chun-wa; Demont, Emmanuel H.; Gordon, Laurie J.; Lindon, Matthew; Prinjha, Rab K.; Watson, Allan J. B.; Hirst, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4317-4334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromodomain and extra-terminal domain (BET) family of proteins bind acetylated lysine residues on histone proteins.  The four BET bromodomains-BRD2, BRD3, BRD4, and BRDT-each contain two bromodomain modules.  BET bromodomain inhibition is a potential therapy for various cancers and immunoinflammatory diseases, but few reported inhibitors show selectivity within the BET family.  Inhibitors with selectivity for the first or second bromodomain are desired to aid investigation of the biol. function of these domains.  Focused library screening identified a series of tetrahydroquinoxalines with selectivity for the second bromodomains of the BET family (BD2).  Structure-guided optimization of the template improved potency, selectivity, and physicochem. properties, culminating in potent BET inhibitors with BD2 selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobBKYwu7NyTbVg90H21EOLACvtfcHk0liYjoU49p_6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Sjtbc%253D&md5=078db91b35feaf1958fa8c33d0544387</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01666%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DR.%2BP.%26aulast%3DAtkinson%26aufirst%3DS.%2BJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%2BB.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520Tetrahydroquinoxalines%2520as%2520Bromodomain%2520and%2520Extra-Terminal%2520Domain%2520%2528BET%2529%2520Inhibitors%2520with%2520Selectivity%2520for%2520the%2520Second%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4317%26epage%3D4334%26doi%3D10.1021%2Facs.jmedchem.7b01666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosario, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betancort, J. M.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Novel 4-Phenylisoquinolinone BET Bromodomain Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29657099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Smsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1811-1816&author=M.+J.+Bennettauthor=Y.+Wuauthor=A.+Boloorauthor=J.+Matuszkiewiczauthor=S.+M.+O%E2%80%99Connellauthor=L.+Shiauthor=R.+K.+Stansfieldauthor=J.+R.+Del+Rosarioauthor=J.+M.+Vealauthor=D.+J.+Hosfieldauthor=J.+Xuauthor=S.+W.+Kaldorauthor=J.+A.+Staffordauthor=J.+M.+Betancort&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+4-Phenylisoquinolinone+BET+Bromodomain+Inhibitors&doi=10.1016%2Fj.bmcl.2018.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors</span></div><div class="casAuthors">Bennett, Michael J.; Wu, Yiqin; Boloor, Amogh; Matuszkiewicz, Jennifer; O'Connell, Shawn M.; Shi, Lihong; Stansfield, Ryan K.; Del Rosario, Joselyn R.; Veal, James M.; Hosfield, David J.; Xu, Jiangchun; Kaldor, Stephen W.; Stafford, Jeffrey A.; Betancort, Juan M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1811-1816</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bromodomain and extra-terminal (BET) family of epigenetic proteins has attracted considerable attention in drug discovery given its involvement in regulating gene transcription.  Screening a focused small mol. library based on the bromodomain pharmacophore resulted in the identification of 2-methylisoquinoline-1-one as a novel BET bromodomain-binding motif.  Structure guided SAR exploration resulted in >10,000-fold potency improvement for the BRD4-BD1 bromodomain.  Lead compds. exhibited excellent potencies in both biochem. and cellular assays in MYC-dependent cell lines.  Compd. 36 demonstrated good physicochem. properties and promising exposure levels in exploratory PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlnVx6qo2COrVg90H21EOLACvtfcHk0liYjoU49p_6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Smsrk%253D&md5=0022a3a3c84c72f7d9a37382df3afd00</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DMatuszkiewicz%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DS.%2BM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%2BK.%26aulast%3DDel%2BRosario%26aufirst%3DJ.%2BR.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DBetancort%26aufirst%3DJ.%2BM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25204-Phenylisoquinolinone%2520BET%2520Bromodomain%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1811%26epage%3D1816%26doi%3D10.1016%2Fj.bmcl.2018.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batiste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unzue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolbois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiliotopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevado, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span> <span> </span><span class="NLM_article-title">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.7b00401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ehu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=180-188&author=L.+Batisteauthor=A.+Unzueauthor=A.+Dolboisauthor=F.+Hasslerauthor=X.+Wangauthor=N.+Deerainauthor=J.+Zhuauthor=D.+Spiliotopoulosauthor=C.+Nevadoauthor=A.+Caflisch&title=Chemical+Space+Expansion+of+Bromodomain+Ligands+Guided+by+in+Silico+Virtual+Couplings+%28AutoCouple%29&doi=10.1021%2Facscentsci.7b00401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)</span></div><div class="casAuthors">Batiste, Laurent; Unzue, Andrea; Dolbois, Aymeric; Hassler, Fabrice; Wang, Xuan; Deerain, Nicholas; Zhu, Jian; Spiliotopoulos, Dimitrios; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-188</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Expanding the chem. space and simultaneously ensuring synthetic accessibility is of upmost importance, not only for the discovery of effective binders for novel protein classes, but more importantly, for the development of compds. against hard-to-drug proteins.  Here, the authors present AutoCouple, a de novo approach to computational ligand design focused on the diversity-oriented generation of chem. entities via virtual couplings.  In a benchmark application, chem. diverse compds. with low-nanomolar potency for the CBP bromodomain and unprecedented selectivity (up to 1500 fold) against the BRD4(1) bromodomain were achieved by the synthesis of ∼50 derivs. of the original fragment.  The binding mode was confirmed by x-ray crystallog., target engagement in cells was demonstrated and anti-proliferative activity showcased in three cancer cell lines.  These results reveal AutoCouple as a useful in silico coupling method to expand the chem. space in hit optimization campaigns resulting in potent, selective and cell permeable bromodomain ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa0J3CCu_dR7Vg90H21EOLACvtfcHk0lhFZzjJhaEwfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ehu7k%253D&md5=92bcfd52911b0f6f07b49569abf2e2e0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00401%26sid%3Dliteratum%253Aachs%26aulast%3DBatiste%26aufirst%3DL.%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DDolbois%26aufirst%3DA.%26aulast%3DHassler%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDeerain%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DChemical%2520Space%2520Expansion%2520of%2520Bromodomain%2520Ligands%2520Guided%2520by%2520in%2520Silico%2520Virtual%2520Couplings%2520%2528AutoCouple%2529%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2018%26volume%3D4%26spage%3D180%26epage%3D188%26doi%3D10.1021%2Facscentsci.7b00401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unzue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiliotopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevado, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1350-1356&author=A.+Unzueauthor=M.+Xuauthor=J.+Dongauthor=L.+Wiedmerauthor=D.+Spiliotopoulosauthor=A.+Caflischauthor=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span></div><div class="casAuthors">Unzue, Andrea; Xu, Min; Dong, Jing; Wiedmer, Lars; Spiliotopoulos, Dimitrios; Caflisch, Amedeo; Nevado, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1350-1356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel ligands of the CREBBP bromodomain were identified by fragment-based docking.  The in silico discovered hits have been optimized by chem. synthesis into selective nanomolar compds., thereby preserving the ligand efficiency.  The selectivity for the CREBBP bromodomain over other human bromodomain subfamilies has achieved by a benzoate moiety which was predicted by docking to be involved in favorable electrostatic interactions with the Arg1173 side chain, a prediction that could be verified a posteriori by the high-resoln. crystal structure of the CREBBP bromodomain in complex with ligand 6 and also by MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy4MHhgfhyu7Vg90H21EOLACvtfcHk0lhFZzjJhaEwfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D&md5=aff73b86b04fc4d7243adcba364ca6a6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWiedmer%26aufirst%3DL.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1350%26epage%3D1356%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of 1-(1H-Indol-1-yl)ethanone Derivatives as CBP/EP300 Bromodomain Inhibitors for the Treatment of Castration-Resistant Prostate Cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.01.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.ejmech.2018.01.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29448139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2018&pages=238-252&author=Q.+Xiangauthor=C.+Wangauthor=Y.+Zhangauthor=X.+Xueauthor=M.+Songauthor=C.+Zhangauthor=C.+Liauthor=C.+Wuauthor=K.+Liauthor=X.+Huiauthor=Y.+Zhouauthor=J.+B.+Smaillauthor=A.+V.+Pattersonauthor=D.+Wuauthor=K.+Dingauthor=Y.+Xu&title=Discovery+and+Optimization+of+1-%281H-Indol-1-yl%29ethanone+Derivatives+as+CBP%2FEP300+Bromodomain+Inhibitors+for+the+Treatment+of+Castration-Resistant+Prostate+Cancer&doi=10.1016%2Fj.ejmech.2018.01.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer</span></div><div class="casAuthors">Xiang, Qiuping; Wang, Chao; Zhang, Yan; Xue, Xiaoqian; Song, Ming; Zhang, Cheng; Li, Chenchang; Wu, Chun; Li, Kuai; Hui, Xiaoyan; Zhou, Yulai; Smaill, Jeff B.; Patterson, Adam V.; Wu, Donghai; Ding, Ke; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">238-252</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The CREB (cAMP responsive element binding protein) binding protein (CBP) and its homolog EP300 have emerged as new therapeutic targets for the treatment of cancer and inflammatory diseases.  Here the authors report the identification, optimization and evaluation of 1-(1H-indol-1-yl)ethanone derivs. as CBP/EP300 inhibitors starting from fragment-based virtual screening (FBVS).  A cocrystal structure of the inhibitor (22e, (S)-1-(2-(3-acetyl-1H-indol-1-yl)acetyl)piperidine-3-carboxylic acid) in complex with CBP provides a solid structural basis for further optimization.  The most potent compd. 32h (3-(1-acetyl-5-methoxy-1H-indole-3-carboxamido)-4-fluoro-5-(1-methyl-1H-pyrazol-4-yl)benzoic acid) binds to the CBP bromodomain and has an IC50 value of 0.037 μM in the AlphaScreen assay which was 2 times more potent than the reported CBP bromodomain inhibitor SGC-CBP30 in the authors' hands.  Compd. 32h also exhibit high selectivity for CBP/EP300 over other bromodomain-contg. proteins.  Notably, the ester deriv. (29h) of compd. 32h markedly inhibits cell growth in several prostate cancer cell lines including LNCaP, 22Rv1 and LNCaP derived C4-2B.  Compd. 29h suppresses the mRNA expression of full length AR (AR-FL), AR target genes and other oncogene in LNCaP cells.  Compd. 29h also reduces the expression of PSA, the biomarker of prostate cancer.  CBP/EP300 inhibitor 29h represents a promising lead compd. for the development of new therapeutics for the treatment of castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfhyhecrKteLVg90H21EOLACvtfcHk0lit62O3Sn8MMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCmurc%253D&md5=960cb1e07d8d587d4b0f45eefe92f9af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.01.087%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DHui%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%25201-%25281H-Indol-1-yl%2529ethanone%2520Derivatives%2520as%2520CBP%252FEP300%2520Bromodomain%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Castration-Resistant%2520Prostate%2520Cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D147%26spage%3D238%26epage%3D252%26doi%3D10.1016%2Fj.ejmech.2018.01.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Migoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bery, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataille, C. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulmin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehebauer, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fuentes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbitts, T. H.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of RAS-Effector Protein Interactions Derived Using an Intracellular Antibody Fragment</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3169</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05707-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41467-018-05707-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30093669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ms12mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3169&author=C.+E.+Quevedoauthor=A.+Cruz-Migoniauthor=N.+Beryauthor=A.+Millerauthor=T.+Tanakaauthor=D.+Petchauthor=C.+J.+R.+Batailleauthor=L.+Y.+W.+Leeauthor=P.+S.+Fallonauthor=H.+Tulminauthor=M.+T.+Ehebauerauthor=N.+Fernandez-Fuentesauthor=A.+J.+Russellauthor=S.+B.+Carrauthor=S.+E.+V.+Phillipsauthor=T.+H.+Rabbitts&title=Small+Molecule+Inhibitors+of+RAS-Effector+Protein+Interactions+Derived+Using+an+Intracellular+Antibody+Fragment&doi=10.1038%2Fs41467-018-05707-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment</span></div><div class="casAuthors">Quevedo Camilo E; Cruz-Migoni Abimael; Bery Nicolas; Miller Ami; Tulmin Hanna; Ehebauer Matthias T; Rabbitts Terence H; Cruz-Migoni Abimael; Fernandez-Fuentes Narcis; Carr Stephen B; Phillips Simon E V; Tanaka Tomoyuki; Petch Donna; Tanaka Tomoyuki; Bataille Carole J R; Russell Angela J; Lee Lydia Y W; Fallon Phillip S; Tulmin Hanna; Ehebauer Matthias T; Fernandez-Fuentes Narcis; Carr Stephen B; Phillips Simon E V</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3169</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeting specific protein-protein interactions (PPIs) is an attractive concept for drug development, but hard to implement since intracellular antibodies do not penetrate cells and most small-molecule drugs are considered unsuitable for PPI inhibition.  A potential solution to these problems is to select intracellular antibody fragments to block PPIs, use these antibody fragments for target validation in disease models and finally derive small molecules overlapping the antibody-binding site.  Here, we explore this strategy using an anti-mutant RAS antibody fragment as a competitor in a small-molecule library screen for identifying RAS-binding compounds.  The initial hits are optimized by structure-based design, resulting in potent RAS-binding compounds that interact with RAS inside the cells, prevent RAS-effector interactions and inhibit endogenous RAS-dependent signalling.  Our results may aid RAS-dependent cancer drug development and demonstrate a general concept for developing small compounds to replace intracellular antibody fragments, enabling rational drug development to target validated PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIUnXfwZaCRvxQvRxYU81tfW6udTcc2eYcDp68RDTc9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ms12mtQ%253D%253D&md5=79679120c60be8cd9be9fbbfe0c9fdb6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05707-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05707-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuevedo%26aufirst%3DC.%2BE.%26aulast%3DCruz-Migoni%26aufirst%3DA.%26aulast%3DBery%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPetch%26aufirst%3DD.%26aulast%3DBataille%26aufirst%3DC.%2BJ.%2BR.%26aulast%3DLee%26aufirst%3DL.%2BY.%2BW.%26aulast%3DFallon%26aufirst%3DP.%2BS.%26aulast%3DTulmin%26aufirst%3DH.%26aulast%3DEhebauer%26aufirst%3DM.%2BT.%26aulast%3DFernandez-Fuentes%26aufirst%3DN.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DCarr%26aufirst%3DS.%2BB.%26aulast%3DPhillips%26aufirst%3DS.%2BE.%2BV.%26aulast%3DRabbitts%26aufirst%3DT.%2BH.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520RAS-Effector%2520Protein%2520Interactions%2520Derived%2520Using%2520an%2520Intracellular%2520Antibody%2520Fragment%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3169%26doi%3D10.1038%2Fs41467-018-05707-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salovich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogliotti, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tansey, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent 2-Aryl-6,7-dihydro-5 H-pyrrolo[1,2- a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5623</span>– <span class="NLM_lpage">5642</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5623-5642&author=F.+Wangauthor=K.+O.+Jeonauthor=J.+M.+Salovichauthor=J.+D.+Macdonaldauthor=J.+Alvaradoauthor=R.+D.+Gogliottiauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=Q.+Sunauthor=S.+Wangauthor=D.+Camperauthor=J.+P.+Yuhauthor=J.+G.+Shawauthor=J.+Saiauthor=O.+W.+Rossaneseauthor=W.+P.+Tanseyauthor=S.+R.+Staufferauthor=S.+W.+Fesik&title=Discovery+of+Potent+2-Aryl-6%2C7-dihydro-5+H-pyrrolo%5B1%2C2-+a%5Dimidazoles+as+WDR5-WIN-Site+Inhibitors+Using+Fragment-Based+Methods+and+Structure-Based+Design&doi=10.1021%2Facs.jmedchem.8b00375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent 2-Aryl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Wang, Feng; Jeon, Kyu Ok; Salovich, James M.; Macdonald, Jonathan D.; Alvarado, Joseph; Gogliotti, Rocco D.; Phan, Jason; Olejniczak, Edward T.; Sun, Qi; Wang, Shidong; Camper, DeMarco; Yuh, Joannes P.; Shaw, J. Grace; Sai, Jiqing; Rossanese, Olivia W.; Tansey, William P.; Stauffer, Shaun R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5623-5642</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted pyrroloimidazoles such as I [R = 3,4-Cl2C6H3CH2, 3-MeO-4-MeC6H3, 2-Me-4-pyridinyl, 3,5-(MeO)2-4-MeC6H2] were prepd. as inhibitors of the chromatin-regulatory scaffold protein WDR5 WDR5-interaction (WIN) site as lead compds. for development of antitumor agents.  NMR-based screening of a large fragment library identified several chem. distinct hit series that bind to the WIN site within WDR5.  Using a structure-based design approach, pyrroloimidazoles were found with dissocn. consts. < 10 nM for WDR5 and micromolar cellular activity against an AML-leukemia cell line.  The structures of I (R = 3-MeO-4-MeC6H3) and of four other compds. bound to a fragment of WDR5 were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBSZaiiuG6OrVg90H21EOLACvtfcHk0ljEZE3cgDisLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrsLjN&md5=2322c6458b2a060005bf5250a46f5cbd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00375%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DJ.%2BD.%26aulast%3DAlvarado%26aufirst%3DJ.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DYuh%26aufirst%3DJ.%2BP.%26aulast%3DShaw%26aufirst%3DJ.%2BG.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DTansey%26aufirst%3DW.%2BP.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Potent%25202-Aryl-6%252C7-dihydro-5%2520H-pyrrolo%255B1%252C2-%2520a%255Dimidazoles%2520as%2520WDR5-WIN-Site%2520Inhibitors%2520Using%2520Fragment-Based%2520Methods%2520and%2520Structure-Based%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5623%26epage%3D5642%26doi%3D10.1021%2Facs.jmedchem.8b00375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemyn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span> <span> </span><span class="NLM_article-title">Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5295</span>, <span class="refDoi"> DOI: 10.1002/anie.201712581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fanie.201712581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVeiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5292-5295&author=E.+Pardonauthor=C.+Bettiauthor=T.+Laeremansauthor=F.+Chevillardauthor=K.+Guillemynauthor=P.+Kolbauthor=S.+Balletauthor=J.+Steyaert&title=Nanobody-Enabled+Reverse+Pharmacology+on+G-Protein-Coupled+Receptors&doi=10.1002%2Fanie.201712581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors</span></div><div class="casAuthors">Pardon, Els; Betti, Cecilia; Laeremans, Toon; Chevillard, Florent; Guillemyn, Karel; Kolb, Peter; Ballet, Steven; Steyaert, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5292-5295</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The conformational complexity of transmembrane signaling of G-protein-coupled receptors (GPCRs) is a central hurdle for the design of screens for receptor agonists.  In their basal states, GPCRs have lower affinities for agonists compared to their G-protein-bound active state conformations.  Moreover, different agonists can stabilize distinct active receptor conformations and do not uniformly activate all cellular signaling pathways linked to a given receptor (agonist bias).  Comparative fragment screens were performed on a β2-adrenoreceptor-nanobody fusion locked in its active-state conformation by a G-protein-mimicking nanobody, and the same receptor in its basal-state conformation.  This simple biophys. assay allowed the identification and ranking of multiple novel agonists and permitted classification of the efficacy of each hit in agonist, antagonist, or inverse agonist categories, thereby opening doors to nanobody-enabled reverse pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8ltArcxl9PrVg90H21EOLACvtfcHk0lhmguaPBtlkLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVeiu7g%253D&md5=89f5488d7644ed663a97c770bee85cfe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201712581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201712581%26sid%3Dliteratum%253Aachs%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DChevillard%26aufirst%3DF.%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DKolb%26aufirst%3DP.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26atitle%3DNanobody-Enabled%2520Reverse%2520Pharmacology%2520on%2520G-Protein-Coupled%2520Receptors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D5292%26epage%3D5295%26doi%3D10.1002%2Fanie.201712581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drapier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulumaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span> <span> </span><span class="NLM_article-title">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5279</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5279-5291&author=T.+Drapierauthor=P.+Geubelleauthor=C.+Bouckaertauthor=L.+Nielsenauthor=S.+Laulumaaauthor=E.+Goffinauthor=S.+Dillyauthor=P.+Francotteauthor=J.+Hansonauthor=L.+Pochetauthor=J.+S.+Kastrupauthor=B.+Pirotte&title=Enhancing+Action+of+Positive+Allosteric+Modulators+through+the+Design+of+Dimeric+Compounds&doi=10.1021%2Facs.jmedchem.8b00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds</span></div><div class="casAuthors">Drapier, Thomas; Geubelle, Pierre; Bouckaert, Charlotte; Nielsen, Lise; Laulumaa, Saara; Goffin, Eric; Dilly, Sebastien; Francotte, Pierre; Hanson, Julien; Pochet, Lionel; Kastrup, Jette Sandholm; Pirotte, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5279-5291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study describes the identification of highly potent dimeric 1,2,4-benzothiadiazine 1,1-dioxide (BTD)-type pos. allosteric modulators of the AMPA receptors (AMPApams) obtained by linking two monomeric BTD scaffolds through their resp. 6-positions.  Using previous X-ray data from monomeric BTDs cocrystd. with the GluA2 ligand-binding domain (LBD), a mol. modeling approach was performed to predict the preferred dimeric combinations.  Two 6,6-ethylene-linked dimeric BTD compds. (16 and 22) were prepd. and evaluated as AMPApams on HEK293 cells expressing GluA2o(Q) (calcium flux expt.).  These compds. were found to be about 10,000 times more potent than their resp. monomers, the most active dimeric compd. being the bis-4-cyclopropyl-substituted compd. 22 [6,6'-(ethane-1,2-diyl)bis(4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide], with an EC50 value of 1.4 nM.  As a proof of concept, the bis-4-methyl-substituted dimeric compd. 16 (EC50 = 13 nM) was successfully cocrystd. with the GluA2o-LBD and was found to occupy the two BTD binding sites at the LBD dimer interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6AJCoOPIir7Vg90H21EOLACvtfcHk0lhmguaPBtlkLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12lsrw%253D&md5=d438a5a16c5ab50e72cda5a71f6c5550</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00250%26sid%3Dliteratum%253Aachs%26aulast%3DDrapier%26aufirst%3DT.%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DBouckaert%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLaulumaa%26aufirst%3DS.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DFrancotte%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DEnhancing%2520Action%2520of%2520Positive%2520Allosteric%2520Modulators%2520through%2520the%2520Design%2520of%2520Dimeric%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5279%26epage%3D5291%26doi%3D10.1021%2Facs.jmedchem.8b00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6724</span>– <span class="NLM_lpage">6735</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12jsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6724-6735&author=D.+A.+Carcacheauthor=A.+Vulpettiauthor=J.+Kallenauthor=H.+Mattesauthor=D.+Orainauthor=R.+Stringerauthor=E.+Vangrevelingheauthor=R.+M.+Wolfauthor=K.+Kaupmannauthor=J.+Ottlauthor=J.+Dawsonauthor=N.+G.+Cookeauthor=K.+Hoegenauerauthor=A.+Billichauthor=J.+Wagnerauthor=C.+Guntermannauthor=S.+Hintermann&title=Optimizing+a+Weakly+Binding+Fragment+into+a+Potent+ROR%CE%B3t+Inverse+Agonist+with+Efficacy+in+an+in+Vivo+Inflammation+Model&doi=10.1021%2Facs.jmedchem.8b00529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model</span></div><div class="casAuthors">Carcache, David A.; Vulpetti, Anna; Kallen, Joerg; Mattes, Henri; Orain, David; Stringer, Rowan; Vangrevelinghe, Eric; Wolf, Romain M.; Kaupmann, Klemens; Ottl, Johannes; Dawson, Janet; Cooke, Nigel G.; Hoegenauer, Klemens; Billich, Andreas; Wagner, Juergen; Guntermann, Christine; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6724-6735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor RORγt is an attractive drug-target due to its role in the differentiation of IL-17 producing Th17 cells that play a crit. role in the etiopathol. of several autoimmune diseases.  Identification of starting points for RORγt inverse agonists with good properties has been a challenge.  We report the identification of a fragment hit and its conversion into a potent inverse agonist through fragment optimization, growing and merging efforts.  Further anal. of the binding mode revealed that inverse agonism was achieved by an unusual mechanism.  In contrast to other reported inverse agonists, there is no direct interaction or displacement of helix 12 obsd. in the crystal structure.  Nevertheless, compd. 9 proved to be efficacious in a delayed-type hypersensitivity (DTH) inflammation model in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNfQTVtmUt7Vg90H21EOLACvtfcHk0lhmguaPBtlkLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12jsbjK&md5=6032c6b6a85377ea247a92314736db06</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00529%26sid%3Dliteratum%253Aachs%26aulast%3DCarcache%26aufirst%3DD.%2BA.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DOptimizing%2520a%2520Weakly%2520Binding%2520Fragment%2520into%2520a%2520Potent%2520ROR%25CE%25B3t%2520Inverse%2520Agonist%2520with%2520Efficacy%2520in%2520an%2520in%2520Vivo%2520Inflammation%2520Model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6724%26epage%3D6735%26doi%3D10.1021%2Facs.jmedchem.8b00529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Miller, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmartin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoute, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span> <span> </span><span class="NLM_article-title">A Hit Deconstruction Approach for the Discovery of Fetal Hemoglobin Inducers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3676</span>– <span class="NLM_lpage">3680</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30554630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVGlt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3676-3680&author=A.+B.+Benowitzauthor=H.+C.+Eberlauthor=C.+L.+Erickson-Millerauthor=A.+G.+Gilmartinauthor=E.+R.+Goreauthor=M.+N.+Montouteauthor=Z.+Wu&title=A+Hit+Deconstruction+Approach+for+the+Discovery+of+Fetal+Hemoglobin+Inducers&doi=10.1016%2Fj.bmcl.2018.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A hit deconstruction approach for the discovery of fetal hemoglobin inducers</span></div><div class="casAuthors">Benowitz, Andrew B.; Eberl, H. Christian; Erickson-Miller, Connie L.; Gilmartin, Aidan G.; Gore, Elizabeth R.; Montoute, Monica N.; Wu, Zining</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">3676-3680</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Beta-hemoglobinopathies such as sickle cell disease represent a major global unmet medical need.  De-repression of fetal Hb in erythrocytes is a clin. validated approach for the management of sickle cell disease, but the only FDA-approved medicine for this purpose has limitations to its use.  We conducted a phenotypic screen in human erythroid progenitor cells to identify mols. with the ability to de-repress fetal Hb, which resulted in the identification of the benzoxaborole-contg. hit compd. 1.  This compd. was found to have modest cellular potency and lead-like pharmacokinetics, but no identifiable SAR to enable optimization.  Systematic deconstruction of a closely related analog of 1 revealed the fragment-like carboxylic acid 12, which was then optimized to provide tetrazole 31, which had approx. 100-fold improved cellular potency compared to 1, high levels of oral exposure in rats, and excellent soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdoiMb2V7dyLVg90H21EOLACvtfcHk0lgsvZUgq6TwDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVGlt7%252FE&md5=8dcb0533662581a03f4b935fffae848b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DA.%2BB.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DErickson-Miller%26aufirst%3DC.%2BL.%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DGore%26aufirst%3DE.%2BR.%26aulast%3DMontoute%26aufirst%3DM.%2BN.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DA%2520Hit%2520Deconstruction%2520Approach%2520for%2520the%2520Discovery%2520of%2520Fetal%2520Hemoglobin%2520Inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3676%26epage%3D3680%26doi%3D10.1016%2Fj.bmcl.2018.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span>; <span class="NLM_string-name">Weininger, D.</span></span> Clogp Reference Manual, Daylight version 4.9. <a href="http://www.daylight.com/dayhtml/doc/clogp/" class="extLink">http://www.daylight.com/dayhtml/doc/clogp/</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Leo%2C+A.%3B+Weininger%2C+D.+Clogp+Reference+Manual%2C+Daylight+version+4.9.+http%3A%2F%2Fwww.daylight.com%2Fdayhtml%2Fdoc%2Fclogp%2F+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DA.%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ea6gC35GF9IMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-Like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgsvZUgq6TwDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-Like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span> <span> </span><span class="NLM_article-title">Rapid Assessment of a Novel Series of Selective CB(2) Agonists Using Parallel Synthesis Protocols: A Lipophilic Efficiency (LipE) Analysis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4406</span>– <span class="NLM_lpage">4409</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+Assessment+of+a+Novel+Series+of+Selective+CB%282%29+Agonists+Using+Parallel+Synthesis+Protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+Analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhHgliZIC8EUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520Assessment%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%2520CB%25282%2529%2520Agonists%2520Using%2520Parallel%2520Synthesis%2520Protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520Analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Assessing the Lipophilicity of Fragments and Early Hits</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+Lipophilicity+of+Fragments+and+Early+Hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0lhHgliZIC8EUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520Lipophilicity%2520of%2520Fragments%2520and%2520Early%2520Hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayotte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descoteaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1386</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fcmdc.201800161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29722149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1377-1386&author=Y.+Ayotteauthor=F.+Bilodeauauthor=A.+Descoteauxauthor=S.+R.+LaPlante&title=Fragment-Based+Phenotypic+Lead+Discovery%3A+Cell-Based+Assay+to+Target+Leishmaniasis&doi=10.1002%2Fcmdc.201800161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis</span></div><div class="casAuthors">Ayotte, Yann; Bilodeau, Francois; Descoteaux, Albert; LaPlante, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1377-1386</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A rapid and practical approach for the discovery of new chem. matter for targeting pathogens and diseases is described.  Fragment-based phenotypic lead discovery (FPLD) combines aspects of traditional fragment-based lead discovery (FBLD), which involves the screening of small-mol. fragment libraries to target specific proteins, with phenotypic lead discovery (PLD), which typically involves the screening of drug-like compds. in cell-based assays.  To enable FPLD, a diverse library of fragments was first designed, assembled, and curated.  This library of sol., low-mol.-wt. compds. was then pooled to expedite screening.  Axenic cultures of Leishmania promastigotes were screened, and single hits were then tested for leishmanicidal activity against intracellular amastigote forms in infected murine bone-marrow-derived macrophages without evidence of toxicity toward mammalian cells.  These studies demonstrate that FPLD can be a rapid and effective means to discover hits that can serve as leads for further medicinal chem. purposes or as tool compds. for identifying known or novel targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC85ixZC9T9bVg90H21EOLACvtfcHk0lhHgliZIC8EUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsrjF&md5=6b732097feb3a6f81f0c4d6309fbae63</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800161%26sid%3Dliteratum%253Aachs%26aulast%3DAyotte%26aufirst%3DY.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DDescoteaux%26aufirst%3DA.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26atitle%3DFragment-Based%2520Phenotypic%2520Lead%2520Discovery%253A%2520Cell-Based%2520Assay%2520to%2520Target%2520Leishmaniasis%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D1377%26epage%3D1386%26doi%3D10.1002%2Fcmdc.201800161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1787</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7847-2_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2F978-1-4939-7847-2_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29736714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFOnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1787&publication_year=2018&pages=115-127&author=A.+Galmozziauthor=C.+G.+Parkerauthor=B.+P.+Kokauthor=B.+F.+Cravattauthor=E.+Saez&title=Discovery+of+Modulators+of+Adipocyte+Physiology+Using+Fully+Functionalized+Fragments&doi=10.1007%2F978-1-4939-7847-2_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of modulators of adipocyte physiology using fully functionalized fragments</span></div><div class="casAuthors">Galmozzi, Andrea; Parker, Christopher G.; Kok, Bernard P.; Cravatt, Benjamin F.; Saez, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1787</span>
        (<span class="NLM_cas:issue">Phenotypic Screening</span>),
    <span class="NLM_cas:pages">115-127</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Defects in adipocyte function assocd. with obesity drive the development of systemic insulin resistance and type 2 diabetes.  Agents that correct obesity-linked adipocyte dysfunction serve as useful insulin sensitizers in humans, as is exemplified by the thiazolidinediones (TZDs).  We have developed a new platform that integrates advanced chemoproteomics with phenotypic screening to identify small mols. that promote differentiation and lipid storage in adipocytes, and, in tandem, their mol. target(s).  These mols. mimic the activity of TZDs in culture and thus may also serve as insulin sensitizers in vivo.  Central to this platform is the use of fully functionalized fragment (FFF) probes that consist of a variable, fragment-like recognition element linked to an alkyne-diazirine group that enables the photoactivated capture of probe-bound proteins directly in living cells and subsequent copper-catalyzed azide-alkyne cycloaddn. to reporter tags for enrichment and identification of these probe-bound proteins by mass spectrometry.  This platform, which can be adapted to diverse screens and cell types beyond adipocytes, has the potential to uncover new biol. pathways amenable to pharmacol. modulation that may impact human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZufLOat8ZrVg90H21EOLACvtfcHk0lgfPwAimBGwzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFOnsg%253D%253D&md5=c8eeae1a30e3afc5b1739cb0846eea3e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7847-2_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7847-2_9%26sid%3Dliteratum%253Aachs%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DKok%26aufirst%3DB.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DSaez%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520Modulators%2520of%2520Adipocyte%2520Physiology%2520Using%2520Fully%2520Functionalized%2520Fragments%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2018%26volume%3D1787%26spage%3D115%26epage%3D127%26doi%3D10.1007%2F978-1-4939-7847-2_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joslyn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narvaiza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.cell.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=28111073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=527-541&author=C.+G.+Parkerauthor=A.+Galmozziauthor=Y.+Wangauthor=B.+E.+Correiaauthor=K.+Sasakiauthor=C.+M.+Joslynauthor=A.+S.+Kimauthor=C.+L.+Cavallaroauthor=R.+M.+Lawrenceauthor=S.+R.+Johnsonauthor=I.+Narvaizaauthor=E.+Saezauthor=B.+F.+Cravatt&title=Ligand+and+Target+Discovery+by+Fragment-Based+Screening+in+Human+Cells&doi=10.1016%2Fj.cell.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span></div><div class="casAuthors">Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez, Enrique; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-541.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Advances in the synthesis and screening of small-mol. libraries have accelerated the discovery of chem. probes for studying biol. processes.  Still, only a small fraction of the human proteome has chem. ligands.  Here, we describe a platform that marries fragment-based ligand discovery with quant. chem. proteomics to map thousands of reversible small mol.-protein interactions directly in human cells, many of which can be site-specifically detd.  We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chem. probes.  We further combine fragment-based chem. proteomics with phenotypic screening to identify small mols. that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2.  Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small mols. and their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPk-YJwFlDwbVg90H21EOLACvtfcHk0lgfPwAimBGwzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D&md5=835264291015037ab9b7e446992caba3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DJoslyn%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DCavallaro%26aufirst%3DC.%2BL.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DNarvaiza%26aufirst%3DI.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DLigand%2520and%2520Target%2520Discovery%2520by%2520Fragment-Based%2520Screening%2520in%2520Human%2520Cells%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D527%26epage%3D541%26doi%3D10.1016%2Fj.cell.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istratiy, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjhen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, M. S.</span></span> <span> </span><span class="NLM_article-title">Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5209</span>– <span class="NLM_lpage">5215</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5209-5215&author=M.+Lanierauthor=D.+C.+Coleauthor=Y.+Istratiyauthor=M.+G.+Kleinauthor=P.+A.+Schwartzauthor=R.+Tjhenauthor=A.+Jenningsauthor=M.+S.+Hixon&title=Repurposing+Suzuki+Coupling+Reagents+as+a+Directed+Fragment+Library+Targeting+Serine+Hydrolases+and+Related+Enzymes&doi=10.1021%2Facs.jmedchem.6b01224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes</span></div><div class="casAuthors">Lanier, Marion; Cole, Derek C.; Istratiy, Yelena; Klein, Michael G.; Schwartz, Phillip A.; Tjhen, Richard; Jennings, Andy; Hixon, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5209-5215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are susceptible to potent reversible inhibition by boronic acids.  Large collections of chem. diverse boronic acid fragments are com. available because of their utility in coupling chem.  The authors repurposed the approx. 650 boronic acid reagents in the collection as a directed fragment library targeting serine hydrolases and related enzymes.  Highly efficient hits (LE > 0.6) often result.  The utility of the approach is illustrated with the results against autotaxin, a phospholipase implicated in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofvo73rlh3BbVg90H21EOLACvtfcHk0lgfPwAimBGwzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCjsb8%253D&md5=3aa5885e6b53ece7d230233730bae90c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01224%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DIstratiy%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DM.%2BG.%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DTjhen%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DRepurposing%2520Suzuki%2520Coupling%2520Reagents%2520as%2520a%2520Directed%2520Fragment%2520Library%2520Targeting%2520Serine%2520Hydrolases%2520and%2520Related%2520Enzymes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5209%26epage%3D5215%26doi%3D10.1021%2Facs.jmedchem.6b01224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viacava Follis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Efflux Ratio and Permeability of Covalent Irreversible BTK Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3307</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30243592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3307-3311&author=H.+Qiuauthor=L.+Liu-Bujalskiauthor=R.+D.+Caldwellauthor=A.+Viacava+Follisauthor=A.+Gardbergauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=J.+Headauthor=T.+Johnsonauthor=C.+C.+V.+Jonesauthor=R.+Jonesauthor=I.+Mochalkinauthor=F.+Morandiauthor=C.+Neaguauthor=J.+Potnickauthor=B.+Sherer&title=Optimization+of+the+Efflux+Ratio+and+Permeability+of+Covalent+Irreversible+BTK+Inhibitors&doi=10.1016%2Fj.bmcl.2018.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors</span></div><div class="casAuthors">Qiu, Hui; Liu-Bujalski, Lesley; Caldwell, Richard D.; Viacava Follis, Ariele; Gardberg, Anna; Goutopoulos, Andreas; Grenningloh, Roland; Head, Jared; Johnson, Theresa; Jones, Christopher C. V.; Jones, Reinaldo; Mochalkin, Igor; Morandi, Federica; Neagu, Constantin; Potnick, Justin; Sherer, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3307-3311</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (Btk) is a member of the Tec kinase family that is expressed in cells of hematopoietic lineage (e.g. B cells, macrophages, monocytes, and mast cells).  Small mol. covalent irreversible Btk inhibitors targeting Cys481 within the ATP-binding pocket have been applied in the treatment of B-cell malignancies.  Starting from a fragment, we discovered a novel series of potent covalent irreversible Btk inhibitors that bear N-linked groups occupying the solvent accessible pocket (SAP) of the active site of the Btk kinase domain.  The hit mols., however, displayed high P-gp mediated efflux ratio (ER) and poor A-B permeability in Caco-2 assay.  By decreasing tPSA, installing steric hindrance and adjusting clogP, one top mol. 9 was discovered, which showed a 99% decrease in efflux ratio and a 90-fold increase in A-B permeability compared to hit mol. 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0AD3kgaWRCbVg90H21EOLACvtfcHk0lj0-gKoPX31gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOltr7I&md5=1152f21924092ac251e1dced388cb8c7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DViacava%2BFollis%26aufirst%3DA.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DHead%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DC.%2BC.%2BV.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DPotnick%26aufirst%3DJ.%26aulast%3DSherer%26aufirst%3DB.%26atitle%3DOptimization%2520of%2520the%2520Efflux%2520Ratio%2520and%2520Permeability%2520of%2520Covalent%2520Irreversible%2520BTK%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3307%26epage%3D3311%26doi%3D10.1016%2Fj.bmcl.2018.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Bujalski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenningloh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochalkin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Highly Selective Covalent Irreversible BTK Inhibitors from a Fragment Hit</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2939</span>– <span class="NLM_lpage">2944</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2018.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30122225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2939-2944&author=H.+Qiuauthor=L.+Liu-Bujalskiauthor=R.+D.+Caldwellauthor=A.+V.+Follisauthor=A.+Gardbergauthor=A.+Goutopoulosauthor=R.+Grenninglohauthor=J.+Headauthor=T.+Johnsonauthor=R.+Jonesauthor=I.+Mochalkinauthor=F.+Morandiauthor=C.+Neaguauthor=B.+Sherer&title=Discovery+of+Potent%2C+Highly+Selective+Covalent+Irreversible+BTK+Inhibitors+from+a+Fragment+Hit&doi=10.1016%2Fj.bmcl.2018.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit</span></div><div class="casAuthors">Qiu, Hui; Liu-Bujalski, Lesley; Caldwell, Richard D.; Follis, Ariele Viacava; Gardberg, Anna; Goutopoulos, Andreas; Grenningloh, Roland; Head, Jared; Johnson, Theresa; Jones, Reinaldo; Mochalkin, Igor; Morandi, Federica; Neagu, Constantin; Sherer, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2939-2944</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bruton's Tyrosine Kinase (BTK) is a member of the TEC kinase family that is expressed in cells of hematopoietic lineage (e.g., in B cells, macrophages, monocytes, and mast cells).  Small mol. covalent irreversible BTK inhibitor targeting Cys481 within the ATP-binding pocket, for example ibrutinib, has been applied in the treatment of B-cell malignancies.  Starting from a fragment hit, we discovered a novel series of potent covalent irreversible BTK inhibitors that occupy selectivity pocket of the active site of the BTK kinase domain.  Guided by x-ray structures and a fragment-based drug design (FBDD) approach, we generated mols. showing comparable cellular potency to ibrutinib and higher kinome selectivity against undesirable off-targets like EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUzH2Fde_MUbVg90H21EOLACvtfcHk0lj0-gKoPX31gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfJ&md5=f4019ea46ab1a06cab875c0b7af5b1fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLiu-Bujalski%26aufirst%3DL.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DFollis%26aufirst%3DA.%2BV.%26aulast%3DGardberg%26aufirst%3DA.%26aulast%3DGoutopoulos%26aufirst%3DA.%26aulast%3DGrenningloh%26aufirst%3DR.%26aulast%3DHead%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DMorandi%26aufirst%3DF.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DSherer%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Highly%2520Selective%2520Covalent%2520Irreversible%2520BTK%2520Inhibitors%2520from%2520a%2520Fragment%2520Hit%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2939%26epage%3D2944%26doi%3D10.1016%2Fj.bmcl.2018.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottschalk, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Hafez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farag, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span> <span> </span><span class="NLM_article-title">Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1218-1230&author=R.+Schulzauthor=A.+Atefauthor=D.+Beckerauthor=F.+Gottschalkauthor=C.+Tauberauthor=S.+Wagnerauthor=C.+Arkonaauthor=A.+A.+Abdel-Hafezauthor=H.+H.+Faragauthor=J.+Rademannauthor=G.+Wolber&title=Phenylthiomethyl+Ketone-Based+Fragments+Show+Selective+and+Irreversible+Inhibition+of+Enteroviral+3C+Proteases&doi=10.1021%2Facs.jmedchem.7b01440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases</span></div><div class="casAuthors">Schulz, Robert; Atef, Amira; Becker, Daniel; Gottschalk, Franziska; Tauber, Carolin; Wagner, Stefan; Arkona, Christoph; Abdel-Hafez, Atef A.; Farag, Hassan H.; Rademann, Joerg; Wolber, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1218-1230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead structure discovery mainly focuses on the identification of noncovalently binding ligands.  Covalent linkage, however, is an essential binding mechanism for a multitude of successfully marketed drugs, although discovered by serendipity in most cases.  The authors present a concept for the design of fragments covalently binding to proteases.  Covalent linkage enables fragment binding unrelated to affinity to shallow protein binding sites and at the same time allows differentiated targeted hit verification and binding location verification through mass spectrometry.  The authors describe a systematic and rational computational approach for the identification of covalently binding fragments from compd. collections inhibiting enteroviral 3C protease, a target with high therapeutic potential.  By implementing reactive groups potentially forming covalent bonds as a chem. feature in the authors' 3D pharmacophore methodol., covalent binders were discovered by high-throughput virtual screening.  The authors present careful exptl. validation of the virtual hits using enzymic assays and mass spectrometry unraveling a novel, previously unknown irreversible inhibition of the 3C protease by phenylthiomethyl ketone-based fragments.  Subsequent synthetic optimization through fragment growing and reactivity anal. against catalytic and noncatalytic cysteines revealed specific irreversible 3C protease inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wUZEbIFMZbVg90H21EOLACvtfcHk0lj0-gKoPX31gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gtg%253D%253D&md5=82d13071a89ce3e06a55090c0c1ff19a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01440%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DAtef%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DD.%26aulast%3DGottschalk%26aufirst%3DF.%26aulast%3DTauber%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DArkona%26aufirst%3DC.%26aulast%3DAbdel-Hafez%26aufirst%3DA.%2BA.%26aulast%3DFarag%26aufirst%3DH.%2BH.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DWolber%26aufirst%3DG.%26atitle%3DPhenylthiomethyl%2520Ketone-Based%2520Fragments%2520Show%2520Selective%2520and%2520Irreversible%2520Inhibition%2520of%2520Enteroviral%25203C%2520Proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1218%26epage%3D1230%26doi%3D10.1021%2Facs.jmedchem.7b01440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craven, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affron, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. J.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5257</span>– <span class="NLM_lpage">5261</span>, <span class="refDoi"> DOI: 10.1002/anie.201711825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2Fanie.201711825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5257-5261&author=G.+B.+Cravenauthor=D.+P.+Affronauthor=C.+E.+Allenauthor=S.+Matthiesauthor=J.+G.+Greenerauthor=R.+M.+L.+Morganauthor=E.+W.+Tateauthor=A.+Armstrongauthor=D.+J.+Mann&title=High-Throughput+Kinetic+Analysis+for+Target-Directed+Covalent+Ligand+Discovery&doi=10.1002%2Fanie.201711825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery</span></div><div class="casAuthors">Craven, Gregory B.; Affron, Dominic P.; Allen, Charlotte E.; Matthies, Stefan; Greener, Joe G.; Morgan, Rhodri M. L.; Tate, Edward W.; Armstrong, Alan; Mann, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5257-5261</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cysteine-reactive small mols. are used as chem. probes of biol. systems and as medicines.  Identifying high-quality covalent ligands requires comprehensive kinetic anal. to distinguish selective binders from pan-reactive compds.  Quant. irreversible tethering (qIT), a general method for screening cysteine-reactive small mols. based upon the maximization of kinetic selectivity, is described.  This method was applied prospectively to discover covalent fragments that target the clin. important cell cycle regulator Cdk2.  Crystal structures of the inhibitor complexes validate the approach and guide further optimization.  The power of this technique is highlighted by the identification of a Cdk2-selective allosteric (type IV) kinase inhibitor whose novel mode-of-action could be exploited therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Cxjlad3Kq7Vg90H21EOLACvtfcHk0lj5NS6Dkm-ZiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOlsLc%253D&md5=58c46f4d3ee87791fe857d186127b923</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fanie.201711825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201711825%26sid%3Dliteratum%253Aachs%26aulast%3DCraven%26aufirst%3DG.%2BB.%26aulast%3DAffron%26aufirst%3DD.%2BP.%26aulast%3DAllen%26aufirst%3DC.%2BE.%26aulast%3DMatthies%26aufirst%3DS.%26aulast%3DGreener%26aufirst%3DJ.%2BG.%26aulast%3DMorgan%26aufirst%3DR.%2BM.%2BL.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DD.%2BJ.%26atitle%3DHigh-Throughput%2520Kinetic%2520Analysis%2520for%2520Target-Directed%2520Covalent%2520Ligand%2520Discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D5257%26epage%3D5261%26doi%3D10.1002%2Fanie.201711825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomala, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiera-Mularz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzanik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zieba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musielak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalniak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holak, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of Small-Molecule Inhibitors of USP2a</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.ejmech.2018.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29529503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=261-267&author=M.+D.+Tomalaauthor=K.+Magiera-Mularzauthor=K.+Kubicaauthor=S.+Krzanikauthor=B.+Ziebaauthor=B.+Musielakauthor=M.+Pustulaauthor=G.+M.+Popowiczauthor=M.+Sattlerauthor=G.+Dubinauthor=L.+Skalniakauthor=T.+A.+Holak&title=Identification+of+Small-Molecule+Inhibitors+of+USP2a&doi=10.1016%2Fj.ejmech.2018.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of USP2a</span></div><div class="casAuthors">Tomala, Marcin D.; Magiera-Mularz, Katarzyna; Kubica, Katarzyna; Krzanik, Sylwia; Zieba, Bartosz; Musielak, Bogdan; Pustula, Marcin; Popowicz, Grzegorz M.; Sattler, Michael; Dubin, Grzegorz; Skalniak, Lukasz; Holak, Tad A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-267</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">USP2a is a deubiquitinating protease that rescues its target proteins from destruction by the proteasome by reversing the process of protein ubiquitination.  USP2a shows oncogenic properties in vivo and has been found to be a specific activator of cyclin D1.  Many types of cancers are addicted to cyclin D1 expression.  Targeting USP2a is a promising strategy for cancer therapy but little progress has been made in the field of inhibition of USP2a.  Using NMR-based fragment screening and biophys. binding assays, the authors have discovered small mols. that bind to USP2a.  Iterations of fragment combination and structure-driven design identified two 5-(2-thienyl)-3-isoxazoles as the inhibitors of the USP2a-ubiquitin protein-protein interaction.  The affinity of these mols. for the catalytic domain of USP2a parallels their ability to interfere with USP2a binding to ubiquitin in vitro.  Altogether, the results establish the 5-(2-thienyl)-3-isoxazole pharmacophore as an attractive starting point for lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve1h82GTItrVg90H21EOLACvtfcHk0lj5NS6Dkm-ZiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlylsLc%253D&md5=737e41f0a0b5574839ad6a3cc4d2f70a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DTomala%26aufirst%3DM.%2BD.%26aulast%3DMagiera-Mularz%26aufirst%3DK.%26aulast%3DKubica%26aufirst%3DK.%26aulast%3DKrzanik%26aufirst%3DS.%26aulast%3DZieba%26aufirst%3DB.%26aulast%3DMusielak%26aufirst%3DB.%26aulast%3DPustula%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DDubin%26aufirst%3DG.%26aulast%3DSkalniak%26aufirst%3DL.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520USP2a%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D261%26epage%3D267%26doi%3D10.1016%2Fj.ejmech.2018.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span>; <span class="NLM_string-name">Jahnke, W.</span></span> <i>Fragment-Based Drug Discovery: Lessons and Outlook</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1002%2F9783527683604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Erlanson&author=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Lessons+and+Outlook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F9783527683604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527683604%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26btitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Lessons%2520and%2520Outlook%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Penzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basse, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deboves, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschkinat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, A. D.</span></span> <span> </span><span class="NLM_article-title">Insight into Small Molecule Binding to the Neonatal Fc Receptor by X-Ray Crystallography and 100 kHz Magic-Angle-Spinning NMR</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">e2006192</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.2006192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1371%2Fjournal.pbio.2006192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=29782488" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=e2006192&author=D.+Stopplerauthor=A.+Macphersonauthor=S.+Smith-Penzelauthor=N.+Basseauthor=F.+Lecomteauthor=H.+Debovesauthor=R.+D.+Taylorauthor=T.+Normanauthor=J.+Porterauthor=L.+C.+Watersauthor=M.+Westwoodauthor=B.+Cossinsauthor=K.+Cainauthor=J.+Whiteauthor=R.+Griffinauthor=C.+Prosserauthor=S.+Kelmauthor=A.+H.+Sullivanauthor=D.+Foxauthor=M.+D.+Carrauthor=A.+Henryauthor=R.+Taylorauthor=B.+H.+Meierauthor=H.+Oschkinatauthor=A.+D.+Lawson&title=Insight+into+Small+Molecule+Binding+to+the+Neonatal+Fc+Receptor+by+X-Ray+Crystallography+and+100+kHz+Magic-Angle-Spinning+NMR&doi=10.1371%2Fjournal.pbio.2006192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.2006192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.2006192%26sid%3Dliteratum%253Aachs%26aulast%3DStoppler%26aufirst%3DD.%26aulast%3DMacpherson%26aufirst%3DA.%26aulast%3DSmith-Penzel%26aufirst%3DS.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DDeboves%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26aulast%3DNorman%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DWaters%26aufirst%3DL.%2BC.%26aulast%3DWestwood%26aufirst%3DM.%26aulast%3DCossins%26aufirst%3DB.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DProsser%26aufirst%3DC.%26aulast%3DKelm%26aufirst%3DS.%26aulast%3DSullivan%26aufirst%3DA.%2BH.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DCarr%26aufirst%3DM.%2BD.%26aulast%3DHenry%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26aulast%3DOschkinat%26aufirst%3DH.%26aulast%3DLawson%26aufirst%3DA.%2BD.%26atitle%3DInsight%2520into%2520Small%2520Molecule%2520Binding%2520to%2520the%2520Neonatal%2520Fc%2520Receptor%2520by%2520X-Ray%2520Crystallography%2520and%2520100%2520kHz%2520Magic-Angle-Spinning%2520NMR%26jtitle%3DPLoS%2520Biol.%26date%3D2018%26volume%3D16%26spage%3De2006192%26doi%3D10.1371%2Fjournal.pbio.2006192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derviaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collette, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span> <span> </span><span class="NLM_article-title">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5719</span>– <span class="NLM_lpage">5732</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00653</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5719-5732&author=L.+Hofferauthor=Y.+V.+Voitovichauthor=B.+Rauxauthor=K.+Carrascoauthor=C.+Mullerauthor=A.+Y.+Fedorovauthor=C.+Derviauxauthor=A.+Amouricauthor=S.+Betziauthor=D.+Horvathauthor=A.+Varnekauthor=Y.+Colletteauthor=S.+Combesauthor=P.+Rocheauthor=X.+Morelli&title=Integrated+Strategy+for+Lead+Optimization+Based+on+Fragment+Growing%3A+The+Diversity-Oriented-Target-Focused-Synthesis+Approach&doi=10.1021%2Facs.jmedchem.8b00653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span></div><div class="casAuthors">Hoffer, Laurent; Voitovich, Yuliia V.; Raux, Brigitt; Carrasco, Kendall; Muller, Christophe; Fedorov, Aleksey Y.; Derviaux, Carine; Amouric, Agnes; Betzi, Stephane; Horvath, Dragos; Varnek, Alexandre; Collette, Yves; Combes, Sebastien; Roche, Philippe; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5719-5732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past few decades, hit identification has been greatly facilitated by advances in high-throughput and fragment-based screenings.  One major hurdle remaining in drug discovery is process automation of hit-to-lead (H2L) optimization.  Here, we report a time- and cost-efficient integrated strategy for H2L optimization as well as a partially automated design of potent chem. probes consisting of a focused-chem.-library design and virtual screening coupled with robotic diversity-oriented de novo synthesis and automated in vitro evaluation.  The virtual library is generated by combining an activated fragment, corresponding to the substructure binding to the target, with a collection of functionalized building blocks using in silico encoded chem. reactions carefully chosen from a list of one-step org. transformations relevant in medicinal chem.  The proof of concept was demonstrated using the optimization of bromodomain inhibitors as a test case, leading to the validation of several compds. with improved affinity by several orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocVtdmg7D67Vg90H21EOLACvtfcHk0lhSHJTMT010-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK&md5=0e5f18636e2b1df24314efa81e67e2b5</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00653%26sid%3Dliteratum%253Aachs%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DAmouric%26aufirst%3DA.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DVarnek%26aufirst%3DA.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DIntegrated%2520Strategy%2520for%2520Lead%2520Optimization%2520Based%2520on%2520Fragment%2520Growing%253A%2520The%2520Diversity-Oriented-Target-Focused-Synthesis%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5719%26epage%3D5732%26doi%3D10.1021%2Facs.jmedchem.8b00653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chevillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hilten, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, P.</span></span> <span> </span><span class="NLM_article-title">Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1118</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01558</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01558" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1118-1129&author=F.+Chevillardauthor=H.+Rimmerauthor=C.+Bettiauthor=E.+Pardonauthor=S.+Balletauthor=N.+van+Hiltenauthor=J.+Steyaertauthor=W.+E.+Diederichauthor=P.+Kolb&title=Binding-Site+Compatible+Fragment+Growing+Applied+to+the+Design+of+%CE%B22-Adrenergic+Receptor+Ligands&doi=10.1021%2Facs.jmedchem.7b01558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands</span></div><div class="casAuthors">Chevillard, Florent; Rimmer, Helena; Betti, Cecilia; Pardon, Els; Ballet, Steven; van Hilten, Niek; Steyaert, Jan; Diederich, Wibke E.; Kolb, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1118-1129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery is intimately linked to fragment extension approaches that can be accelerated using software for de novo design.  Although computers allow for the facile generation of millions of suggestions, synthetic feasibility is however often neglected.  In this study the authors computationally extended, chem. synthesized, and exptl. assayed new ligands for the β2-adrenergic receptor (β2AR) by growing fragment-sized ligands.  To address the synthetic tractability issue, the authors' in silico work-flow aims at derivatized products based on robust org. reactions.  The study started from the predicted binding modes of five fragments.  The authors suggested a total of eight diverse extensions that were easily synthesized, and further assays showed that four products had an improved affinity (up to 40-fold) compared to their resp. initial fragment.  The described work-flow, which the authors call "growing via merging" and for which the key tools are available online, can improve early fragment-based drug discovery projects, making it a useful creative tool for medicinal chemists during structure-activity relationship (SAR) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNVNIASFV5LVg90H21EOLACvtfcHk0lhSHJTMT010-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKnu7s%253D&md5=f915fcba6096ec506f49274a2b628b97</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01558%26sid%3Dliteratum%253Aachs%26aulast%3DChevillard%26aufirst%3DF.%26aulast%3DRimmer%26aufirst%3DH.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3Dvan%2BHilten%26aufirst%3DN.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DW.%2BE.%26aulast%3DKolb%26aufirst%3DP.%26atitle%3DBinding-Site%2520Compatible%2520Fragment%2520Growing%2520Applied%2520to%2520the%2520Design%2520of%2520%25CE%25B22-Adrenergic%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1118%26epage%3D1129%26doi%3D10.1021%2Facs.jmedchem.7b01558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raju, T. N.</span></span> <span> </span><span class="NLM_article-title">The Nobel Chronicles. 1988: James Whyte Black, (B 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98)</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1022</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)74775-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2FS0140-6736%2805%2974775-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10768469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ivV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2000&pages=1022&author=T.+N.+Raju&title=The+Nobel+Chronicles.+1988%3A+James+Whyte+Black%2C+%28B+1924%29%2C+Gertrude+Elion+%281918-99%29%2C+and+George+H+Hitchings+%281905-98%29&doi=10.1016%2FS0140-6736%2805%2974775-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The Nobel chronicles. 1988: James Whyte Black, (b 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98)</span></div><div class="casAuthors">Raju T N</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">9208</span>),
    <span class="NLM_cas:pages">1022</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTWLVzWjiD66qcneEtCi92fW6udTcc2eZGhDSSIpRhMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ivV2mtA%253D%253D&md5=c89d64b40317d0d0cb4a76c1cceecb58</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2974775-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252974775-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaju%26aufirst%3DT.%2BN.%26atitle%3DThe%2520Nobel%2520Chronicles.%25201988%253A%2520James%2520Whyte%2520Black%252C%2520%2528B%25201924%2529%252C%2520Gertrude%2520Elion%2520%25281918-99%2529%252C%2520and%2520George%2520H%2520Hitchings%2520%25281905-98%2529%26jtitle%3DLancet%26date%3D2000%26volume%3D355%26spage%3D1022%26doi%3D10.1016%2FS0140-6736%2805%2974775-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drwal, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bret, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquemard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desaphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellenberger, E.</span></span> <span> </span><span class="NLM_article-title">Structural Insights on Fragment Binding Mode Conservation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5963</span>– <span class="NLM_lpage">5973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCnu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5963-5973&author=M.+N.+Drwalauthor=G.+Bretauthor=C.+Perezauthor=C.+Jacquemardauthor=J.+Desaphyauthor=E.+Kellenberger&title=Structural+Insights+on+Fragment+Binding+Mode+Conservation&doi=10.1021%2Facs.jmedchem.8b00256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights on Fragment Binding Mode Conservation</span></div><div class="casAuthors">Drwal, Malgorzata N.; Bret, Guillaume; Perez, Carlos; Jacquemard, Celien; Desaphy, Jeremy; Kellenberger, Esther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5963-5973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aiming at a deep understanding of fragment binding to ligandable targets, we performed a large scale anal. of the Protein Data Bank.  Binding modes of 1832 drug-like ligands and 1079 fragments to 235 proteins were compared.  We obsd. that the binding modes of fragments and their drug-like superstructures binding to the same protein are mostly conserved, thereby providing exptl. evidence for the preservation of fragment binding modes during mol. growing.  Furthermore, small chem. changes in the fragment are tolerated without alteration of the fragment binding mode.  The exceptions to this observation generally involve conformational variability of the mols.  Our data anal. also suggests that, provided enough fragments have been crystd. within a protein, good interaction coverage of the binding pocket is achieved.  Last, we extended our study to 126 crystn. additives and discuss in which cases they provide information relevant to structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQaTwivC9OA7Vg90H21EOLACvtfcHk0lgy07otV65SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCnu7bL&md5=60541171c9cc385735c2ba9ea6e107de</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00256%26sid%3Dliteratum%253Aachs%26aulast%3DDrwal%26aufirst%3DM.%2BN.%26aulast%3DBret%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DJacquemard%26aufirst%3DC.%26aulast%3DDesaphy%26aufirst%3DJ.%26aulast%3DKellenberger%26aufirst%3DE.%26atitle%3DStructural%2520Insights%2520on%2520Fragment%2520Binding%2520Mode%2520Conservation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5963%26epage%3D5973%26doi%3D10.1021%2Facs.jmedchem.8b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.chembiol.2018.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30482678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=9-15&author=D.+A.+Erlansonauthor=B.+J.+Davisauthor=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Advancing+Fragments+in+the+Absence+of+Crystal+Structures&doi=10.1016%2Fj.chembiol.2018.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures</span></div><div class="casAuthors">Erlanson, Daniel A.; Davis, Ben J.; Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fragment-based drug discovery typically requires an interplay between screening methods, structural methods, and medicinal chem.  X-ray crystallog. is generally the method of choice to obtain three-dimensional structures of the bound ligand/protein complex, but this can sometimes be difficult, particularly for early, low-affinity fragment hits.  In this Perspective, we discuss strategies to advance and evolve fragments in the absence of crystal structures of protein-fragment complexes, although the structure of the unliganded protein may be available.  The strategies can involve other structural techniques, such as NMR spectroscopy, mol. modeling, or a variety of chem. approaches.  Often, these strategies are aimed at guiding evolution of initial fragment hits to a stage where crystal structures can be obtained for further structure-based optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmStmkIpx6bLVg90H21EOLACvtfcHk0lgy07otV65SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzI&md5=2f5fb9d063b7ccabb4f7eb611c00ce30</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DDavis%26aufirst%3DB.%2BJ.%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Advancing%2520Fragments%2520in%2520the%2520Absence%2520of%2520Crystal%2520Structures%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D9%26epage%3D15%26doi%3D10.1016%2Fj.chembiol.2018.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span> <span> </span><span class="NLM_article-title">Learning from Our Mistakes: The ’Unknown Knowns’ in Fragment Screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2844</span>– <span class="NLM_lpage">2852</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1016%2Fj.bmcl.2013.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=23562240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltlOns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2844-2852&author=B.+J.+Davisauthor=D.+A.+Erlanson&title=Learning+from+Our+Mistakes%3A+The+%E2%80%99Unknown+Knowns%E2%80%99+in+Fragment+Screening&doi=10.1016%2Fj.bmcl.2013.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from our mistakes: The 'unknown knowns' in fragment screening</span></div><div class="casAuthors">Davis, Ben J.; Erlanson, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2844-2852</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past 15 years, fragment-based lead discovery (FBLD) has been adopted widely throughout academia and industry.  The approach entails discovering very small mol. fragments and growing, merging, or linking them to produce drug leads.  Because the affinities of the initial fragments are often low, detection methods are pushed to their limits, leading to a variety of artifacts, false positives, and false negatives that too often go unrecognized.  This Digest discusses some of these problems and offers suggestions to avoid them.  Although the primary focus is on FBLD, many of the lessons also apply to more established approaches such as high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfFRxp9cNiurVg90H21EOLACvtfcHk0lgy07otV65SzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltlOns7s%253D&md5=823da57ab8f5c433e4a123bebf16666f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DB.%2BJ.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26atitle%3DLearning%2520from%2520Our%2520Mistakes%253A%2520The%2520%25E2%2580%2599Unknown%2520Knowns%25E2%2580%2599%2520in%2520Fragment%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2844%26epage%3D2852%26doi%3D10.1016%2Fj.bmcl.2013.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Firth, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2516</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/ci300293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2516-2525&author=N.+C.+Firthauthor=N.+Brownauthor=J.+Blagg&title=Plane+of+Best+Fit%3A+A+Novel+Method+to+Characterize+the+Three-Dimensionality+of+Molecules&doi=10.1021%2Fci300293f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules</span></div><div class="casAuthors">Firth, Nicholas C.; Brown, Nathan; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2516-2525</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a computational method, plane of best fit (PBF), to quantify and characterize the 3D character of mols.  This method is rapid and amenable to anal. of large diverse data sets.  We compare PBF with alternative literature methods used to assess 3D character and apply the method to diverse data sets of fragment-like, drug-like, and natural product compd. libraries.  We show that exemplar fragment libraries underexploit the potential of 3D character in fragment-like chem. space and that drug-like mols. in the libraries examd. are predominantly 2D in character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszhZRQVuP0LVg90H21EOLACvtfcHk0ljoMEts476MAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rt7zP&md5=747bb9c5fb38eb34af4e1047f83633e8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fci300293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300293f%26sid%3Dliteratum%253Aachs%26aulast%3DFirth%26aufirst%3DN.%2BC.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DPlane%2520of%2520Best%2520Fit%253A%2520A%2520Novel%2520Method%2520to%2520Characterize%2520the%2520Three-Dimensionality%2520of%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2516%26epage%3D2525%26doi%3D10.1021%2Fci300293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">The ’Rule of Three’ for Fragment-Based Drug Discovery: Where Are We Now?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1038/nrd3926-c1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fnrd3926-c1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=23845999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ks7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=644-645&author=H.+Jhotiauthor=G.+Williamsauthor=D.+C.+Reesauthor=C.+W.+Murray&title=The+%E2%80%99Rule+of+Three%E2%80%99+for+Fragment-Based+Drug+Discovery%3A+Where+Are+We+Now%3F&doi=10.1038%2Fnrd3926-c1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The 'rule of three' for fragment-based drug discovery: where are we now?</span></div><div class="casAuthors">Jhoti, Harren; Williams, Glyn; Rees, David C.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The value of using the RO3 in FBDD is being (correctly) challenged as many useful fragment hits do not adhere to its restrictions (see the Practical Fragments blog website).  We have always believed that the RO3 concept has limitations and, like other rules related to desirable physicochem. properties, such as the 'rule of five' guidelines, it is simply a guideline that should not be overemphasized.  Nevertheless, we believe that the RO3 has been useful in ensuring that fragment libraries really do consist of compds. with fragment-like properties, although reports of 'fragment' hits that actually resemble lead-like compds. - particularly considering their substantial mol. mass - do still appear.  The fundamental concept of fragment screening is to use simpler mols. so that the chem. space can be sampled much more efficiently than is possible when using mols. of greater complexity.  One consequence of screening smaller, simpler fragments is that their affinity is expected to be relatively low (>1 mM), given the limited nos. of potential interactions that they can make with the protein.  Although weak in potency, fragment hits make high-quality interactions with the protein as they must overcome a substantial entropic barrier to binding, relative to their size.  The detection of low-potency fragment hits presents substantial tech. challenges, but to avoid these challenges and succumb to the temptation to screen larger, more complex mols. runs counter to the whole raison d'être of fragment screening.  We now have experience of over 30 fragment screens against a broad range of protein classes, and our results support the view that less complex mols. give a higher hit rate.  Consequently, our fragment library now almost exclusively contains mols. with fewer than 17 non-hydrogen atoms (mol. mass <230 Da).  As such, we believe the RO3 concept has assisted in limiting the mol. complexity in our fragment libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Jd0pJhvtnbVg90H21EOLACvtfcHk0ljoMEts476MAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ks7zP&md5=36ee69ae9c183b59da9afb8cb07c2c48</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnrd3926-c1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3926-c1%26sid%3Dliteratum%253Aachs%26aulast%3DJhoti%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DThe%2520%25E2%2580%2599Rule%2520of%2520Three%25E2%2580%2599%2520for%2520Fragment-Based%2520Drug%2520Discovery%253A%2520Where%2520Are%2520We%2520Now%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D644%26epage%3D645%26doi%3D10.1038%2Fnrd3926-c1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand Efficiency Metrics Considered Harmful</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9757-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1007%2Fs10822-014-9757-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=24899110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2ksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=699-710&author=P.+W.+Kennyauthor=A.+Leitaoauthor=C.+A.+Montanari&title=Ligand+Efficiency+Metrics+Considered+Harmful&doi=10.1007%2Fs10822-014-9757-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency metrics considered harmful</span></div><div class="casAuthors">Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ligand efficiency metrics are used in drug discovery to normalize biol. activity or affinity with respect to physicochem. properties such as lipophilicity and mol. size.  This Perspective provides an overview of ligand efficiency metrics and summarizes thermodn. of protein-ligand binding.  Different classes of ligand efficiency metric are critically examd. and the study concludes with suggestions for alternative ways to account for physicochem. properties when prioritizing and optimizing leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWFJmrjl6YXrVg90H21EOLACvtfcHk0ljoMEts476MAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2ksLw%253D&md5=48885bcd2fcc646577ef78a5e7037494</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9757-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9757-8%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520Efficiency%2520Metrics%2520Considered%2520Harmful%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D699%26epage%3D710%26doi%3D10.1007%2Fs10822-014-9757-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of Ligand Efficiency Metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+Ligand+Efficiency+Metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0ljoMEts476MAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520Ligand%2520Efficiency%2520Metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4611-4625&author=E.+Tamaniniauthor=I.+M.+Buckauthor=G.+Chessariauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=M.+Fredericksonauthor=C.+M.+Griffiths-Jonesauthor=K.+Hearnauthor=T.+D.+Heightmanauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsher&title=Discovery+of+a+Potent+Nonpeptidomimetic%2C+Small-Molecule+Antagonist+of+Cellular+Inhibitor+of+Apoptosis+Protein+1+%28cIAP1%29+and+X-Linked+Inhibitor+of+Apoptosis+Protein+%28XIAP%29&doi=10.1021%2Facs.jmedchem.6b01877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Tamanini, Emiliano; Buck, Ildiko M.; Chessari, Gianni; Chiarparin, Elisabetta; Day, James E. H.; Frederickson, Martyn; Griffiths-Jones, Charlotte M.; Hearn, Keisha; Heightman, Tom D.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP and cIAP1 are members of the inhibitor of apoptosis protein (IAP) family and are key regulators of anti-apoptotic and pro-survival signaling pathways.  Overexpression of IAPs occurs in various cancers and has been assocd. with tumor progression and resistance to treatment.  Structure-based drug design (SBDD) guided by structural information from X-ray crystallog., computational studies, and NMR soln. conformational anal. was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chem. probe for IAP biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIPJYPfW1ubVg90H21EOLACvtfcHk0lgtb9z5b4jFLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D&md5=2e00e53298df3ebe16bc02ad7cd7bf65</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01877%26sid%3Dliteratum%253Aachs%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Nonpeptidomimetic%252C%2520Small-Molecule%2520Antagonist%2520of%2520Cellular%2520Inhibitor%2520of%2520Apoptosis%2520Protein%25201%2520%2528cIAP1%2529%2520and%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4611%26epage%3D4625%26doi%3D10.1021%2Facs.jmedchem.6b01877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millemaggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7314</span>– <span class="NLM_lpage">7329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7314-7329&author=C.+N.+Johnsonauthor=J.+S.+Ahnauthor=I.+M.+Buckauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=A.+Hopkinsauthor=S.+Howardauthor=E.+J.+Lewisauthor=V.+Martinsauthor=A.+Millemaggiauthor=J.+M.+Munckauthor=L.+W.+Pageauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+Saxtyauthor=T.+Smythauthor=N.+T.+Thompsonauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=G.+Chessari&title=A+Fragment-Derived+Clinical+Candidate+for+Antagonism+of+X-Linked+and+Cellular+Inhibitor+of+Apoptosis+Proteins%3A+1-%286-%5B%284-Fluorophenyl%29methyl%5D-5-%28hydroxymethyl%29-3%2C3-dimethyl-1+H%2C2+H%2C3+H-pyrrolo%5B3%2C2-+b%5Dpyridin-1-yl%29-2-%5B%282+R%2C5+R%29-5-methyl-2-%28%5B%283R%29-3-methylmorpholin-4-yl%5Dmethyl%29piperazin-1-yl%5Dethan-1-one+%28ASTX660%29&doi=10.1021%2Facs.jmedchem.8b00900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span></div><div class="casAuthors">Johnson, Christopher N.; Ahn, Jong Sook; Buck, Ildiko M.; Chiarparin, Elisabetta; Day, James E. H.; Hopkins, Anna; Howard, Steven; Lewis, Edward J.; Martins, Vanessa; Millemaggi, Alessia; Munck, Joanne M.; Page, Lee W.; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Saxty, Gordon; Smyth, Tomoko; Thompson, Neil T.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7314-7329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are promising anticancer targets, given their roles in the evasion of apoptosis.  Several peptidomimetic IAP antagonists, with inherent selectivity for cellular IAP (cIAP) over X-linked IAP (XIAP), have been tested in the clinic.  A fragment screening approach followed by structure-based optimization has previously been reported that resulted in a low-nanomolar cIAP1 and XIAP antagonist lead mol. with a more balanced cIAP-XIAP profile.  We now report the further structure-guided optimization of the lead, with a view to improving the metabolic stability and cardiac safety profile, to give the nonpeptidomimetic antagonist clin. candidate (ASTX660), currently being tested in a phase 1/2 clin. trial (NCT02503423).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBj2OOs5EG-7Vg90H21EOLACvtfcHk0lgtb9z5b4jFLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P&md5=9c7ca5775f42441c971ad8459bb129c2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00900%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DHopkins%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMillemaggi%26aufirst%3DA.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DA%2520Fragment-Derived%2520Clinical%2520Candidate%2520for%2520Antagonism%2520of%2520X-Linked%2520and%2520Cellular%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%253A%25201-%25286-%255B%25284-Fluorophenyl%2529methyl%255D-5-%2528hydroxymethyl%2529-3%252C3-dimethyl-1%2520H%252C2%2520H%252C3%2520H-pyrrolo%255B3%252C2-%2520b%255Dpyridin-1-yl%2529-2-%255B%25282%2520R%252C5%2520R%2529-5-methyl-2-%2528%255B%25283R%2529-3-methylmorpholin-4-yl%255Dmethyl%2529piperazin-1-yl%255Dethan-1-one%2520%2528ASTX660%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7314%26epage%3D7329%26doi%3D10.1021%2Facs.jmedchem.8b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span>Sosei
Heptares <a href="https://soseiheptares.com/our-pipeline/rd-pipeline/in-house-programs.html" class="extLink">https://soseiheptares.com/our-pipeline/rd-pipeline/in-house-programs.html</a> (accessed Nov 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sosei%0AHeptares+https%3A%2F%2Fsoseiheptares.com%2Four-pipeline%2Frd-pipeline%2Fin-house-programs.html+%28accessed+Nov+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tron, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricks, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Mcl-1-Specific Inhibitor AZD5991 and Preclinical Activity in Multiple Myeloma and Acute Myeloid Leukemia</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5341</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07551-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=10.1038%2Fs41467-018-07551-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=30559424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5341&author=A.+E.+Tronauthor=M.+A.+Belmonteauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+H.+Boiseauthor=E.+Chiarparinauthor=J.+Cidadoauthor=K.+J.+Embreyauthor=E.+Ganglauthor=F.+D.+Gibbonsauthor=G.+P.+Gregoryauthor=D.+Hargreavesauthor=J.+A.+Hendricksauthor=J.+W.+Johannesauthor=R.+W.+Johnstoneauthor=S.+L.+Kazmirskiauthor=J.+G.+Kettleauthor=M.+L.+Lambauthor=S.+M.+Matulisauthor=A.+K.+Nookaauthor=M.+J.+Packerauthor=B.+Pengauthor=P.+B.+Rawlinsauthor=D.+W.+Robbinsauthor=A.+G.+Schullerauthor=N.+Suauthor=W.+Yangauthor=Q.+Yeauthor=X.+Zhengauthor=J.+P.+Secristauthor=E.+A.+Clarkauthor=D.+M.+Wilsonauthor=S.+E.+Fawellauthor=A.+W.+Hird&title=Discovery+of+Mcl-1-Specific+Inhibitor+AZD5991+and+Preclinical+Activity+in+Multiple+Myeloma+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fs41467-018-07551-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span></div><div class="casAuthors">Tron, Adriana E.; Belmonte, Matthew A.; Adam, Ammar; Aquila, Brian M.; Boise, Lawrence H.; Chiarparin, Elisabetta; Cidado, Justin; Embrey, Kevin J.; Gangl, Eric; Gibbons, Francis D.; Gregory, Gareth P.; Hargreaves, David; Hendricks, J. Adam; Johannes, Jeffrey W.; Johnstone, Ricky W.; Kazmirski, Steven L.; Kettle, Jason G.; Lamb, Michelle L.; Matulis, Shannon M.; Nooka, Ajay K.; Packer, Martin J.; Peng, Bo; Rawlins, Philip B.; Robbins, Daniel W.; Schuller, Alwin G.; Su, Nancy; Yang, Wenzhan; Ye, Qing; Zheng, Xiaolan; Secrist, J. Paul; Clark, Edwin A.; Wilson, David M.; Fawell, Stephen E.; Hird, Alexander W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5341</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers.  High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 inhibitors as anticancer drugs.  Here, we describe AZD5991, a rationally designed macrocyclic mol. with high selectivity and affinity for Mcl-1 currently in clin. development.  Our studies demonstrate that AZD5991 binds directly to Mcl-1 and induces rapid apoptosis in cancer cells, most notably myeloma and acute myeloid leukemia, by activating the Bak-dependent mitochondrial apoptotic pathway.  AZD5991 shows potent antitumor activity in vivo with complete tumor regression in several models of multiple myeloma and acute myeloid leukemia after a single tolerated dose as monotherapy or in combination with bortezomib or venetoclax.  Based on these promising data, a Phase I clin. trial has been launched for evaluation of AZD5991 in patients with hematol. malignancies (NCT03218683).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLv1vdwF2TY7Vg90H21EOLACvtfcHk0lh1cuxEwo8vOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK&md5=10ccf1fda947aca212bede3927eaabfa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07551-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07551-w%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DA.%2BE.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHendricks%26aufirst%3DJ.%2BA.%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DKazmirski%26aufirst%3DS.%2BL.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMatulis%26aufirst%3DS.%2BM.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobbins%26aufirst%3DD.%2BW.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DClark%26aufirst%3DE.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DHird%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520Mcl-1-Specific%2520Inhibitor%2520AZD5991%2520and%2520Preclinical%2520Activity%2520in%2520Multiple%2520Myeloma%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D5341%26doi%3D10.1038%2Fs41467-018-07551-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01581&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-9%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01581%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01581" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a97110cc03d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
